

























































Cover image: Immunofluorescence image assessing direct contact effects on viability 
(Biodentine on osteoblasts) and analysis of X-ray diffraction pattern of cement powder 
(Medcem). 
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The scientific man does not aim at an immediate result. He does not expect that his advanced 
ideas will be readily taken up. His work is like that of the planter - for the future. His duty is to lay 
the foundation for those who are to come, and point the way. 
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Egyptian, Greek and Roman civilizations used slaked lime (calcium hydroxide) mixed with a fine 
form of silica, a mixture denoted as pozzolanic cement. Gradually pozzolanic cements were 
replaced by hydraulic Portland cement invented in 1824 by Joseph Aspin. Portland cements differ 
from pozzolanic cements by using pre-reacted hydraulic calcium silicate powders rather than 
hydration of calcium oxide or calcium hydroxide with silica. Hydraulic cements not only harden by 
reacting with water but also forms a water resistant product. The major phases of Portland cement 
are tricalcium silicate, dicalcium silicate, tricalcium aluminate and a ferrite phase. Tricalcium 
silicate and dicalcium silicate together make up 75-80% of Portland cement. In the presence of a 
limited amount of water, the reaction of tricalcium silicate with water is represented in Equation 1. 
The chemical equation is somewhat approximate because it is not easy to estimate the 
composition of C-S-H (Calcium Silicate Hydrate). The stoichiometry of C-S-H in cement paste is 
variable and the state of chemically and physically bound water in its structure is not transparent, 
which is why "-" is used between C, S, and H. 
 
2[3CaO.SiO2] + 7H20 → 3Ca0.2SiO2.4H2O + 3Ca(OH)2 …………………………………………….[1]  
 
The first reported use of Portland cement in dentistry was in 1878 to fill root canals and to treat 
vital pulp tissue (Witte, 1878). Unfortunately, the use of this material has since not been pursued. 
About a century later, Mineral Trioxide Aggregate (MTA) was introduced in the year 1993 by Dr. 
Mahmoud Torabinejad and Dean White. The hydraulic ProRoot® MTA (Dentsply, Tulsa Dental 
Specialities, Tulsa OK, USA) was initially marketed as a calcium phosphate cement but was 
composed of Portland cement and bismuth oxide in 1:4 proportions, added as radiopacifier. 
Radiopacifiers are added to dental cements to impart radiopacity to distinguish dental restorative 
materials from other surrounding structures.  
 
Formocresol, ferric sulphate, zinc oxide eugenol, iodoform and calcium hydroxide are a few 
pulpotomy medication   that were used before the era of tricalcium silicates in dentistry. However, 
after the introduction of tricalcium silicate based cements, namely MTA, the use of these cements 
have been reduced owing to the excellent biocompatibility and bioactivity potential to induce 
mineralized tissues formation when immersed in phosphate-containing solution. MTA has been 
used in dentistry for pulp capping, pulpotomy, retrograde obturation, apexification, internal or 




successful endodontic cement in all the above mentioned applications, several drawbacks such 
as difficult handling, long setting time, possible coronal discolouration if used in the visible crown 
area, and lower compressive and flexural strength than dentine have also been reported (Parirokh 
& Torabinejad 2010).  
 
To overcome the disadvantages of ProRoot® MTA, many different formulations have been 
commercially manufactured. The main changes introduced were modification of cement 
formulation, alternative radiopacifiers, introduction of additives and minimizing particle size. The 
challenge lied in effectively introducing these modifications without diminishing the advantages of 
ProRoot® MTA. The first formulation, which included all the above modifications was marketed as 
Biodentine™ (Septodont, St Maur de Fosses, France). In the recent years, numerous commercial 
tricalcium silicate based cements which exhibit similar components to the original MTA 
composition are available in the market. Hence, it has become a necessity to propose a 





A classification system of all the commercial calcium silicate based cements available in the 
market has been proposed based on their composition (refer Table 1.2.1). Group 1 cements 
consist of those with composition similar to that of ProRoot® MTA. These endodontic cements are 
Portland cement based with bismuth oxide as radiopacifier. Group II cements are also Portland 
cement based but contain radiopacifiers other than bismuth oxide. Both Group I and Group II 
cements are manufactured from type 1 Portland cement. Theracal in Group II is an exception as 
it is manufactured from type 3 Portland cement. Type 3 Portland cement has a relatively higher 
early strength and is composed of finer particles ground to a specific surface area, typically 50–
80% higher than type 1 Portland cement. Group III cements claim to consist of synthetic tricalcium 
silicate cement manufactured by sol-gel process and hence claim to be devoid of heavy metal 
contamination unlike Portland cement based formulations. The cements in this group are believed 
to be alumina free. Group IV consists of cements with composition and manufacturing process 
similar to Group III but devoid of dicalcium silicate. They contain only tricalcium silicate as their 
main ingredient. Group V cements are quite different from the previous groups as they contain 
calcium silicate based formulations other than tri-/dicalcium silicate. These cements are based on 




Majority of the chapters presented in this thesis shall compare one representative cement from 
Group I (ProRoot® MTA), Group II (Medcem® MTA) and Group IV (Biodentine™) with specific 
interest in the clinical efficiency of Biodentine™.  
 
No. Group Brand Name Radiopacifier Country 
I Portland cement based 
(Bismuth oxide as 
radiopacifier) 
ProRoot® MTA Bismuth oxide  USA 
MTA Angelus Bismuth oxide  Brazil 
Grey MTA Plus Bismuth oxide  USA 
Cerkamed MTA + Bismuth oxide  Poland 
MTA Bio Bismuth oxide  Brazil 
MicroMega MTA Bismuth oxide  France 
Nano modified MTA Bismuth oxide  USA 
Neo MTA Plus Bismuth oxide  USA 
EndoCem MTA Bismuth oxide  Korea 
Ortho MTA Bismuth oxide  Korea 
Zendo MTA universal Bismuth oxide  Switzerland 
Zendo MTA firm Fast set Bismuth oxide  Switzerland 
Zendo MTA firm Normal 
set 
Bismuth oxide  Switzerland 
Zendo MTA flow fast set Bismuth oxide  Switzerland 
Trioxident Bismuth oxide Russia 
NEX MTA Bismuth oxide Japan 
Viscosity Enhanced 
Root Repair Material 
(VERRM) 
Bismuth oxide Singapore 
ProRoot® Endo Bismuth oxide  USA 
MTA Filla apex Bismuth oxide  Brazil 
F doped MTA (FMTA) Bismuth oxide Italy 
MTA Obtura Bismuth oxide Brazil 
Endoseal MTA Bismuth oxide  Korea 
Endoseal Bismuth oxide  Korea 
II Portland cement based 
(Other radiopacifier) 
Retro MTA (Ortho MTA 
II) 
Zirconium oxide Korea 
EndoCem Zr Zirconium oxide  Korea 
Medcem MTA® Zirconium oxide Switzerland 
MTA Caps Calcium tungstate  France 
Endo CPM Barium sulfate  Argentina 
Neo MTA Tantalum 
pentoxide 
USA 









Barium sulphate  Brazil 
Endo CPM Barium sulfate  Argentina 
MTA sealer (MTAS) Zirconium oxide Brazil 
Theracal  Barium zirconate USA 
III Tri/di-calcium silicate 
based  
(Aluminium free) 
I Root BP Zirconium oxide  Canada 
I Root BP Plus Zirconium oxide  Canada 
I Root BP FS  Zirconium oxide  Canada 
Bioaggregate Tantalum oxide  Canada 
Endosequence Root 











I Root SP Zirconium oxide  Canada 
Endosequence BC Zirconium oxide 
Tantalum oxide  
USA 
BioRoot RCS Zirconium oxide   France 
IV Tricalcium silicate 
based 
(Absence of dicalcium 
silicate) 
Biodentine™ Zirconium oxide France 
V Calcium silicate based 
(Absence of both 
tricalcium silicate and 
dicaclium silicate) 
TechBio Sealer Root 
end 
Bismuth oxide  Italy 
TechBio Sealer Capping None Italy 
TechBio Sealer Apex None Italy 
TechBio Sealer ENDO Bismuth oxide  Italy 
Legend: Sealer materials are shown in italics.  
 
Table 1.2.1: List of commercially available calcium silicate based bulk materials and sealers 
used in dentistry 
 
To obtain an overview of the existing literature, a narrative review of Biodentine™ was 
performed with the composition, physical and biological properties being compared to other 





1.3 Review of the literature 
 
The preservation and protection of dental pulp with specific emphasis on regeneration is the new 
research focus in the fields of paediatric dentistry, endodontics and dental traumatology. The use 
of hydraulic calcium silicate cement apparently stimulates pulpal cell recruitment and 
differentiation, up-regulates transformation factors (gene expression), and promotes 
dentinogenesis (Bogen and Chandler, 2012). Hydraulic calcium silicate cements are bioactive 
materials showing a dynamic interaction with dentine and pulp tissue interface (Gandolfi et al., 
2011). Improved knowledge at both biomaterial and cellular level has led to the development and 
modification of many new dental cements to achieve the aforementioned goals. 
 
Biodentine™ (Septodont Ltd., Saint Maur des Faussés, France) is a relatively new tricalcium 
silicate (Ca3SiO5) based inorganic restorative cement commercialized and advertised as 
‘bioactive dentine substitute’. The material is claimed to possess better physical and biological 
properties compared to other tricalcium silicate cements such as MTA.  
 
A concise review of a recently introduced material could help the clinician to make an informed 
choice. Based on available literature, the authors aim to provide an objective review as to whether 
Biodentine™ could be a suitable alternative to the existing range of tricalcium cements used in 
endodontics and dental traumatology. 
 
Materials and Methods 
 
A comprehensive literature search for publications from 1980 to 30th June 2016 was done by two 
independent reviewers (L.M and R.C) in Medline (PubMed), Embase, Web of Science, CENTRAL 
(Cochrane), System for Information on Grey Literature in Europe (SIGLE), SciELO, Scopus, Lilacs 
and clinicaltrials.gov using the search terms Biodentine, “tricalcium silicate”, Ca3SiO5, bioceramic, 
“dentine substitute”, “dentin substitute” and RD 94 (former name of Biodentine™). Randomised 
control trials (RCT), case control studies, case series, case reports, in vitro studies, animal studies 
and short communications in English language were considered for this review. Conference 
proceedings were excluded. The search was supplemented by checking citations of relevant 
articles and hand searching for articles published in journals not indexed in Medline. The 
electronic search resulted in 783 articles while hand search and citation search led to an additional 




The detailed search methodology and selection criteria are represented in Figure 1.3.1. Most of 




Figure 1.3.1: Overview of the search methodology and selection criteria. 
 
The present review is organized as follows. The composition and setting is briefly reviewed in 
Section I. Physical and mechanical properties are discussed in Section II and biological properties 







Section I: Composition and Setting 
 
Biodentine™ is a powder and liquid system where the powder is composed of tricalcium silicate 
(main component), calcium carbonate (filler material), zirconium oxide (radiopacifier), dicalcium 
silicate (traces), calcium oxide (traces), iron oxide (traces) and the liquid is an aqueous solution 
of a hydrosoluble polymer (water reducing agent) with calcium chloride (decreases the setting 
time) (Camilleri et al., 2013b).  
 
Septodont claims to use a new technological platform named ‘Active Biosilicate Technology™’ to 
control the purity of the raw materials. Manufacturing pure synthetic tricalcium silicate instead of 
purifying the natural tricalcium silicate is advantageous as the mineral content is not changed by 
the sintering conditions or variations in the chemical composition of the raw materials (Camilleri 
et al., 2013b). Moreover, synthetic tricalcium silicate does not contain heavy metals contrary to 
purified natural tricalcium silicate. This has been proved by analysis of acid extracts and leached 
species of Biodentine™ which demonstrated absence of heavy element contamination (Camilleri 
et al., 2012, Grech et al., 2013a). The use of pure synthetic tricalcium silicate instead of specific 
clinker has also been shown to be responsible for the enhanced material properties of 
Biodentine™ and Bioaggregate in comparison to MTA (Camilleri et al., 2013b). Portland cement 
clinker consists of tricalcium silicate, dicalcium silicate, tricalcium aluminate, calcium 
aluminoferrite and other trace components.  
  
Although tricalcium silicate appears to be a common ingredient in both MTA and Biodentine™, X-
ray diffractometry of unhydrated cements revealed that Biodentine™ consisted of triclinic form of 
tricalcium silicate while MTA consisted of the monoclinic form. The triclinic and monoclinic forms 
are two different crystal systems where all the axes are of different length. The difference between 
these crystal systems lie in the fact that in the triclinic form none of the axes meet at 90 degrees 
whereas in the monoclinic form, two of the axes meet at 90 degrees but the third one does not. 
Another difference would be the finer particle size of tricalcium silicate in Biodentine™ as shown 
by the greater value of specific surface area of Biodentine™ (2.811 m²/g) in comparison to that of 
MTA (1.0335 m²/g) (Camilleri et al., 2013b).  
 
The mixing of Biodentine™ powder and liquid results in a gel structure, allowing ionic exchanges 
and polymerisation over time to form a solid network. The reaction product consists of a 




oxide and the authors claim that calcium carbonate acts as a nucleation site  which allows the 
formation of reaction rims around it, thereby enhancing the hydration and producing a denser 
microstructure (Camilleri et al., 2013b, Grech et al., 2013a).  
 
The initial setting time according to the manufacturer of Biodentine™ is about 12 min. Setting of 
Biodentine™ is at least partially due to polymerization of the silicate phase to a Q2 chain-like 
structure, similar to that present in Portland cement but the setting kinetics are faster (12 minutes) 
in Biodentine™ (Goldberg et al., 2009). The initial setting time of Biodentine™ was evaluated to 
be 6.5±1.7 minutes (Butt et al., 2014) and 30±0 minutes (Alhodiry et al., 2014). The difference in 
the determined setting time may be explained by the different ISO standards used. According to 
the International Organization for Standardization guidelines, ISO 9917-1:2007, the setting time 
of Biodentine™ was assessed as 15±1 minutes (Jang et al., 2014) and 13.1±1.1 minutes (Dawood 
et al., 2014). In the study by Kaup et al., the final setting time of Biodentine™ was 85.66±6.03 
minutes (Kaup et al., 2015b) while another study assessed it to be 45 minutes (Grech et al., 
2013b). In all the studies, the setting time of Biodentine™ was significantly shorter than that of 
ProRoot® MTA. The short setting time of Biodentine™ compared to ProRoot® MTA could be 
explained by the absence of dicalcium silicate, which is known to be associated with a slower 
hydration reaction (Darvell and Wu, 2011). An initial volume reduction due to chemical contraction 
and capillary absorption occurs during the first hours followed by a secondary expansion due to 
continuation of the hydration process. 
 
The effect of saliva and blood contamination on the setting time of Biodentine™ was estimated 
by adding one drop of the contaminant to the cement before mixing. Both saliva and blood 
contamination, increased the setting time of Biodentine™ by 1±6.51 and 16±8.21 minutes 
respectively. While, the blood contaminated group showed a significantly longer setting time 
compared to the non-contaminated Biodentine™ group (p<0.01), there was no significant 
difference in the saliva-contaminated group (p>0.05) (Alhodiry et. al., 2014).  
 
The set Biodentine™ consists of 5 µm round particles embedded in a calcium silicate hydrate 
matrix (Camilleri, 2013). A dense microstructure is seen in set Biodentine™ as the porosity is 
almost filled by calcium silicate hydrate and calcium hydroxide. An isothermic calorimetry analysis 
performed at 37oC to follow the kinetics of hydration of the cement paste revealed the following; 
Biodentine™ paste displayed a narrow and intense exothermic peak after 30 minutes whereas 




that Biodentine™ has greater kinetics of hydration than pure tricalcium silicate. The early 
exothermic peak after 30 minutes is also an indicator of the rise of mechanical strength of the set 
Biodentine™ cement (Camilleri, 2013).  
 
Energy Dispersive X-ray spectroscopy (EDX) analysis of set Biodentine™ confirmed elemental 
peaks for calcium, silicon, carbon, oxygen, zirconium and chlorine with zirconium concentrated in 
specific areas while all other elements were equally distributed. ESEM-EDX analysis of 
unhydrated Biodentine™ powder revealed the elemental composition (wt%) as described by two 
studies (Gandolfi et al., 2015, Setbon et al., 2014). Carbon (4.34 & 9.7), Oxygen (42 & 38.5), 
Silicon (7.3 & 7.7), Calcium (39 & 41.9) and Zirconium (2.2 & 2.2) in wt% respectively.  
 
X-ray diffraction (XRD) analysis exhibited definite peaks for calcium silicate, calcium carbonate, 
zirconium oxide and calcium hydroxide with a wavy base line indicating the presence of an 
amorphous compound. Fourier transform infrared spectroscopy (FT-IR) analysis of set 
Biodentine™ showed peaks at 3400 (water or calcium  hydroxide), 700 and 1420 cm-1 (calcium 
carbonate) and an Si-O absorption band at 960 cm-1 referring to calcium silicate hydrate (Camilleri, 
2013).  
 
Section II: Physical and mechanical properties 
 
Table 1.3.1 summarises the physical and mechanical properties of Biodentine™ compared to 
other tricalcium silicate based cements. The radiopacity of Biodentine™ after immersion in Hanks 
balanced salt solution (HBSS) was 4.1/mmAl and 3.3/mmAl after 1 and 28 days respectively 
(Grech et al., 2013b). The radiopacity of Biodentine™ was found to be significantly lower than 
ProRoot® MTA (Kaup et al., 2015b), MTA Angelus, Micro Mega MTA (MM-MTA) (Tanalp et al., 
2013), MTA Plus and Neo MTA Plus (Camilleri, 2015). Furthermore, the radiopacity of 
Biodentine™ varied between studies and in some studies was lower than the requirement of ISO 
6876:2001 (Kaup et al., 2015b, Tanalp et al., 2013). In a cone-beam computer tomography study, 
Biodentine™ and MTA generated fewer artifacts than amalgam. It was concluded that the use of 
84 kVp or 96kVp with metal arifact reduction (MAR) and low resolution reduced artifacts and 
generated lowest effective dose (Helvacioglu-Yigit et al., 2016, Demirturk Kocasarac et al., 2016).  
 
Biodentine™ maintained colour stability of the crown for up to 6 months and exhibited significantly 




Ortho MTA (Shokouhinejad et al., 2016), gray MTA and white MTA (Kohli et al., 2015). Vallés et 
al. demonstrated the colour stability of Biodentine™ over time independent of oxygen and light 
irradiation thereby proving that the material is suitable for use under light-cured restorative 
materials in esthetically sensitive areas (Valles et al., 2013). The presence of bismuth oxide in 
the various MTA products were considered to be a significant contributor to discolouration 
(Marconyak et al., 2016).  On the contrary Beatty et al. concluded that Biodentine™ discoloured 
significantly more than ProRoot® MTA (Beatty and Svec, 2015). Clinically perceptible 
discolouration was observed with Biodentine™ in the presence of sodium hypochlorite (Keskin et 
al., 2015, Camilleri, 2015), chlorhexidine gluconate (Keskin et al., 2015) and blood 
(Shokouhinejad et al., 2016).  
 
Biodentine™ is reported to be denser and less porous when compared to MTA (Camilleri et al., 
2013b). Mean porosity percentage for Biodentine™ is 7.09 ± 1.87 while that of MTA is 6.65 ± 1.93 
(De Souza et al., 2013). In a similar study, Biodentine™ and ProRoot® MTA demonstrated lower 
average pore diameter, porosity, total pore area and higher bulk density when compared to 
Bioaggregate, MTA Angelus and MTA Plus (Camilleri et al., 2014a, Gandolfi et al., 2015). The 
difference in the chemical composition between Biodentine™ and ProRoot® MTA did not affect 
surface topography and both materials showed similar levels of surface roughness (Attik et al., 
2014). 
 
Compressive strength of Biodentine™ was consistently found to be significantly higher than MTA-
Angelus, trial MTA (GCMTA) and calcium-enriched mixture (Dawood et al., 2014, Natale et al., 
2015, Butt et al., 2014, Kayahan et al., 2013).  The compressive strength of Biodentine™ amounts 
to 10.6 ± 2, 57.1 ± 12 and 72.6 ± 8 MPa after 35 minutes, 24 hours and 28 days respectively 
(Grech et al., 2013b). The greater strength of Biodentine™ in comparison to other tricalcium 
silicate cements is attributed to the low water/cement ratio made possible by the water soluble 
polymer in the liquid.  
 
Exposure to different pH (4.4, 5.4, 6.4 and 7.4) environments for 7 days led to Biodentine™ 
displaying significantly higher compressive strength than white MTA (Elnaghy, 2014). In this 
study, white MTA appeared to be more sensitive to acidic pH than Biodentine™. On the other 
hand, another study showed that acid etching procedures after 7 days did not reduce the 




recommendations to delay the placement of final restoration for at least 1 week to achieve mature 
crystalline formations. 
 
Biodentine™ exhibited significantly higher hardness, flexural strength and elastic modulus than 
ProRoot® MTA, MTA Angelus and GCMTA (Dawood et al., 2014, Kaup et al., 2015b, Natale et 
al., 2015). The physical properties of Biodentine™ such as flexural strength (34 MPa), elastic 
modulus (22,000 MPa) and Vickers microhardness (60 HV) were identical to sound human 
dentine but more than 2-fold higher than that of ProRoot® MTA (Kaup et al., 2015b). Surface 
hardness of Biodentine™ was not affected by moist or dry storage environment (Caronna et al., 
2014) but decreased significantly in the presence of acidic pH (6.4, 5.4 and 4.4) (Elnaghy, 2014).  
Saliva and blood caused no significant difference in the bi-axial flexural strength of either 
Biodentine™ or Portland cement (Alhodiry et al., 2014). 
 
According to ISO 6876:2001, studies confirmed that Biodentine™ displayed solubility similar to 
ProRoot® MTA upto 10 day exposure times. Thereafter, Biodentine™ demonstrated a marked 
increase in solubility (Dawood et al., 2014, Singh et al., 2015, Kaup et al., 2015b). The greater 
solubility of Biodentine™ could be explained by the higher dissolution of calcium and silicium ions 
(Singh et al., 2015). Though Biodentine™ solubility values were higher than ProRoot® MTA, this 
solubility occurred only at the surface which is exposed to the solution and caused negligible 
dimensional change (Singh et al., 2015). The solubility of Biodentine™ was higher in distilled 
water than in phosphate buffered saline (PBS) (Kaup et al., 2015b). The increased solubility of 
Biodentine™ has been attributed to the use of water soluble polycarboxylate in the liquid 
component. This hydrosoluble polymer has a surfactant effect and thus leads to increased 
dissolution by applying a charge on their surfaces (Dawood et al., 2014). Conflicting results were 
obtained in the study by Gandolfi et al. with significantly lower solubility values for Biodentine™ 
compared to ProRoot® MTA, MTA Angelus and MTA Plus (Gandolfi et al., 2015).  
 
Biodentine™ exhibited the lowest fluid uptake and absorption in HBSS which were similar to IRM. 
Bioaggregate and Biodentine™, however, gained weight indicating the deposition of substance 
on the material when immersed in HBSS. There was no statistically significant difference between 
the weight gain of Biodentine™ and Bioaggregate when immersed in HBSS (Grech et al., 2013b).  
 
Nine heavy metal ions released in distilled water (µg/L)  for 7 days were evaluated in the study by 




and zinc (91.7 ± 17.2) were released significantly higher in Biodentine™ than MTA and 
Bioaggregate. Cadmium (0.1 ± 01), chromium (46.2 ± 30.8), nickel (59.0 ± 58.3) and lead (1.1 ± 
0.3) release was also higher in Biodentine™ but without any significant difference in comparison 
to Bioaggregate and MTA (Jang et al., 2014). In another study, leaching of trace elements was 
found when Biodentine™ was stored in HBSS for a period of 28 days amounting to 0.06 mg/kg 
chromium, 0.19 mg/kg arsenic and 0.17 mg/kg lead. Similar amounts were found for Bioaggregate 
and MTA Angelus. Acid soluble trace element concentration was 4.50 mg/kg chromium; 52.25 
mg/kg arsenic and 14.50 mg/kg lead which was similar to the values found for Bioaggregate but 
higher than those for MTA Angelus. Although, the leaching in HBSS was minimal, the authors 
concluded that all three cements had a higher level of acid-extractable arsenic than the limit set 
by ISO 9917-1 (2007) (Camilleri et al., 2012). The higher heavy metal release in Biodentine™ 
could be correlated to increased solubility.  
 
The amount of calcium ions released from Biodentine™ immersed in distilled water is 0.598 ± 
0.132, 0.848 ± 0.086, 0.689 ± 0.041 and 0.367 ± 0.05 mM at 5, 5-24, 24-48 and 144 –168 hours 
respectively. The depth of incorporation of calcium into human root canal dentine amounts to 39 
± 8.2, 74 ± 18.8, 118 ± 11.5 and 166 ± 22.5 µm after 1, 7, 30 and 90 days respectively and the 
values for the incorporation of silicon are 32 ± 14.8, 46 ± 12.9, 86 ± 9.6,130 ± 12.7 µm after 1, 7, 
30 and 90 days respectively (Han & Okiji, 2013). At all time periods, the amount of calcium ions 
released as well as the depth of incorporation into human root canal dentine were significantly 
higher than those found for MTA (Han & Okiji, 2011). Along with calcium and silicon, intertubular 
diffusion of carbonate occurred from Biodentine™ into dentine, leading to the formation of the 
“mineral infiltration zone” (Atmeh et al., 2012). The latter indicates that the dentine-Biodentine™ 
interface is highly dynamic and interactive.  
 
Biodentine™ released significantly more calcium ions than MTA Angelus and GCMTA after 1, 3, 
7 and 14 days (Dawood et al., 2014). In a similar study, Biodentine™ showed significantly higher 
calcium ion release at short-term (3 hours) than ProRoot® MTA, MTA Angelus and MTA Plus but 
in the long-term (28 days) calcium ion release from Biodentine™ was significantly higher than 
MTA Plus alone (Gandolfi et al., 2015). Biodentine™ released more calcium ions in the early 
stages and the calcium ion release at 1 month was significantly lower than at 1 day (Li et al., 
2016). The higher calcium ion release from Biodentine™ could be attributed to the presence of 
pure tricalcium silicate, calcium chloride, increased calcium hydroxide formation and high 




When comparing calcium ion release in pH 5.5 and pH 7.0, Biodentine™ released significantly more calcium at neutral pH (Natale et 
al., 2015). In an attempt to compare the effect of leaching in different soaking solutions, it was found that Biodentine™ leached more 
calcium ions in HBSS than in distilled water (Camilleri, 2014). Also, Biodentine™ induced a rise in pH of the soaking water indicating 
alkalinization (Gandolfi et al., 2015). 
 
The pH of the leachate when set Biodentine™ was stored in deionized water is recorded as 9.14 ± 0.16, 8.88 ± 0.27 and 8.02 ± 0.19 
at 3 hours, 1 day and 1 week respectively (Khan et al., 2012). In another study where the pH of the leachate in HBSS was measured, 
the pH was recorded as 11.7, 12.1, 12.3, 12.4 and 12.3 at 1, 7, 14, 21 and 28 days respectively confirming the alkalinity of the cement. 
The pH of Biodentine™ is similar to that of Bioaggregate and IRM (Grech et al., 2013a). 
 
In an analysis of the sealing ability by fluid-filtration technique, Biodentine™ provided a valid and stable apical seal for the entire 12 
week period tested. At 4 and 24 hour period Biodentine™ provided a seal similar to ProRoot® MTA, Grey Portland cement and Tech 
Biosealer (El-Khodary et al., 2015, Bani et al., 2015) but significantly superior than MTA Angelus (Butt et al., 2014). Better adhesion of 
Biodentine™ to dentine may result from the physical process of crystal growth within the dentinal tubules leading to micromechanical 
bonding (Naik et al., 2015).  
 
Material characteristics Time 
period 
Biodentine™ Other tricalcium silicate cement groups in 
the study 
Reference 
Initial setting time (min)  6.5 ± 1.7 MTA Angelus (8.5 ± 2.4) Butt et al., (2014) 
Initial Setting time (min)  30 ± 0 Portland cement (74 ± 5.47) Alhodiry et al., 
(2014) Initial setting time in saliva (min)  31 ± 6.51 Portland cement (108 ± 4.47) 
Initial setting time in blood (min)  46 ± 8.21 Portland cement (114 ± 5.47) 
Final setting time (min)  85.66 ± 6.03 ProRoot® MTA (228.33 ± 2.88) Kaup et al., (2015) 
Final setting time (min)  45 Bioaggregate (1260) Grech et al., (2013b) 
Setting time (min)  15 ± 1 MTA (275 ± 15) 
Bioaggregate (385 ± 20) 




Setting time (min)  13.1 ± 1.1 MTA Angelus (20.7 ± 2.6) 
GC MTA (233 ± 11.8) 
Dawood et al., 
(2015) 
Compressive strength (MPa) at pH 7.4 7 days 95.2 ± 9.3 White MTA Angelus (71.0 ± 6.9) Elnaghy et al., 
(2014) Compressive strength (MPa) at pH 6.4 7 days 81.4 ± 7.7 White MTA Angelus (60.1 ± 5.1) 
Compressive strength (MPa) at pH 5.4 7 days 73.6 ± 6.6 White MTA Angelus (53.4 ± 4.7) 
Compressive strength (MPa) at pH 4.4 7 days 58.8 ± 4.8 White MTA Angelus (31.6 ± 2.4) 
Compressive strength (MPa) 2 days 
7 days 
45.1 ± 12.5 
49.1 ± 2.6 
MTA Angelus (16.1 ± 5.0) 
MTA Angelus (18.0 ± 6.5) 
Natale et al., (2014) 





61.35 ± 5.09 
 
62.57 ± 3.75 
 
62.64 ± 0.07 
MTA (36.67 ± 2.95) 
Bioaggregate (17.65 ± 8.61) 
MTA (48.51 ± 3.63) 
Bioaggregate (20.52 ± 3.02) 
MTA (57.51 ± 2.16) 
Bioaggregate (22.03 ± 0.11) 
Jang et al., (2014) 




139.5 ± 1.19 
170.78 ± 1.14 
269.08 ± 1.07 
304.78 ± 2.59 
MTA Angelus (0) 
MTA Angelus (41.51 ± 1.41) 
MTA Angelus (91.35 ± 0.93) 
MTA Angelus (76.82 ± 2.91) 
Butt et al., (2014) 
Compressive strength (MPa) 7 days 78.5 ± 3.8 MTA Angelus (46.4 ± 2.8) 
GC MTA (44.1 ± 2.3) 
Dawood et al., 
(2015) 
Compressive strength (MPa) 28 days 67.18 Bioaggregate (16.34) Grech et al., (2013b) 
Vickers hardness  (HV) 28 days 48.4 Bioaggregate (10.7) 
Vickers hardness testing at 2mm (N/mm2) 10 days 47.59 ± 11.55 ProRoot® white MTA (87.36 ± 18.80) 
ESRRM (31.73 ± 9.69) 
Caronna  et al., 
(2014) 
Vickers hardness testing at 4mm (N/mm2) 10 days 50.61 ± 12.91 ProRoot® white MTA (99.82 ± 17.20) 
ESRRM (58.92 ± 33.54) 
Microhardness (VHN) at pH 7.4 7 days 58.9 ± 3.5 White MTA Angelus (44.4 ± 3.9) Elnaghy et al., 
(2014) Microhardness (VHN) at pH 6.4 7 days 47.6 ± 3.0 White MTA Angelus (35.9 ± 2.9) 
Microhardness (VHN) at pH 5.4 7 days 43.7 ± 2.1 White MTA Angelus (31.2 ± 1.7) 
Microhardness (VHN) at pH 4.4 7 days 26.1 ± 1.9 White MTA Angelus (16.3 ± 1.4) 




Surface microhardness (VHN, kg/mm2) 7 days 45.4 ± 2.4 MTA Angelus (32.7 ± 1) 
GC MTA (32.4 ± 1.5) 
Dawood et al., 
(2015) 
Radiopacity (/mmAl)  2.8 ± 0.48 MTA Angelus (4.72 ± 0.45) 
MM-MTA (5.18 ± 0.51) 
Tanalp et al., (2013) 
Radiopacity (/mmAl)  1.5 ± 0.10 ProRoot® MTA (6.40 ± 0.06) Kaup et al., (2015) 
Radiopacity (/mmAl)  3.1 MTA Plus (4.5) 
Neo MTA Plus (5.0) 
Camilleri et al., 
(2015) 






Grech et al., (2013b) 
Mean value of artifact  274.7 MTA (290.3) Helvacioglu-Yigit et 
al., (2016) 
Solubility in distilled water (%) 1 day 11.83 ± 0.52 MTA Plus (18.55 ± 0.77) 
MTA Plus + gel (14.68 ± 3.62) 
MTA Angelus (29.55 ± 2.35) 
ProRoot® MTA (10.89 ± 0.48) 
Tech Biosealer capping (27.87 ± 1.13) 
Theracal (2.75 ± 1.04) 
Gandolfi et al., 
(2014) 











0.252 ± 0.100 
0.999 ± 0.202 
1.437 ± 0.426 
2.647 ± 0.583 
3.700 ± 0.782 
4.610 ± 1.402 
ProRoot® MTA (0.026 ± 0.017) 
ProRoot® MTA (0.247 ± 0.114) 
ProRoot® MTA (0.763 ± 0.235) 
ProRoot® MTA (0.880 ± 0.237) 
ProRoot® MTA (0.940 ± 0.516) 
ProRoot® MTA (1.144 ± 0.328) 
Kaup et al., (2015) 
Solubility in distilled water (%)  5.4 ± 0.6 MTA Angelus (0.6 ± 0.1) 
GC MTA (1.4 ± 0.1) 
Dawood et al., 
(2015) 





2.74 ± 0.002 
2.74 ± 0.002 
2.90 ± 0.004 
3.97 ± 0.005 
6.86 ± 0.002 
ProRoot® MTA (2.38 ± 0.002) 
ProRoot® MTA (2.38 ± 0.002) 
ProRoot® MTA (2.38 ± 0.002) 
ProRoot® MTA (2.56 ± 0.005) 
ProRoot® MTA (2.56 ± 0.005) 
Singh et al., (2015) 









0.253 ± 0.144 
1.367 ± 0.264 
3.415 ± 0.684 
3.274 ± 1.075 
-0.053 ± 0.669 
ProRoot® MTA (0.077 ± 0.074) 
ProRoot® MTA (-0.688 ± 0.098) 
ProRoot® MTA (-2.871 ± 0.256) 
ProRoot® MTA (-5.187 ± 1.019) 
ProRoot® MTA (-5.383 ± 0.501) 
Water sorption (%) 1 day 12.60 ± 0.15 MTA Plus (24.87 ± 1.45) 
MTA Plus + gel (26.46 ± 6.25) 
MTA Angelus (37.02 ± 5.36) 
ProRoot® MTA (14.73 ± 0.52) 
Tech Biosealer capping (36.67 ± 2.74) 
Theracal (13.96 ± 1.56) 
Gandolfi et al., 
(2014) 

















Grech et al., (2013b) 
 
Sorption (%) (stored in HBSS for 28 days)  0.007 Bioaggregate (0.024) 
Weight loss (%) (stored in HBSS for 28 days)  - 0.002 Bioaggregate (- 0.0025) 
Percentage  washout  by  mass  of  the  test  
materials  following 1st drop 
(stored in HBSS for 28 days) 
 23.3537 Bioaggregate (4.6856) 
Percentage  washout  by  mass  of  the  test  
materials  following 2nd drop 
(stored in HBSS for 28 days) 
 41.2466 Bioaggregate (6.6855) 
Percentage  washout  by  mass  of  the  test  
materials  following 3rd drop 
(stored in HBSS for 28 days) 
 50.5970 Bioaggregate (8.0772) 




1.600 ± 0.512 
 
 
1.737 ± 0.434 
Biodentine™ + Prime & Bond NT (9.127 ± 
3.161) 
Biodentine™ + Clearfil SE Bond (16.903 ± 
8.112) 





Biodentine™ + Clearfil S3 Bond (11.057 ± 
3.850) 
Biodentine™ + Prime & Bond NT (15.990 ± 
3.409) 
Biodentine™ + Clearfil SE Bond (19.559 ± 
7.582) 
Biodentine™ + Clearfil S3 Bond (15.193 ± 
3.344) 
Shear bond strength (MPa) 2 days 
7 days 
14 days 
3.14 ± 1.09 
9.75 ± 2.19 
9.34 ± 1.01 
ProRoot® MTA (0.0) 
ProRoot® MTA (0.85 ± 1.42) 
ProRoot® MTA (4.96 ± 4.54) 
Kaup et al., (2015) 
Mean shear bond strength (MPa) in 
permanent teeth 
 3.441 ± 1.953   Agrafioti et al., 
(2015) 
Mean shear bond strength (MPa) in primary 
teeth 
 2.485 ± 1.151  
Microleakage (mm)  0.13 ± 0.006 MTA (0.73 ± 0.13) Kokate et al., (2012) 
Microleakage (µm) in interface exposed to 
normal saline 
 0.50 ± 0.76 ProRoot® MTA (0.81 ± 1.07) 
CEM (1.13 ± 0.88) 
Bioaggregate (0.66 ± 1.05) 
Bolhari et al., (2014) 
Microleakage (µm) in interface exposed to 
human blood 
 1.58 ± 1.31 ProRoot® MTA (1.36 ± 1.17) 
CEM (1.36 ± 1.08) 










0.268 ± 0.0054 
0.109 ± 0.0146 
0.052 ± 0.0236 
0.035 ± 0.0036 
0.017 ± 0.0026 
0.005 ± 0.0013 
0.005 ± 0.0005 
MTA Angelus (0.951 ± 0.064) 
MTA Angelus (0.499 ± 0.0469) 
MTA Angelus (0.070 ± 0.0035) 
MTA Angelus (0.050 ± 0.0021) 
MTA Angelus (0.024 ± 0.0029) 
MTA Angelus (0.006 ± 0.0006) 
MTA Angelus (0.005 ± 0.0013) 
Butt et al., (2014) 
Mean microleakage in permanent teeth  0.76 ± 0.83   Agrafioti et al., 




Microleakage (µm) 6 days  ProRoot® MTA + MTAD (1.021133 ± 
0.0648227) 
ProRoot® MTA + Saline (0.544600 ± 
0.0140173) 
Biodentine™ + MTAD (0.014133 ± 0.0020882) 
Biodentine™ + Saline (0.327067 ± 0.0193128) 
Naik et al., (2015) 








0.54 ± 0.12 
 
0.43 ± 0.14 
 
0.42 ± 0.15 
 
0.42 ± 0.15 
ProRoot® MTA (0.59 ± 0.17) 
Grey Portland Cement (0.61 ± 0.19) 
ProRoot® MTA (0.49 ± 0.09) 
Grey Portland Cement (0.50 ± 0.13) 
ProRoot® MTA (0.47 ± 0.09) 
Grey Portland Cement (0.50 ± 0.14) 
ProRoot® MTA (0.46 ± 0.07) 
Grey Portland Cement (0.50 ± 0.12) 
El-Khodary et al., 
(2015) 
Microleakage (mm) (Endosonic tip used for 
preparation) 
2 days 0.5650 ± 0.0728 MTA (0.9090 ± 0.1083) Nanjappa et al., 
(2015) 
Microleakage (mm) (Er:YAG laser  used for 
preparation) 
2 days 0.3380 ± 0.1202 MTA (0.7940 ± 0.0445) 
Microleakage (retropreparation done with 
ultrasonic retrotip) 
 1065.1 MTA (321.2) Mandava et al., 
(2015) 
Microleakage (retropreparation done with 
conventional bur) 
 1171.0 MTA (490.1) 
Apical leakage at 1mm (µL.cmH2O-1.min-1) 2 days 2.03 ± 0.11 MTA (2.39 ± 0.14) Bani et al., (2015) 
Apical leakage at 2mm (µL.cmH2O-1.min-1) 2 days 1.85 ± 0.10 MTA (1.98 ± 0.17) 
Apical leakage at 3mm (µL.cmH2O-1.min-1) 2 days 0.71 ± 0.04 MTA (0.67 ± 0.05) 
Apical leakage at 4mm (µL.cmH2O-1.min-1) 2 days 0.60 ± 0.05 MTA (0.56 ± 0.05) 
Marginal gap at dentine-retrograde filling 
material interface at 1mm root section (µm) 
5 days 1.345 ± 0.717 
 
MTA (0.847 ± 0.298) 
 
Soundappan et al., 
(2013) 
Marginal gap at dentine-retrograde filling 
material interface at 2mm root section (µm) 
5 days 1.489 ± 0.459 
 





Marginal gap area (µm2) 2 days 11143.42 ± 
967.753 
ProRoot® MTA (22300.97 ± 3068.883) Ravichandra et al., 
(2014) 
Calcium ion concentration (mmol/L)  0.21 ± 0.03 MTA Angelus (0.22 ± 0.01) Natale et al., (2014) 
Calcium ion leaching in water (µg/g) 28 days 8.216 Theracal (3.289) Camilleri et al., 
(2014) Calcium ion leaching in HBSS (µg/g) 28 days 10.453 Theracal (4.756) 
Cumulative calcium ions released in 



























95.3 ± 13.0 & 





113.4 ± 11.1 & 





135.1 ± 15.9 & 





177.8 ± 16.2 & 





205.5 ± 17.5 & 
9.43 ± 0.28 
MTA Plus (46.6 ± 12.8) & (11.77 ± 0.34) 
MTA Plus + gel (97.8 ± 27.8) & (12.00 ± 0.23) 
MTA Angelus (48.0 ± 7.3) & (11.31 ± 0.22) 
ProRoot® MTA (27.4 ± 5.4) & (10.99 ± 0.40) 
Tech Biosealer capping (162.7 ± 28.2) & 
(11.42 ± 0.05) 
Theracal (18.0 ± 2.3) & (9.53 ± 0.15) 
MTA Plus (68.1 ± 12.3) & (11.48 ± 0.59) 
MTA Plus + gel (165.8 ± 31.9) & (12.52 ± 
0.27) 
MTA Angelus (84.9 ± 12.3) & (11.22 ± 0.11) 
ProRoot® MTA (61.0 ± 14.1) & (10.53 ± 0.59) 
Tech Biosealer capping (190.1 ± 21.0) & 
(11.79 ± 0.25) 
Theracal (52.2 ± 3.8) & (7.89 ± 0.02) 
MTA Plus (83.9 ± 12.9) & (10.10 ± 1.06) 
MTA Plus + gel (183.7 ± 33.5) & (10.90 ± 
1.37) 
MTA Angelus (110.6 ± 12.3) & (11.15 ± 0.72) 
ProRoot® MTA (78.9 ± 17.3) & (9.25 ± 0.30) 
Tech Biosealer capping (209.8 ± 20.8) & 
(10.65 ± 0.84) 
Theracal (79.3 ± 6.9) & (8.54 ± 0.29) 
MTA Plus (96.1 ± 16.4) & (8.74 ± 0.54) 
MTA Plus + gel (196.2 ± 36.3) & (9.99 ± 1.18) 
MTA Angelus (161.8 ± 17.5) & (11.29 ± 0.65) 














245.8 ± 17.9 
9.26 ± 0.66 
ProRoot® MTA (96.2 ± 22.0) & (8.78 ± 0.20) 
Tech Biosealer capping (320.8 ± 24.7) & 
(10.14 ± 0.51) 
Theracal (91.9 ± 8.1) & (8.00 ± 0.26) 
MTA Plus (105.4 ± 16.4) & (8.68 ± 0.29) 
MTA Plus + gel (207.8 ± 36.6) & (8.60 ± 0.70) 
MTA Angelus (176.1 ± 18.9) & (10.34 ± 0.59) 
ProRoot® MTA (125.3 ± 26.8) & (7.87 ± 0.29) 
Tech Biosealer capping (344.7 ± 24.9) & (7.95 
± 0.42) 
Theracal (113.8 ± 12.4) & (8.43 ± 0.22) 
MTA Plus (112.6 ± 16.0) & (8.24 ± 0.45) 
MTA Plus + gel (230.9 ± 32.4) & (7.99 ± 0.22) 
MTA Angelus (198.1 ± 21.0) & (8.94 ± 0.73) 
ProRoot® MTA (146.1 ± 29.7) & (7.20 ± 0.12) 
Tech Biosealer capping (370.9 ± 27.5) & (7.81 
± 0.49) 
Theracal (137.8 ± 12.9) & (8.12 ± 0.07) 








65.8 ± 2.7 
 
33.9 ± 0.9 
 
32.7 ± 0.8 
 
30.8 ± 0.7 
MTA Angelus (27.7 ± 0.4)  
GC MTA (36.2 ± 1.7) 
MTA Angelus (24.7 ± 0.7)  
GC MTA (28.3 ± 1) 
MTA Angelus (22.8 ± 0.9) 
GC MTA (34.4 ± 0.8) 
MTA Angelus (16.1 ± 1.1) 
GC MTA (36.1 ± 0.9) 
Dawood et al., 
(2015) 












Tricalcium silicate (133.554) 
Tricalcium silicate + 30% zirconium oxide 
(173.570) 
Tricalcium silicate + 50% zirconium oxide 
(156.899) 
Tricalcium silicate (258.323) 




1 month 84.486 Tricalcium silicate + 30% zirconium oxide 
(382.574) 
Tricalcium silicate + 50% zirconium oxide 
(357.166) 
Tricalcium silicate (124.028) 
Tricalcium silicate + 30% zirconium oxide 
(58.673) 
Tricalcium silicate + 50% zirconium oxide 
(142.183) 
Calcium ion release (mg/l) (when immersed 
in distilled water) 
5 hours 
5 – 24 
24 – 48  
144 – 168  
24 ± 5.28  
34 ± 3.44 
27.6 ± 1.66 
14.7 ± 2.01 
MTA (17.7 ± 0.21) 
MTA (24 ± 0.52) 
MTA (20.2 ± 3.44) 
MTA (9.7 ± 0.26) 
Han & Okiji (2013) 
Incorporation depths of Ca into human root 





39 ± 8.2 
74 ± 18.8 
118 ± 11.5 
166 ± 22.5 
MTA (23 ± 5.7) 
MTA (50 ± 19) 
MTA (75 ± 22.6) 
MTA (133 ± 19.2) 
Incorporation depths of Si into human root 





32 ± 14.8 
46 ± 12.9 
86 ± 9.6 
130 ± 12.7 
MTA (21 ± 6.5) 
MTA (41 ± 9.6) 
MTA (62 ± 12) 
MTA (107 ± 12.5) 
Leaching of chromium in HBSS (mg/kg) 28 days 0.06 MTA (0.06) 
Bioaggregate (0.13) 
Camilleri et al., 
(2012) 
Leaching of arsenic in HBSS (mg/kg) 28 days 0.19 MTA (0.22) 
Bioaggregate (0.08) 
Leaching of lead in HBSS (mg/kg) 28 days 0.17 MTA (0.10) 
Bioaggregate (0.01) 
Acid soluble chromium concentration mg/kg)  28 days 4.50 MTA (6.25) 
Bioaggregate (22.25) 





Acid soluble lead concentration (mg/kg) 28 days 14.50 MTA (0.03) 
Bioaggregate (4.25) 
Hydroxyl ion concentration (mmol/L)  0.42 ± 0.06 MTA Angelus (0.42 ± 0.02) Natale et al., (2014) 
pH of  leachate (Deionized water)  3 hours 
24 hours 
168 hours 
9.14 ± 0.16 
8.88 ± 0.27 
8.02 ± 0.19 
MTA (9.52 ± 0.33)   
MTA (9.32 ± 0.51)  
MTA (8.45 ± 0.26) 
Khan et al., (2012) 















Grech et al., (2013a) 
Number of closed pores  32.016 ± 18.107 MTA (22.274 ± 4.281)  De Souza et al., 
(2013) Volume of closed pores (mm³)  3.86 ± 0.13 MTA (3.52 ± 0.57) 
Surface of closed pores (mm²)  476.74 ± 70.86 MTA (398.90 ± 54.99) 
Closed porosity (%)  5.15 ± 0.30 MTA (4.60 ± 0.73) 
Porosity (%) (detected by micro CT)  7.09 ± 1.87 MTA (6.65 ± 1.93) 
Porosity (%)  13.44 Bioaggregate (36.86) 
TCS-20-Zr (30.98) 
Camilleri et al., 
(2014) 
Volume of open pores (cm3) 1 day 0.02284 ± 0.0011 MTA Plus (0.03802 ± 0.0018) 
MTA Plus + gel (0.0420 ± 0.0067) 
MTA Angelus (0.0364 ± 0.0078) 
ProRoot® MTA (0.0316 ± 0.0023) 
Tech Biosealer capping (0.0518 ± 0.0018) 
Theracal (0.0278 ± 0.0039) 
Gandolfi et al., 
(2014) 
Volume of pore space (mm³)  4.92 ± 0.67 MTA (5.20 ± 1.5) De Souza et al., 
(2013) 
Volume of impervious portion (cm3) 1 day 0.0766 ± 0.0036 MTA Plus (0.0562 ± 0.0036) 
MTA Plus + gel (0.06476 ± 0.0085)  
MTA Angelus (0.0370 ± 0.0068) 
ProRoot® MTA (0.0759 ± 0.0048) 
Tech Biosealer capping (0.0613 ± 0.0032) 





Theracal (0.0951 ± 0.0063) 
Average pore diameter (µm)  0.0121 Bioaggregate (0.0337) 
TCS-20-Zr (0.0508) 
Camilleri et al., 
(2014) 
Total pore area (m2/g)  21.752 Bioaggregate (24.321) 
TCS-20-Zr (13.101) 
Apparent porosity (Vop/V%) 1 day 22.93 ± 0.24 MTA Plus (40.34 ± 1.07) 
MTA Plus + gel (39.30 ± 6.30) 
MTA Angelus (49.47 ± 3.8) 
ProRoot® MTA (29.36 ± 0.78) 
Tech Biosealer capping (45.80 ± 2.10) 
Theracal (22.58 ± 2.01) 
Gandolfi et al., 
(2014) 
Bulk density (g/ml)  2.0444 Bioaggregate (1.8007) Camilleri et al., 
(2014) 





2.78 ± 1.13 
3.76 ± 1.48 
4.08 ± 1.75 
4.19 ± 1.39 
5.28 ± 2.12 
ProRoot® White MTA (10.93 ± 2.81) 
ProRoot® White MTA (14.65 ± 3.75) 
ProRoot® White MTA (12.97 ± 3.15) 
ProRoot® White MTA (14.27 ± 3.28) 
ProRoot® White MTA (16.65 ± 4.58) 
Vallés et al., (2015) 










6.88 ± 1.60 
 
3.94 ± 1.26 
 
3.77 ± 0.99 
 
4.48 ± 1.02 
 
4.95 ± 1.09 
ProRoot® MTA (5.29 ± 1.60) 
ESRRM (7.44 ± 1.40) 
ProRoot® MTA (2.68 ± 2.08) 
ESRRM (2.08 ± 0.66) 
ProRoot® MTA (2.06 ± 1.45) 
ESRRM (3.46 ± 0.79) 
ProRoot® MTA (2.27 ± 1.22) 
ESRRM (4.54 ± 0.95) 
ProRoot® MTA (2.60 ± 1.26) 
ESRRM (5.18 ± 0.98) 
Beatty et al., (2015) 
Micro-push-out (MPa) at pH 7.4 7 days 9.1 ± 1.8 White MTA Angelus (7.0 ± 1.2) Elnaghy et al., 
(2014) Micro-push-out (MPa) at pH 6.4 7 days 7.2 ± 1.1 White MTA Angelus (5.2 ± 0.7) 




Micro-push-out (MPa) at pH 4.4 7 days 4.3 ± 0.7 White MTA Angelus (2.5 ± 0.4) 
Push-out bond strength at pH 7.4 (MPa)  19.5 ± 0.9  Poplai et al., 2012 
Push-out bond strength at pH 6.4 (MPa)  19.2 ± 0.8   
Push-out bond strength at pH 5.4 (MPa)  17.9 ± 1.1   
Push-out bond strength at pH 4.4 (MPa)  11.7 ± 0.5   
Push-out bond strength (MPa) 3 days 21.8578 ± 
6.89735 
ProRoot® White MTA (23.2637 ± 5.485) 
Bioaggregate (9.5739 ± 3.45483) 
Alsubait et al., 
(2014) 
Push-out bond strength (MPa) in dentine 
thickness of 0.75mm 
 3.11 ± 0.86 Bioaggregate (2.72 ± 0.90) Ulusoy et al., (2015) 
Push-out bond strength (MPa) in dentine 
thickness of 1.50mm 
 8.13 ± 1.89 Bioaggregate (3.10 ± 0.98) 
Push-out bond strength (MPa) in dentine 
thickness of 2.25mm 
 9.63 ± 1.58 Bioaggregate (5.73 ± 1.95) 
Median of bond strength (MPa) 7 days 5.70 MTA Angelus (1.53) Centenaro et al., 
(2015) 
Push-out bond strength (MPa)  7 days 2.59 ± 0.38 ProRoot® MTA (2.09 ± 0.34) Nagas et al., (2015) 




1.37 ± 0.41 
8.06 ± 3.14 
16.8 ± 7.60 
7.77 ± 3.80 
 Cechella et al., 
(2015) 




0.32 ± 0.16 
9.85 ± 7.36 
9.97 ± 4.49 
2.84 ± 1.38 
 
Push-out bond strength after immersion in 
NaOCl (MPa) 
 7.23 ± 4.22 MTA (3.49 ± 3.02) Guneser et al., 2013 
Push-out bond strength after immersion in 
CHX  (MPa) 
 7.13 ± 2.17 MTA (2.45 ± 1.99) 
Push-out bond strength after immersion in 
saline (MPa) 
 7.22 ± 3.14 MTA (6.18 ± 3.80) 




Retro MTA (7.57 ± 3.5) 
Supra MTA (2.83 ± 1.94) 
 
Push-out bond strength (MPa) after 
contamination with blood 
14 days 4.36 ± 2.55 ProRoot® MTA (8.34 ± 3.9) 
Retro MTA (6.37 ± 0.82) 
Supra MTA (2.32 ± 1.01) 
Push-out bond strength when smear layer is 
preserved (MPa) (Irrigation with 1% NaOCl 
between filing) 
 8.79 ± 1.55 MTA (7.54 ± 1.11) EL-Ma’aita et al., 
(2013) 
Push-out bond strength when smear layer is 
removed (MPa) (Irrigation with 1% NaOCl 
between filing and 17% EDTA + 2ml NaOCl 
+ 5 ml sterile water after filing) 
 7.71 ± 1.81 MTA (6.58 ± 1.13) 
Bi-axial flexural strength (MPa)  9.49 ± 2.90 Portland cement (7.91 ± 4.08) Alhodiry et al., 
(2014) Bi-axial flexural strength (MPa) in the 
presence of saliva 
 9.10 ± 2.45 Portland cement (108 ± 4.47) 
Bi-axial flexural strength (MPa) in the 
presence of blood 
 8.94 ± 2.44 Portland cement (114 ± 5.47) 
Flexural strength (MPa)  24.4 ± 7.5 MTA Angelus (6.5 ± 1.3) Natale et al., (2014) 
Flexural modulus (GPa)  7.1 ± 3.1 MTA Angelus (2.4 ± 0.9) 
Fracture resistance   814.54 ± 138.54  Topcuoglu et al., 
(2014) 
Root fracture resistance (kN) 3 days 2.22 ± 0.54  Fiore et al., (2015) 
Fracture resistance (MPa) 1 year 38.29 ± 4.58 White MTA Angelus (36.72 ± 6.09) Elnaghy et al., 
(2015) 
Fracture resistance (N)  529.0284 ± 
90.73658 
MTA (568.3618 ± 91.78048) 
Bioaggregate (481.6923 ± 126.77524) 
Bayram et al., 
(2016) 
Fracture resistance (N)  1130.61 ± 223.46 MTA (1238.58 ± 142.16) 
CEM (1309.46 ± 177.65) 




Flexural modulus of dentine after being in 





14.9 ± 2.0 
14.6 ± 2.5 
13.1 ± 2.4 
13.8 ± 2.7 
MTA (15.7 ± 3.1) 
MTA (14.2 ± 2.3) 
MTA (13.8 ± 3.5) 
MTA (13.9 ± 3.2) 
Sawyer et al., (2012) 
Flexural strength of dentine after being in 





206.8 ± 12.6 
187.4 ± 18.5 
163.3 ± 19 
165.3 ± 17.8 
MTA (201.30 ± 23.5) 
MTA (200.4 ± 19.1) 
MTA (178.3 ± 21.7) 
MTA (172.5 ± 23.4) 
Modulus of toughness of dentine after being 





3.58 ± 1.01 
2.22 ± 0.38 
2.52 ± 0.89 
2.15 ± 0.32 
MTA (3.48 ± 0.96) 
MTA (3.69 ± 1.08) 
MTA (3.27 ± 0.82) 
MTA (2.66 ± 0.57) 
Mean thicknesses of the hard-tissue dentin 
bridge after direct pulp capping (µm) 
6 weeks 221.56 MTA (230.31) Nowicka et al., 
(2013) 
Specific surface area (m²/g)  2.8116 MTA (1.0335) Camilleri et al., 
(2013) 
Cytotoxicity after indirect contact (undiluted) 
(%) 
 0  ±  8 MTA (0  ±  9) Laurent et al., 
(2008) 
Cytotoxicity after indirect contact (diluted) 
(%) 
 0  ±  8 MTA (0  ±  9) 
Legend: MTA: Mineral Trioxide Aggregate; MM-MTA: Micro Mega MTA; NT: Nano-Technology; SE: Self Etch; CEM: Calcium Enriched Mixture; 
ESRRM: Endosequence Root Repair Material; PBS: Phosphate buffered saline; TCS-20-Zr: Tricalcium silicate, zirconium oxide and water; min: 
minute(s). 
 




With the dye penetration technique, it was seen that Biodentine™ showed a significantly lesser 
microleakage than MTA (Nanjappa et al., 2015, Soundappan et al., 2014, Agrafioti et al., 2015, 
Mandava et al., 2015) but significantly higher than ProRoot® MTA, MM-MTA, Glass ionomer 
cement (Fuji IX GP) and Endosequence (Jeevani et al., 2014, Vemisetty et al., 2014, Raju et al., 
2014). Using 1% methylene blue as a tracer, resulted in significantly less leakage for Biodentine™ 
(0.13 ± 0.006 mm) when compared to MTA (0.73 ± 0.13 mm) and Glass Ionomer Cement (1.49 ± 
0.23 mm) (Kokate and Pawar, 2012). These results are substantiated by a study of Raskin et al. 
who concluded that Biodentine™ provides adequate marginal seal at the interface of enamel, 
dentine and dentine bonding agents (Raskin et al., 2012).  
 
Microleakage assessed in open sandwich restorations showed that glucose diffusion at the 
interface between Biodentine™ and dentine walls is similar to that of resin modified glass ionomer 
cement (Koubi et al., 2012). When the materials were stored in an acidic environment, no 
statistical significant difference was found between Biodentine™ and ProRoot® MTA after 3 
months (Agrafioti et al., 2015). However, in another study, Biodentine™ exhibited leakage at the 
dentine to material interface either with or without etching whereas Fuji IX and Vitrebond exhibited 
zero-leakage when used in a sandwich restoration overlaid with composite resin.  It can also be 
noted that in the same study there was no difference between the micro hardness whether 
Biodentine™ was etched or not (Camilleri, 2013). Confocal microscopy used in conjunction with 
fluorescent tracers demonstrated that dry storage of Biodentine™ resulted in cracks in the 
material and also gaps at the root dentine to material interface (Camilleri et al., 2013a).  
 
Also, in a comparison of various root-end cavity preparation techniques, Er:YAG laser preparation 
showed better sealing ability with Biodentine™ than ultrasonic preparation (Nanjappa et al., 
2015). Moreover, El-Ma'aita et al. demonstrated that smear layer removal is detrimental to the 
push out bond strength between calcium silicate cements and dentine. Also, roots filled with 
Biodentine™ exhibited significantly higher push-out bond strength than MTA whether the smear 
layer was removed or not (El-Ma'aita et al., 2013). The authors attribute this mainly to the inability 
of the calcium silicate cement particles to penetrate the dentinal tubules due to their large particle 
size (2.44 – 3.05µm) (Komabayashi and Spangberg, 2008) and also because the smear layer 
plays an important role in the formation of an interfacial layer and is actively engaged in the 





Upon assessing various manipulation techniques, more microleakage was seen when 
Biodentine™ was manually manipulated as compared to machine trituration. This could be 
explained by the more homogenous mix obtained by mechanical trituration (Gupta et al., 2015). 
When different storage environments were tested, dry storage of Biodentine™ resulted in 
microstructural changes and cracks at the root dentine to Biodentine™ interface (Camilleri et al., 
2014a). Biodentine™ samples stored in PBS produced larger amounts of calcium phosphate 
precipitates and higher percentage of marginal adaptation than MTA Angelus (Aggarwal et al., 
2015). In the presence of simulated body fluid, Biodentine™ demonstrated the presence of an 
interfacial layer formation on root canal dentine indicating bioactivity (Kim et al., 2015). However, 
the thickness of the interfacial layer hence formed was significantly lesser than that of white 
ProRoot® MTA. Blood contamination does not affect the marginal adaptation of Biodentine™, 
Bioaggregate, MTA and CEM (Bolhari et al., 2015). It has also been established that Biodentine™ 
exhibited greater dentine mineralisation in totally demineralised dentine than glass ionomer 
cement (Atmeh et al., 2015). 
 
The capacity of Biodentine™ to resist dislodgement was greater than Bioaggregate (Ulusoy et 
al., 2015, Alsubait et al., 2014), ProRoot® MTA (Nagas et al., 2016), MTA Angelus (Dawood et 
al., 2015b, Centenaro et al., 2016, Silva et al., 2016a, Elnaghy, 2014, De-Deus et al., 2016), 
GCMTA (Dawood et al., 2015b) and MTA HP (high plasticity). The higher dislodgement resistance 
of Biodentine™ is speculated to be a result from smaller particle size that has the potential to 
enhance penetration of cement into dentinal tubules. This effect is further reinforced through 
formation of ‘mineral tags’ leading to increased micromechanical retention (Han & Okiji, 2011, 
Nagas et al., 2016). The micromechanical anchorage is also partly due to increased calcium and 
hydroxyl ion release responsible for improved apatite formation at the Biodentine™-dentine 
interface (Silva et al., 2016a). Biodentine™ and ProRoot® MTA were found to fill gaps between 
dentine and cement by calcium phosphate deposition without any chemical changes to the 
adjacent dentine. The thickness of the transition zone as measured by micro Raman spectroscopy 
was 7.5 ± 4.2 µm for Biodentine™ compared to 6.2 ± 5.4 µm for ProRoot® MTA with no significant 
difference between the groups (Li et al., 2015). On the contrary, one study concluded that 
Biodentine™ showed significantly lower bond strength than ProRoot® MTA and Retro MTA (Ustun 
et al., 2015). 
 
The dislodgement resistance was influenced by remaining dentine thickness which in turn 




Er:YAG laser demonstrated a very good adaptation of Biodentine™ and ProRoot® MTA 
(Stefanova et al., 2015). Also, prior use of calcium hydroxide medication improved the bond 
strength of Biodentine™ to root dentine (Nagas et al., 2016, Centenaro et al., 2016). Push-out 
bond strength (MPa) of Biodentine™ with respect to different intracanal medicationss showed the 
highest values for calcium hydroxide (2.80 ± 0.49) followed by no intracanal medication (2.59 ± 
0.38). Augmentin, Triple antibiotic paste and Ledermix treatment prior to Biodentine™ application 
resulted in a push-out bond strength of 2.34 ± 0.36, 2.30 ± 0.52 and 2.16 ± 0.39 MPa respectively 
(Nagas et al., 2016). Micro-push-out bond strength of Biodentine™ decreased significantly with 
decreasing pH (pH 7.4, 6.4, 5.4 and 4.4) (Elnaghy, 2014, Poplai et al., 2012). On the other hand, 
blood contamination did not affect the dislocation resistance of Biodentine™ (Ustun et al., 2015). 
A study performed on push-out bond strength in furcation perforation repair in extracted 
mandibular molars showed that blood contamination did not have an effect on the push-out bond 
strength of Biodentine™. On the other hand, blood contamination reduced the push-out bond 
strength of MTA samples with a setting time of 7 days, but had no significant effect on 24 hour 
samples. The study also showed that there was a significant increase in the push-out bond 
strength of Biodentine™ and MTA with increase in setting time from 24 hours to 7 days 
irrespective of the blood contamination (Aggarwal et al., 2013).  
 
Endodontic irrigants did not influence the mean push-out bond strength of Biodentine™. Push-
out bond strength recorded after immersion of samples in 3.5% sodium hypochlorite, 2% 
Chlorhexidine or saline solution for 30 minutes was recorded as 7.23 ± 4.22, 7.13 ± 2.17 and 7.22 
± 3.14 MPa respectively (Guneser et al., 2013). Conflicting results have been published regarding 
the effect of PBS on the push-out bond strength of Biodentine™. Long-term PBS immersion (60 
days) was found to positively influence the resistance to dislodgement in the study by De-Deus 
et al. whereas the study by Cechella et al., showed that the bond strength of Biodentine™ 
increased up to 3 days but reduced significantly after 28 days when exposed to PBS (De-Deus et 
al., 2016, Cechella et al., 2015). Immersion in saline solution increased the push-out bond 
strength of MTA whereas immersion in chlorhexidine reduced it (Guneser et al., 2013). 
 
Biodentine™ exhibited lower shear bond strength than MTA Angelus (Altunsoy et al., 2015), CEM 
(Altunsoy et al., 2015) and glass ionomer cement (Fuji IX GP) (Raju et al., 2014) but higher shear 
bond strength than ProRoot® MTA (Cantekin and Avci, 2014, Kaup et al., 2015a). Biodentine™ 
presented significantly lower shear bond strength values when immediately bonded to resin 




phase (Deepa et al., 2016). The unanimous results of published studies concluded that a final 
resin composite restoration should best be delayed for more than 2 weeks to allow adequate 
setting and sufficient intrinsic maturation of Biodentine™ for withstanding contraction forces from 
the resin composite (Hashem et al., 2014, Deepa et al., 2016). Also, the placement of glass 
ionomer cement based materials prior to composite resin restorations decreased the shear bond 
strength (Cengiz and Ulusoy, 2016).  For immediate permanent restoration, a stainless steel 
crown loaded with glass ionomer cement could be seated on unset Biodentine™ after the third 
minute of mixing in pulpotomy cases (Dawood et al., 2015a). 
 
In the treatment of simulated immature teeth with open apices, treatment with Biodentine™, White 
MTA Angelus, Calcium-enriched mixture (CEM) and Bioaggregate did not show any significant 
difference regarding cervical root fracture resistance (Evren et al., 2016, Elnaghy and Elsaka, 
2016, Bayram and Bayram, 2016). In the treatment of mature maxillary anterior permanent 
incisors, no significant difference was found in resistance to cervical fracture in teeth filled with 
Biodentine™ or gutta-percha. Subsequent inspection of the fractured tooth revealed fracture 
along the same plane as surrounding dentine and no areas of material de-bonding from dentine 
(Di Fiore et al., 2016).   
 
The modulus of toughness (MOT) and the flexural strength of dentine exposed to Biodentine™ 
decreased by 37.3% and 17.6% respectively after 3 months and the results were not significantly 
different from those obtained with MTA (22.3% reduction in MOT and 14% reduction in flexural 
strength). MOT of dentine in contact with Biodentine™ was significantly different from that in 
contact with MTA after 1 and 2 months but not after 3 months. The authors concluded that 
Biodentine™ and MTA reduce ability of dentine to resist deformation (strength) and to absorb 
energy without fracturing (toughness) (Sawyer et al., 2012). This could be due to the adverse 
effect of the material on the integrity of the dentine collagen matrix (Leiendecker et al., 2012). 
These in vitro results could represent limitations to the use of Biodentine™ or MTA for the full 
canal obturation of root canals with thin dentinal walls. 
 
No statistically significant difference was found between different adhesive systems (Colak et al., 
2016) but the placement of composite resin with self-etch adhesive systems over Biodentine™ 
showed higher shear bond strength. In particular, 2-step self-etch adhesives exhibited higher 
shear bond strength to Biodentine™ in comparison to 1-step self-etch adhesives and etch-and-




In an attempt to improve the properties of Biodentine™, CPP-ACP has been added to the original 
composition in varying concentrations (0.5%, 1%, 2% and 3%). The addition of up to 1% CPP-
ACP did not affect the physical properties of Biodentine™ except for a significant increase in 
setting time, calcium and phosphate ion release (Dawood et al., 2014) and push-out bond strength 
(Dawood et al., 2015b). The incorporation of 3% CPP-ACP into Biodentine™ increased solubility 
but reduced the compressive strength and surface microhardness by 36% and 31% respectively.  
 
Section III: Biological properties 
 
Antibacterial activity of Biodentine™ was strongest against the Streptococcus sanguis strains and 
this was significantly higher than MTA Angelus, ProRoot® MTA and intermediate restorative 
material (IRM) (Poggio et al., 2014a, Ceci et al., 2015, Poggio et al., 2015a). The weakest 
antibacterial activity of Biodentine™ was seen against Streptococcus mutans with Biodentine™ 
exhibiting minimal or almost no antibacterial activity (Poggio et al., 2014a, Ceci et al., 2015, 
Poggio et al., 2015a). Against Streptococcus salivarius MTA Angelus and ProRoot® MTA showed 
significantly higher antibacterial activity than Biodentine™ (Poggio et al., 2014a, Ceci et al., 2015, 
Poggio et al., 2015a). Biodentine™ exhibited antibacterial activity similar to MTA Angelus but 
significantly higher than ProRoot® MTA and MTA Plus against Enterococcus faecalis (Koruyucu 
et al., 2015, Hiremath et al., 2015, Bhavana et al., 2015) and Escherichia coli (Bhavana et al., 
2015). Antifungal activity of Biodentine™ against Candida albicans was similar to MTA Angelus 
and MTA Plus (Hiremath et al., 2015) but significantly higher than ProRoot® MTA (Bhavana et al., 
2015). Addition of 2% chlorhexidine to Biodentine™ enhanced the antibacterial activity of 
Biodentine™ against Staphylococcus aureus, Enterococcus faecalis and Streptococcus mutans 
while the addition of 10% doxycycline to Biodentine™ decreased the antibacterial activity. On the 
other hand, antifungal activity of Biodentine™ against Candida albicans was reduced by addition 
of either 2% chlorhexidine or 10% doxycycline (Nikhil et al., 2014). In all the studies mentioned, 
antibacterial activity was tested against planktonic bacterial cultures. 
 
Biodentine™ showed the capacity to induce odontoblastic differentiation of human dental pulp 
stem cells (hDPSCs) obtained from impacted third molars via heme oxygenase-1 (HO-1), reactive 
oxygen species (ROS), nuclear factor-E2-related factor-2 (Nrf2), mitogen-activated protein kinase 
(MAPK) and calmodulin-dependent protein kinase (CAMKII) pathways (Jung et al., 2015, Chang 
et al., 2014, Luo et al., 2014b). Biodentine™ increased phosphorylation of extracellular signal-




ProRoot® MTA, Biodentine™ induced the up-regulation of osteocalcin (OCN), dentin 
sialophosphoprotein (DSPP), dentin matrix acidic phosphoprotein 1(DMP1), collagen type I 
(COL1A1), runt related transcription factor (Runx2) and bone sialoprotein (BSP) upon exposure 
to hDPSCs (Luo et al., 2014b, Chang et al., 2014, Widbiller et al., 2016). Even though 
Biodentine™ stimulated similar markers as MTA, the staining was more intense and spread over 
a larger area of pulp tissue (Daltoe et al., 2016). Exposure of hDPSCs to Biodentine™ (0.2 mg/ml) 
for 24 hours showed a significantly increased mRNA expression of chemokines such as CXC 
chemokine receptor type 4 (CSCR4), monocyte chemoattractant protein 1 (MCP-1), stromal cell-
derived factor-1 (SDF-1) and adhesion molecules such as fibronectin (FN), intercellular adhesion 
molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and beta1 integrin (Integrinβ1) 
(Luo et al., 2014a). Osteogenic differentiation of hDPSCs were increased after elution of cytotoxic 
components from Biodentine™. The initial cytotoxicity of Biodentine™ could be attributed to the 
high pH values and formation/precipitation of calcium hydroxide (Bortoluzzi et al., 2015). 
Biodentine™ when used in direct contact with the pulp can positively influence healing by 
enhancing proliferation, migration and adhesion of hDPSCs (Luo et al., 2014a).  
 
Cytotoxicity on human stem cells from apical papilla (SCAP), after 24 hours, the cytotoxicity was 
CEM > Biodentine™ > ProRoot® MTA. At 48 and 72 hours the cytotoxicity was reported to be 
MTA > Biodentine™ > CEM (Saberi et al., 2016). Stem cells from apical papilla in contact with 
Biodentine™ showed increased cell viability than control group at day 1 but not at days 3 and 7. 
Exposure to MTA and Biodentine™ stimulated expression of angiogenic genes such as vascular 
endothelial growth factor (VEGFA) and c-fos induced growth factor (FIGF/VEGFD) but 
significantly decreased the mRNA levels of  ANGPT1 (angiopoietin 1) and FGF2 (fibroblast growth 
factor 2)  . On the basis of these findings, Biodentine™ might enhance angiogenesis when used 
in direct contact with SCAP (Peters et al., 2015). Biodentine™ also elicited a favourable response 
on human mesenchymal stem cells (hMSCs) and human umbilical vein endothelial cells 
(HUVECs) but the osteogenic and angiogenic outcome was slightly lower than ProRoot® MTA 
and MTA Plus (Costa et al., 2016). Biodentine™ induced mRNA expression of alkaline 
phosphatase (ALP), osteocalcin (OC) and bone sialoprotein (BSP) in hMSCs (Lee et al., 2014).  
 
Biodentine™ showed significantly less cell viability (73%) after 24 hours of incubation, whereas 
more than 90% cell viability was seen after 48 and 72 hours of incubation with human periodontal 
ligament fibroblasts (Kucukkaya et al., 2016). In comparison to ProRoot® MTA, Biodentine™ 




cells (Jung et al., 2014). The presence of a less toxic radiopacifier (zirconium oxide) in 
Biodentine™ could be responsible for these results (Kucukkaya et al., 2016). Contrasting results 
with ProRoot® MTA showing better human periodontal ligament cell viability than Biodentine™ 
and Endosequence has also been reported (Samyuktha et al., 2014).  
 
Laurent et al. established that Biodentine™ was non cytotoxic and non genotoxic for pulp 
fibroblasts at any concentration and the specific functions of these cells were not modified when 
the material was used as either direct pulp capping agent or as a lining material (Laurent et al., 
2008). Cytotoxicity tests on human gingival fibroblasts (Perard et al., 2011, Zhou et al., 2013) and 
MG63 osteoblast like cells showed a similar response to extracts from Biodentine™ and MTA. 
Biodentine™ and ProRoot® MTA showed similar effects in terms of cytotoxicity and cytokine 
expression (interlukin-1α and interleukin-6) level in mouse embryonic fibroblast cells (Corral 
Nunez et al., 2014) and primary mouse embryonic fibroblast cells (Balb/c 3T3 fibroblasts) (Silva 
et al., 2016b).  
 
In a three dimensional spheroid model study, the proliferation of pseudo-odontoblastic cells 
(MDPC-23) was not affected by Biodentine™ conditioning of the medium, whether observed on 
3rd day or 7th day. The proliferation rates of pulp cells (Od-21) incubated with Biodentine™-
conditioned medium were significantly lower than those incubated with MTA-conditioned medium. 
On contrary, collagen a1 expression levels were slightly higher in cells cultured in the presence 
of Biodentine™ than in those cultured in the presence of MTA. Also, the lower concentrations of 
Biodentine™ and MTA in the deeper layers of the three dimensional spheroids were concluded 
to be associated with weaker cytotoxic effects of both materials on the internal cells compared to 
the peripheral cells (Perard et al., 2013).  
 
Biodentine™ and ProRoot® MTA showed lower cytotoxicity towards murine odontoblasts cells 
(MDPC-23) (Poggio et al., 2015b). In other studies with MDPC-23 cells, at 24 and 48 hours, 
Biodentine™, MTA Angelus and ProRoot® MTA did not show any significant differences in 
cytocompatibility but at 72 hours, Biodentine™ showed significantly higher cytocompatibility than 
MTA Angelus (Poggio et al., 2014a, Ceci et al., 2015, Poggio et al., 2014b). TRPA1 is an ion 
channel considered to be the gatekeeper of pain and inflammation. Its expression was induced 
in cultured odontoblastlike cells by tumor necrosis factor alpha (TNF-α) and this expression was 




Biodentine™ to induce cell proliferation and biomineralization was also demonstrated in vitro on 
immortalized murine pulp cells (Zanini et al., 2012).  
 
Biodentine™, ProRoot® MTA and MTA Plus revealed dose-dependent cytotoxicity and time 
dependent cell viability of osteoblasts (Cornelio et al., 2015). After 1, 3 and 5 days Biodentine™ 
revealed 91.8%, 82.5% and 75.3% cell viability respectively (Cornelio et al., 2015). There was no 
significant difference in osteoblast cell viability between ProRoot® MTA and Biodentine™ 
(Cornelio et al., 2015, Jung et al., 2014). When layered above platelet-rich-fibrin (PRF), larger 
amount of TGF-β1 was released by osteoblasts in the presence of Biodentine™ and the integrity 
of the fibrin structure was maintained when compared to GIC and IRM. Increase in TGF-β1 from 
PRF when layered with Biodentine™ might improve the healing during pulp repair and 
regeneration (Mullaguri et al., 2016). Viability of monocytes significantly improved with increasing 
storage time and at 48 hours Biodentine™ and ProRoot® MTA were significantly less cytotoxic 
than CEM cement (Khedmat et al., 2014). 
 
Biodentine™ and MTA are rich in calcium compounds and an increase in calcium ion 
concentration is known to aid hard tissue formation. X-ray diffractographic (XRD) analysis 
revealed the presence of calcium hydroxide peaks in set Biodentine™ after 1 day whereas this 
compound could not be detected in set MTA. However, both MTA and Biodentine™ exhibited 
calcium hydroxide peaks after 28 days. This difference could be attributed to the slow ongoing 
crystallization process of MTA (Camilleri et al., 2013b).  Laurent et al. showed with a human entire 
tooth culture model that Biodentine™ and ProRoot® MTA induced reparative dentine synthesis 
after direct pulp capping due to a significantly increased transformation growth factor (TGF-β1) 
secretion level (Laurent et al., 2012). 
 
Absence of a statistically significant difference between the responses of teeth to Biodentine™ 
compared with MTA as a pulp capping agent is reported in caries-free intact human molars 
scheduled for orthodontic extraction. The pulp capping material was placed after iatrogenic 
exposure of the pulp (ø 1.2 mm) and the teeth were clinically and histologically evaluated after 
six weeks. Induction of a dentine bridge was histologically analysed and the mean thickness of 
hard tissue was lesser with Biodentine™ (211.56 mm) compared to that obtained with MTA 
(230.31 mm). However, the difference was not statistically significant (Nowicka et al., 2013). The 
use of Biodentine™ as bone substitute material for implant stabilization has been described and 






Subcutaneous implantation of endodontic materials in sixty Holtzman adult male rats (da Fonseca 
et al., 2016), 45 white female Wistar rats (Simsek et al., 2015) and 15 male Wistar rats (Mori et 
al., 2014) concluded that Biodentine™ showed an initial inflammatory response that was quickly 
followed by acceptance of Biodentine™ by the tissue in contact. The reduction in inflammatory 
process and lymphocyte infiltration from 7 days to 14 and 30 days was statistically significant 
(Mori et al., 2014). This process was coupled with the formation of collagen fibre bundles in the 
capsules of Biodentine™ and not harmful to the connective tissue after prolonged implantation in 
subcutaneous tissue (da Fonseca et al., 2016). Biodentine™ could be considered to be 
biocompatible as it allows for reduction in the inflammatory response over time (Mori et al., 2014) 
and the decline in inflammation is more rapid in Biodentine™ when compared to MM-MTA and 
Bioaggregate (Simsek et al., 2015).  
 
Reparative dentine synthesis by application of Biodentine™ to mechanically exposed rat pulps 
was proved to be induced by the expression of dentine sialoprotein (DSP) and osteopontin (Tran 
et al., 2012). The percentage porosity of the resultant dentine bridge formed by Biodentine™ after 
14 and 30 days was comparable to that formed by MTA and the structural quality of the dentine 
bridge  of both materials in terms of homogeneity (lack of porosity) was superior to that of calcium 
hydroxide (Tran et al., 2012).  
 
In a pulp capping study performed in 18 Sprague-Dawley rats (9 weeks old), micro CT analysis 
revealed that Biodentine™ and ProRoot® MTA showed significantly thicker hard tissue formation 
than Bioaggregate. Hematoxylin and eosin staining showed formation of complete dentine bridge 
with normal pulp histology. In comparison to ProRoot® MTA, Biodentine™ showed an irregular, 
heterogeneous distribution of mineralization nodules within a uniform thickness of hard tissue 
barrier. This could be a result of rapid initial disorganized formation of the reparative dentine (Kim 
et al., 2016). Similar results were obtained in the human model, with tomographic evaluation of 
direct pulp capping executed in 44 caries-free human third molars indicated for extraction. The 
dentine bridges in the Biodentine™ group was found to have highest average and maximum 
volumes in comparison to ProRoot® white MTA (Nowicka et al., 2015).  
 
Inflammatory cell response and hard tissue formation after direct pulp capping or pulpotomy with 




showed that the pulp tissue was normal, free of inflammation, presenting with thick calcification 
under the pulpotomy site. In the direct pulp capping group, Biodentine™ showed a complete 
calcified bridge with a normal pulp tissue at the pulp exposure site after 90 days. There was no 
significant difference between Biodentine™ and MTA in either the direct pulp capping or 
pulpotomy group (Shayegan et al., 2012). 
 
In a pulp capping study by Tziafa et al. on 34 teeth of 3 miniature swines revealed that the 
thickness of hard tissue bridges was significantly higher with Biodentine™ that white MTA 
Angelus. In the Biodentine™ group, a thick zone of new osteodentinal matrix with cellular 
inclusions was consistently observed after 3 and 8 weeks. Ectopic formation of osteodentin far 
from the capping materials was also noted to be significantly higher in Biodentine™ than in white 
MTA Angelus (Tziafa et al., 2014). Also, in a study with similar methodology revealed that the 
thickness of tertiary dentine zone was significantly higher in the absence of calcium hydroxide 
(Dycal) protective base (Tziafa et al., 2015).  
 
Pulpotomy performed in 30 teeth of 3 beagle dogs (12 months old) demonstrated mineralized 
tissue bridge formation in significantly more specimens treated with Biodentine™ (96.8%) than 
with ProRoot® white MTA (72.2%). Radiographic visualization of more bridges in Biodentine™ 
was related to the sensitivity of radiographic techniques to detect bridges thinner than 0.5mm. 
The tissue bridges formed by both the cements had similar morphology but the thickness was 
significantly more in the Biodentine™ group (De Rossi et al., 2014). 
 
The analyses of magnesium, aluminium, calcium, chromium, arsenic and lead accumulation in 
the brain, kidney and liver of 18 Wistar albino rats (3-5 months old) was detected after 
subcutaneous implantation of endodontic materials by inductively coupled plasma mass 
spectrometry (ICP-MS) with a sensitivity of 0.2 parts per billion (ppb). Elevated levels of these 
trace elements were identified in the different organs but they were below the toxic levels in all 
cases. One of the most common toxic metals studied, Aluminium, exerts direct genotoxicity in 
primary human neural cells and induces neurodegeneration, through an increase in iron 
accumulation and reactive oxygen species (ROS) production (Fulgenzi et al., 2014). The 
concentration of Aluminium in the rat organs (brain, kidney and liver) in the Biodentine™ group 
was 93.2 ± 55.4, 43.8 ± 14.2, 112.4 ± 19.8 µg/kg. Further, there was no significant difference 
between the control groups and Biodentine™, MM-MTA and Bioaggregate according to the 




Section IV: Clinical applications 
 
The consistency of Biodentine™ is found to be similar to that of phosphate cement. In the study 
by Nowicka et al., the authors reported their opinion that Biodentine™ had better material handling 
properties compared to MTA, which was more time consuming and technically difficult (Nowicka 
et al., 2013).  
 
In a multicentric, randomised, 3-year prospective study by Koubi et al., 116 class I and II posterior 
restorations performed with Biodentine™ did not result clinical complications after 6 months. At 
interim analysis after one year, deterioration of anatomic form, marginal adaptation and proximal 
contact was observed but all teeth maintained vitality. These results indicated that Biodentine™ 
could be used as a dentine substitute for dentinal treatment of posterior teeth for up to 6 months 
(Koubi et al., 2013). 
 
In a randomized clinical study, in children aged 4 – 9 years, Biodentine™ was used as pulpotomy 
agent in 41 primary molars (Cuadros-Fernandez et al., 2015). 100% clinical and 94.9% 
radiographic success was observed after 12 months. In a similar randomised controlled trial of 25 
primary molars treated with Biodentine™, 95.24% clinical and 94.4% radiographic success was 
evident after 18 months (Rajasekharan et al., 2016). In both the studies, clinical and radiographic 
findings did not show any significant difference between Biodentine™ and MTA. In another 
randomised, split-mouth, double blind, controlled clinical trial carried out in 56 primary molars 
showed 100% clinical and radiographic success with Biodentine™ after 6 months (El Meligy et 
al., 2016).  
 
The efficacy of Biodentine™ as an indirect pulp capping material was assessed in 18-76 year old 
adults (Hashem et al., 2015) in a randomised controlled trial model. 36 teeth with reversible 
pulpitis was used in each group with 85% of the restorations placed in molars. After 12 months 
follow-up, clinical success rates for Biodentine™ and Fuji IX GIC were 83.3%.  Clinically, there 
was no difference in the dentine-pulp response between Biodentine™ and Fuji IX GIC.   
 
In the study by Kusum et al. 25 primary molars in 3-10 year old children were treated with 
Biodentine™ (Kusum et al., 2015). MTA and Biodentine™ showed 92% and 80% radiographic 
success respectively after 9 months follow-up. 100% clinical success was observed in both the 




observed between MTA and Biodentine™ as a pulpotomy medication, after 6 months follow-up 
(Niranjani et al., 2015). In this study, 25 primary molars in 5-9 year old children were treated with 
Biodentine™. Both the case-control studies were performed to evaluate the efficiency of 
Biodentine™ as a pulpotomy medication in primary molars. 
 
The use of Biodentine™ in various therapies such as deep carious lesion, direct pulp capping, 
partial pulpotomy, pulpotomy, palatogingival groove, palatoradicular groove, apexification, 
apexogenesis, internal resorption, invasive cervical resorption, cervical and apical external root 
perforation, perforation repair, incomplete vertical root fracture, endodontic surgery and 
retrograde restoration have been reported. All reported case reports have advocated the use of 
Biodentine™ as they showed successful healing without any clinical or radiographic symptoms.  
 
The use of Biodentine™ has been reported to be successful in certain unconventional 
circumstances such as pulpotomy after several days of traumatic pulp exposure, single visit 
apexification, massive resorptive lesion with multiple perforations, combined endodontic-
periodontic lesion and incomplete vertical root fracture. Although Biodentine™ has demonstrated 
successful outcomes in a variety of treatment scenarios, clinical trials with high evidence is still 
scarce. Only with more clinical studies, can the additional benefits and applications of this new 
generation of calcium silicate-based cement be substantiated. 
A summary of the treatment, type of study, number of teeth used, age of the patient and follow-
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Considering the physical (increased compressive strength, push out bond strength and density), 
biologic (immediate formation of calcium hydroxide, higher release and depth of incorporation of 
calcium ions) and handling properties (faster setting time), Biodentine™ could be an efficient 
alternative to MTA to be used in a variety of indications in the field of endodontics, dental 
traumatology, restorative dentistry and paediatric dentistry. However, more prospective clinical 
studies and high quality randomised control trials with adequate sample size and long-term follow-
up are necessary to facilitate definitive conclusions. 
 
Gaps in the knowledge 
 
There was no thorough analysis of the composition of the newly developed cements. Even 
though, the ability of tricalcium silicate cements to form calcium hydroxide during setting was 
stressed repeatedly as an advantage of this class of cements, there was lack of studies that 




analysis of the factors that affect the formation of calcium hydroxide or calcium ion release 
potential of tricalcium silicate cements was lacking. Surface topography has been associated with 
cytotoxicity but no clear studies evaluating the effect of topography on cytotoxicity was available.  
 
This thesis shall compare one representative cement from Group I (ProRoot® MTA), Group II 
(Medcem® MTA) and Group IV (Biodentine™). From the literature review, we could understand 
that ProRoot® MTA has been established as the new gold standard of clinical treatment in 
endodontics and this is based on a series of physical and biological experiments. Even though 
numerous in vitro studies have been published on Biodentine™, this material lacks clinical studies 
of high evidence. On the other hand, Medcem MTA®, is a relatively newly developed cements and 
hence lacks a lot of in vitro studies and subsequent clinical evidence. Also ‘gaps in the knowledge’ 
result from either conflicting results of in vitro studies or from studies that have failed to establish 
the relationship between the compositional, physical, biological and clinical aspects of the 
tricalcium silicate cements. Thus, this thesis shall analyse the above mentioned tricalcium silicate 





































































































From the literature review it became clear that the development and refinement of calcium silicate 
cements gave a new dimension in performing endodontics and managing dental traumatology 
patients. The paradox of calcium silicate systems is that water, which is essential for the hardening 
of the product, can also affect the setting time and strength of the material. In general, the setting 
reaction of calcium silicate cement lasts for several weeks or months after the initial hardening: 
hydration processes continue to take place, the porosity decreases, and the mechanical 
resistance increases (Villiat C et al., 2010). Understanding outcomes of the interaction between 
a dental material and tooth tissue is important in terms of not only biocompatibility but also of the 
potential for the material to modulate the response of the tissue. This interaction is influenced by 
many factors, including the chemistry of the material, any of its eluted components, degradation 
products, and the manner in which the tissue responds to these agents. The ideal material 
theoretically would interact with the living portion of the tooth, the dentin–pulp complex, in such a 
way as to repair the damage created during previous insults, including demineralization from the 
caries attack, mechanical destruction from the cavity preparation, and chemical irritation from 
components of the material itself (Ferracane JL et al., 2010). Past studies of the interaction 
between materials and tooth tissues were primarily aimed at identifying toxic effects of materials 
on cells but recently investigations have focused on specific cellular responses and in particular, 
on understanding how the materials themselves actually may contribute to regenerative 
processes in the tooth, an area of study with exciting potential (Goldberg et al., 2010). The 
preservation and protection of dental pulp with specific emphasis on regeneration has been the 
new treatment strategy in the fields of paediatric dentistry, endodontics and dental traumatology 
alike. Using hydraulic calcium silicate cements stimulates pulpal cell recruitment and 
differentiation, up-regulates transformation factors (gene expression), and promotes 
dentinogenesis; understanding outcomes of the interaction between a dental material and tooth 
tissue is important not only in terms of biocompatibility but also of the potential for the material to 
modulate the response of the tissue. 
 
Devitalization was the first approach to be used with the intention of “mummifying” the radicular 
pulp tissue in pulpotomized primary teeth. The term “mummified” has been ascribed to chemically 
treated pulp tissue that is inert, sterilized, metabolically suppressed, and incapable of autolysis. 
Preservation approach involves medications and techniques that provide minimal insult to  the  
orifice  tissue and maintain  the  vitality  and  normal  histologic  appearance  of  the  entire  
radicular pulp. Regeneration approach includes pulpotomy agents that have cell-inductive 




elements. The ultimate goal of regenerative treatment strategy is to reconstitute lost tissues, and 
to improve altered tissue functions. The current perspective in treatment of the pulp has shifted 
from devitalization and preservation to regeneration. Tricalcium silicate cements could be 
considered as a bridge between regeneration and revascularization. Their placement within the 
dynamic tissue environment of the dentine–pulp complex may potentially give rise to a wide 
spectrum of physicochemical and biological effects. (Ferracane JL et al., 2010).  
 
The following aims of the present study were postulated: 
1. To determine the composition and compare the major constituents of three tricalcium 
silicate cements at various time intervals and to assess the effect of moisture on the setting 
reaction.  
2. To monitor over time the formation of calcium hydroxide and release of calcium ions. To 
analyse the effect of volume and surface area on the calcium ion release and to evaluate 
the calcium ion release exposed to aqueous solutions with different pH. 
3. To evaluate in vitro cytotoxicity in MG-63 osteosarcoma and Human foreskin fibroblast 
(HFF) cell lines along with surface topographic analysis. 
4. To compare the clinical and radiographic efficacy of Biodentine™, ProRoot® White Mineral 
Trioxide Aggregate (WMTA) and Tempophore™ as pulpotomy medications in the 
treatment of carious deciduous molars. Additionally, to document the usage of 
Biodentine™ in specific dental traumatology cases. 







































COMPOSITION, SETTING AND CALCIUM HYDROXIDE 












Part of this chapter has been submitted for publication as: 
 
Composition and setting analysis of three tricalcium silicate cements.  





















































To determine the composition and compare the major constituents of three tricalcium silicate 
cements at various time intervals and to assess the effect of moisture on the setting reaction. The 
formation of calcium hydroxide over time was also monitored. 
Methodology  
ProRoot® white MTA, Medcem MTA® GmbH and Biodentine™ were mixed according to 
manufacturer’s instructions and allowed to set in cylindrical discs 1 mm high and 5 mm in 
diameter. The materials were analysed by splitting them into two 2 groups; samples stored either 
in water or in an atmosphere with 100% relative humidity at 37oC (RH) to determine the effect of 
moisture in the setting reaction. The samples were analysed using Energy-dispersive 
Spectroscopy (EDS), Scanning Electron Microscopy (SEM), X-Ray Diffraction (XRD) and Fourier 
Transformation Infrared spectroscopy (FT-IR) after 12 minutes, 3 hours, 1, 3, 7, 14, 21 & 28 days. 
Results  
The maximum particle size range observed for ProRoot® white MTA and Medcem MTA® was 30 
µm. In contrast, the Biodentine™ particles were smaller (10 µm). Ca/Si molar ratios of 3.34, 3.78 
and 3.85 were observed in ProRoot® white MTA, Medcem MTA® and Biodentine™ respectively. 
Tricalcium silicate was a common constituent found in ProRoot® white MTA, Medcem MTA® and 
Biodentine™ but two different crystalline forms of tricalcium silicate were identified in these 
cements. In ProRoot® white MTA, calcium hydroxide formation was detected only when the set 
cement samples were stored in water. Biodentine™ and Medcem MTA® formed calcium hydroxide 
in both 100% RH and in water. In Biodentine™, calcium hydroxide formation was detected at all 
the time intervals when stored in 100% RH, whereas in Medcem MTA®, calcium hydroxide 
formation was detected only after 28 days when stored in 100% RH.   
Conclusions  
All components mentioned by the manufacturer were identified in ProRoot® white MTA powder 
and Medcem MTA®. In Biodentine™ powder, dicalcium silicate, calcium oxide and iron oxide 
could not be detected. Calcium hydroxide was formed during the setting reaction of all three 
cements. However, in ProRoot® white MTA, calcium hydroxide formation was detected only when 
the set cement samples are stored in water whereas in Biodentine™ and Medcem MTA®, calcium 





Mineral Trioxide Aggregate (MTA) is a well-known tricalcium silicate based cement used in 
dentistry, relying on hydration for setting as opposed to the more usual acid–base systems 
(Darvell & Wu 2011). MTA has been studied extensively with positive results. However, the 
original product, ProRoot® white MTA has several drawbacks such as difficult handling, long 
setting time, coronal discolouration and lower compressive and flexural strength than dentine 
(Parirokh & Torabinejad 2010). Newer products contain other radiopacifiers, finer smaller 
particles, accelerators, and effective water/powder ratio using plasticizers. The challenge lies in 
effectively introducing these modifications without affecting the advantages offered by tricalcium 
silicate cements as such.  
Medcem MTA® GmbH (Weinfelden, Switzerland) is a second generation MTA consisting of pure 
Portland cement and zirconia instead of bismuth oxide as radiopacifier. Zirconia has been used 
as an alternative for bismuth oxide to prevent tooth discolouration. Moreover, it does not affect 
cement hydration and improves cement mixture homogeneity and consistency (Primus 2014). 
 Biodentine™ (Septodont, Saint Maur des Fosses, France) is also a hydraulic calcium silicate 
based cement with zirconia as radiopacifier. However, it differs compositionally from ProRoot® 
white MTA and Medcem MTA® as there is no dicalcium silicate and aluminate containing phase 
present. While Medcem MTA® and MTA are mixed with sterile water, the liquid component of 
Biodentine™ contains a plasticizer (polycarboxylate) and calcium chloride to enhance physico-
mechanical properties by accelerating the setting process. Finally, the pure synthetic tricalcium 
silicate in Biodentine™ is not contaminated with heavy metals (Camilleri et al., 2012, Grech et al., 
2013).  
Scanning electron microscopy allows observation of material microstructure and surface 
topography. Characterisation with EDS or X-ray microprobe analysis by X-ray energy dispersive 
analysis provides qualitative and semi-quantitative information about the elemental constitution 
of the materials under study. Additionally, the X-ray diffractograms are useful as tricalcium silicate 
materials are mostly crystalline and individual mineral phases could be identified.  
The compositional and setting analyses of MTA and Biodentine™ have been well documented 
(Camilleri et al., 2013, Rajasekharan et al., 2014). Along with analysis of the hydrated and 
unhydrated cement, analysing the material over different time intervals during maturation can help 
to identify the different intermediate phases that are formed during and after the initial setting 




the hydration reaction over time interval are lacking.  Likewise, literature on the composition and 
setting of Medcem MTA® is missing. Therefore, the primary aim of the present study was to 
determine the composition and compare the major constituents of three tricalcium silicate based 
cements (ProRoot® white MTA, Medcem MTA® and Biodentine™) at various time intervals up to 
28 days.  
The water/tricalcium silicate ratio affects the setting time and strength of the material (Arora et al., 
2013). The secondary aim of the present study was to assess the effect of moisture on the setting 
reaction of ProRoot® white MTA, Medcem MTA® and Biodentine™. Tricalcium silicate cements 
form calcium hydroxide during the setting, which results in an increase in pH, acts as antibacterial 
agent (Estrela et al., 2000), improves biocompatibility (Ding et al., 2008) and promotes the action 
of cementoblasts (Fridland et al., 2003). Therefore, the third aim of the present study was to 
monitor the formation of calcium hydroxide during setting using XRD and FT-IR analysis.   
Materials and Methods 
Sample preparation 
ProRoot® white MTA (Dentsply, Tulsa dental specialities; Tulsa, OK, USA), Medcem MTA® GmbH 
(Weinfelden, Switzerland) and Biodentine™ (Septodont, Saint Maur des Fosses, France) were 
mixed according to manufacturer’s instructions and allowed to set in cylindrical discs 1 mm high 
and 5 mm in diameter. Seventy discs were moulded and randomly allotted to one of the groups 
(see Figure 3.1). To determine the effect of moisture in the setting reaction, the materials were 
analysed by splitting them into two 2 groups; set cement discs were stored either in water (H2O) 
or in an atmosphere with 100% relative humidity at 37oC (RH). The samples were immersed in 2 
ml of demineralised water after their respective initial setting times i.e. after 12 minutes for 
Biodentine™ and 3 hours for ProRoot® white MTA and Medcem MTA® to monitor the setting 
behaviour of the cements in the presence of moisture.  
The phases in the maturing cement were evaluated using the powder components from each 
cement as a base line reference. Bismuth oxide, zirconium oxide, calcium hydroxide and calcium 
carbonate powder were used as reference. After the specified time period, the samples in each 
group were lyophilized at a pressurised vacuum control of 0.370 mBar overnight using a freeze 






SEM and EDS procedure and analysis 
Scanning electron microscope (SEM) analysis was performed on the powder component of the 
cement samples using a JEOL JSM-5600, Tokyo, Japan. The apparatus was used in the 
secondary electron mode (SE) or in the backscattered compositional contrast mode (BEC). This 
SEM apparatus was equipped with an electron microprobe JED 2300, Tokyo, Japan and an EDS 
(Energy Dispersive Spectroscopy) detector for semi quantitative elemental analysis. SEM-EDS is 
capable of detecting all elements from carbon to uranium, with a detection limit of circa 0.2 weight 
% for most elements. Prior to analyses, all samples were transferred to carbon tape and 
subsequently coated with a thin carbon layer via flash evaporation. The EDS analyses were 
performed in the mapping mode. For each sample, 3 areas (123 µm by 93 µm) were analysed. In 
the elemental composition analysis, carbon was excluded because the evaporated carbon on the 
surface contributes to the total carbon content. 
XRD procedure and analysis 
An X-ray diffractometer (PW1830 Philips diffractometer, Almelo, The Netherlands) with CuKα 
radiation (λ = 0.154 nm) was used. The X-ray diffraction patterns were collected between 2 
degrees to 60 degrees 2θ and scanned at steps of 0.02 degrees lasting 4 seconds each. XRD 
procedure was performed in duplicate to investigate the potential for inhomogeneity. The XRD 
peaks were analysed using the software PANalytical X’pert Quantify, Almelo, The Netherlands. 
To identify crystalline compounds, the XRD patterns were matched using the Powder Diffraction 
File (PDF) database of the International Centre for Diffraction Data (ICDD). The aim was to find 
an exact match with the 3 peaks of highest intensity obtained experimentally and the data of a 
known crystalline compound in the ICDD database to identify this compound as present (or not) 
in the measured sample.  
FT-IR procedure and analysis 
The FT-IR analysis was carried out using an FT-IR transmission instrument (PerkinElmer 
Spectrum One, Connecticut, USA). Samples were prepared for analysis by mixing a known mass 
of the experimental cement (0.85±0.05 mg) with dried potassium bromide (250±1 mg). The 
mixture was vacuum pressed to produce a disk for analysis. Infrared spectra were generated by 
using 32 scans over the wavenumber range 400–4000 cm-1 at a resolution of 1 cm-1. Two samples 





Figure 3.1: Allotment of  samples to different time intervals and medium of storage. Legend: MTA: Mineral Trioxide Aggregate; 
EDS: Energy dispersive spectroscopy; XRD: X-ray Diffractometry; FT-IR: Fourier  Transformation  Infra-red spectroscopy; RH: 
100% relative humidity at 37oC; H2O: water; min: minutes; hrs: hours 
 
The FT-IR patterns were analysed using the Spectrum software (Essential FT-IR, Virginia, USA). The recorded peaks were identified 
by reference to previously published IR data. Intensity ratios were calculated as peak heights. All peaks were noted and classified as 





SEM and EDS 
SEM micrographs of the powder component of the three dental cements at different 
magnifications are displayed in Figure 3.2. The particle size is illustrated in the low magnification 
micrographs. For ProRoot® white MTA, the particle size varies from 1 to 30 µm. The same particle 
size range was observed for Medcem MTA® (maximum diameter = 30 µm). In contrast, the 
Biodentine™ particles were smaller (maximum diameter = 10 µm). Figure 3.3 provides 
micrographs obtained with a secondary electron detector and a backscattered (compositional 
contrast) detector (upper and middle panels, respectively). The lower panels showed elemental 
maps of bismuth or zirconium obtained through EDS analyses. Bismuth oxide is present as 
radiopacifier in ProRoot® white MTA, while zirconia is present in Medcem MTA® and Biodentine™. 
 





The greyscale contrast in the secondary electron micrograph reflects topographical changes of 
the analysed surface. When a backscattered detector is used in compositional contrast mode, the 
grayscale contrast is mainly attributed to differences in composition.  
 
Figure 3.3: Micrographs of identical  regions in the powder component obtained with a secondary 
electron detector (upper panel), a backscattered  detector (middle panel) and a mapping of 
bismuth or zirconium obtained through EDS analyses (lower panel). In the BEC micrographs, a 
large contrast is obtained between material which contains elements with relatively low atomic 
number (Ca, Si and O) and material which contains elements with higher atomic number (Zr or Bi 
in this case). 
The higher the atomic number, the whiter the area or pixel will be. In case of the BEC detector 
analysis mode, the depth of information is in the order of microns while for a secondary detector, 
this value is mainly situated between 1 and 10 nm. Taking this into account, three greyscale 




assigned to the carbon tape which was used for sample preparation. The calcium silicate species 
are the grey areas on the micrographs (see Figure 3.3). 
In each sample, white spots were obtained in the BEC micrograph which can be assigned to 
particles containing atoms with a high atomic number. In case of ProRoot® white MTA, the white 
areas can be attributed to bismuth (in the form of bismuth oxide). The other two dental cements 
also contain white spots which can be attributed to zirconium (in the form of zirconia). The 
distribution of bismuth oxide and zirconia was similar for the back scattered micrograph and the 
elemental maps obtained with SEM-EDS. Furthermore, the elemental maps also show smaller 
particles of the radiopacifiers in all samples compared to the calcium silicate particle sizes. More 
white spots were present in the Medcem MTA® compared to the Biodentine™ cement. This was 
confirmed by the higher zirconia concentration in Medcem MTA® (Table 3.1). 
Species Biodentine™ Medcem MTA® ProRoot® white MTA 
Oxygen 41.0 (0.9) 38.9 (1.2) 38.0 (1.1) 
Calcium 46.9 (0.8) 32.5 (1.2) 44.1 (1.5) 
Silicon 9.0 (0.2) 6.1 (0.1) 8.9 (0.2) 
Bismuth - - 6.8 (0.5) 
Zirconium 3.1 (0.2) 20.5 (0.6) - 
Aluminium - 0.8 (0.1) 1.1 (0.1) 
Copper - - 0.5 (0.1) 
Magnesium - - 0.3 (0.1) 
Sulphur - 1.4 (0.1) - 
Iron - - 0.2 (0.1) 
Molar ratio 
Calcium/Silicon 3.85 3.78 3.34 
Silicon/Calcium 0.26 0.26 0.30 
Zirconium/Calcium 0.03 0.31 - 
Bismuth/Calcium - - 0.03 
Table 3.1. Chemical composition (weight %) and molar ratios determined with EDS analyses (n 




Finally, high magnification scanning electron micrographs are also presented in Figure 3.2. 
Smaller particles of around 500 nm were present on top of the regular particles in Medcem MTA® 
and Biodentine™. The amount of these smaller particles were higher in case of Medcem MTA® 
compared to Biodentine™. These smaller particles can be assigned to zirconia. EDS or scanning 
electron microprobe analysis was performed on the dental cements. For each analysed spot in 
the mapping mode, the elemental composition was determined and elemental maps (colour 
contrast images) were obtained. The chemical composition (wt%) of each species is shown in 
Table 3.1 along with selected molar ratios. 
XRD 
XRD analysis of the powder showed that all the three cements are crystalline, with definite peaks 
attributable to specific phases. The X-ray diffraction patterns of selected samples are presented 
in Figure 3.4. All components mentioned by the manufacturer were identified in ProRoot® white 
MTA powder and Medcem MTA®. In Biodentine™ powder, dicalcium silicate, calcium oxide and 
iron oxide could not be detected (Table 3.2).  
Tricalcium silicate was a common constituent found in ProRoot® white MTA, Medcem MTA® and 
Biodentine™ but two different forms of tricalcium silicate were identified in these cements. While 
a monoclinic form of tricalcium silicate was found in ProRoot® white MTA and Medcem MTA®, 
Biodentine™ contained a triclinic form of tricalcium silicate. 
Calcium hydroxide was formed during the setting reaction of all three cements (Figure 3.4). 
However, in ProRoot® white MTA, calcium hydroxide formation was detected only when the set 
cement samples were stored in water whereas in Medcem MTA® and Biodentine™, calcium 
hydroxide formation was observed in samples stored in 100% RH or in water. Nevertheless, in 
Biodentine™, calcium hydroxide formation was detected at all the time intervals when stored in 
100% RH, whereas in Medcem MTA®, calcium hydroxide formation was detected only after 28 
days when stored in 100% RH.  
FT-IR 
FT-IR patterns of selected samples are presented in Figure 3.5. Peaks which can be ascribed to 
the presence of hydroxyl groups (OH), carbonate (CO32-), silicon-oxygen bond (Si-O) and calcium-
silicate-hydrate (C-S-H) were identified in ProRoot® white MTA (Table 3.3), Medcem MTA® (Table 
3.4) and Biodentine™ (Table 3.5) at various time intervals. Peaks for sulphate (SO42-) were seen 

















Tricalcium silicate Ca3SiO5 42-551 34.42 32.24 29.5 X - X 
Tricalcium silicate Ca3SiO5 31-301 32.06 34.28 41.14 - X - 
Dicalcium Silicate Ca2SiO4 33-302 32.14 32.06 32.60 X - X 
Bismuth oxide α-Bi2O3 41 - 
1449 
27.34 52.38 46.30 X - - 
Calcium aluminium 
oxide 
Ca3Al2O6 38-1429 33.16 47.6 59.22 X - - 
Calcium sulphate CaSO4 37-1496 25.44 31.38 47.36 X - - 
Zirconium oxide ZrO2 37-1481 28.18 31.46 50.08 - X X 
Calcium Carbonate CaCO3 5-586 29.38 43.14 39.4 - X X 
Table 3.2. Constituents of ProRoot® White MTA, Biodentine™ and MedCem® MTA powder as identified by XRD analysis. “X” marks 
the presence of the particular constituent. 
 
4000 cm-1 to 1600 cm-1: The sharp peak for the unassociated hydroxyl group (O-H stretch) of calcium hydroxide was found at 3644 
cm-1 (see Figure 3.5, spectrum of pure Ca(OH)2). As calcium hydroxide is hygroscopic, this compound is partially hydrolysed and 
contains water prior to analysis.  Therefore its spectrum reveals an additional broad band around 3400 cm-1.  A broad band around 
3400 cm-1 is typical for any compound containing (absorbed or adsorbed) water or other hydroxyl groups. The fact that this band is 
broad originates from the hydrogen bridges present in the analysed compound(s). The hydrogen bridges perturb the O-H bond strength. 
Due to this perturbation of the O-H bond, a very large distribution of O-H bond strengths is generated which results in a broad peak 




In this study, three O-H containing species can be present in the cements throughout the 
experiments: water, calcium hydroxide, and silica. Consequently, the broad peak at 3400 cm-1 
cannot be used to distinguish these three compounds from each other with FT-IR. However, the 
sharp peak at 3644 cm-1 is typical for calcium hydroxide and can be used to identify its presence. 
The peak at 3644 cm-1 was observed in Biodentine™ starting from day 1 in both 100% RH and in 
water. In ProRoot® white MTA, this peak was also visible after 1 day but only in those samples 
stored in water. The ProRoot® white MTA samples stored at 100% RH did not reveal this peak in 
the infrared spectra. In Medcem MTA®, this peak was found in the powder itself and also at 12 
minutes and 3 hours interval. However, the sharp peak was absent when stored in 100% RH for 
1, 7, 14 and 21 days but a very weak peak reappeared at 28 days. All the three cements showed 
strong and sharp hydroxide peaks at 3644 cm-1 when the samples were stored in water. When 
the samples were stored in 100% RH, a weak but sharp hydroxide peak at 3644 cm-1 was 
observed only in the Biodentine™ group.  
1600 cm-1 to 1100 cm-1:  
The C-O bands between 1492 and 1420 cm-1 are assigned to v3 of CO32- in calcite in all cement 
groups. A strong shoulder at 1164 cm-1 arising from Si-O band weakens with ageing and shifts to 
1150 cm-1 due to polymerisation of orthosilicate units. This was observed only in the ProRoot® 
white MTA group. On the other hand, in the Medcem MTA® group, a strong shoulder arising 
around 1141 cm-1 shifted to 1150 cm-1 when stored in water. The sulphate bands (SO42-) between 
1160 and 1100 cm-1 in ProRoot® white MTA and Medcem MTA® are obscured due to 
polymerization of the orthosilicate units (Mollah et al., 1993). 
1100 cm-1 to 400 cm-1:  
The v3 of Si-O bands in the SiO44- regions occurs at 1049 – 925 cm-1 in all the cements. The 
intensity of the v3 vibrations of Si-O indicative of SiO44- decreases due to polymerization. 
Asymmetric stretching of the silicate tetrahedra of Si-O (v3 SiO44-) at 938 and 876 cm-1 and 
symmetric stretching of Si-O (v1 SiO44-) at 811 cm-1 could be observed in the Biodentine™ group. 
Out-of-plane bending vibration of Si-O (v4 SiO44-) at 525 cm-1 and the in-plane bending vibration 
of Si-O (v2 SiO44-) centred around 453 cm-1 is seen in all cements. The sharp bands at 875 and 
715 cm-1 in both ProRoot® white MTA and Biodentine™ are due to v2 and v4 vibrations of C-O 
attributed to CO32- from calcium carbonate. In the Medcem MTA®, only a sharp peak at 875 cm-1 




















28 days in 
RH 






v (OH-)       3644 s,sr 3644 s,sr 3644 s,sr 
v1 + v3 (H2O) 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 
CO32- 1796 sr,w     1786 sr,vw    
v2 (H2O) 1630 w,b 1630 w,b 1630 w,b 1630 w,b 1630 w,b 1630 sh 1630 w,b 1630 w,b 1630 w,b 
CO32- 1481 sr,s 1481 sr,m 1481 sr,m 1480 sh 1480 sh 1480 sh 1480 sr,m 1480 sr,m 1480 sr,m 
v (CO32-)  1426 sr,m 1426 sr,m 1426 sr,m 1426 sr,m 1421 sr,m 1426 sr,m 1426 sr,m 1426 sr,m 
v (CO32-) 1411 sh         
SO42- 1164 s,sh 1160 s,sh 1160 s,sh 1150 sh 1150 sh 1150 sh 1150 sh 1150 sh 1150 sh 
v3 (SO42-) 1120 sr,w 1120 sr,w 1120 sr,w 1120 sr,w 
 1100 sh 
1100 sh 1100 sh 1080 sh 1080 sh 1080 sh 
     994 w,sh 994 s,b,sh 994 m,sh 994 s,b,sh 994 s,b,sh 
v3 (Si-O) 923 sr,m 923 sr,m 923 sr,m 923 sr,m 923 sr,m 923 sr,m 923 sr,m 923 sr,m 923 sr,m 
 892 b,sh 892 b,sh 892 b,sh 892 b,sh 892 b,sh 892 b,sh 892 b,sh 892 b,sh 892 b,sh 
CO32-  874 w,sh 874 w,sh 874 w,sh 874 w,sh 874 sr,vw 874 sr,w 874 w,sh 874 w,sh 874 w,sh 
Si-O 846 m,b 846 m,b 847 m,b 847 m,b 848 m,b 848 m,b 847 m,b 848 m,b 848 m,b 
CO32-    720 sr,vw 720 sr,vw 720 sr,vw 720 sr,vw 720 sr,vw 720 sr,vw 
Al-O    617 sr,vw 617 sr,vw 617 sr,vw    
SO42-    595 sr,vw 595 sr,vw 595 sr,vw    
v4 (SiO44-) 524 sr,s 524 sr,s 524 sr,s 524 sr,s 524 sr,s 524 sr,s 520 sr,s 520 sr,s 520 sr,s 
Si-O       505 w,sh 505 w,sh 505 w,sh 
v2 (SiO44-) 454 sr,m 454 sr,m 454 sr,m 454 sr,m 454 sr,m 454 sr,m 454 sr,w 454 sr,vw  
Band intensity; vb: very broad, b: broad, s: strong, sh: shoulder, sr: sharp, m: medium, vw: very weak, w: weak 
OH-: hydroxide; H2O: water band; CO32-: carbonate; Si-O: Silicon-oxygen bond; C-S-H: calcium-silicate-hydrate; min: minutes; RH: 
relative humidity; MTA: ProRoot® white MTA™. 
 












Powder 12 min 3 hours 7 days in 
RH 










v (OH-) 3644 s,sr 3644 s,sr 3644 s,sr   3644 vw 3644 s,sr 3644 s,sr 3644 s,sr 
v1 + v3 
(H2O) 
3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 
CO32- 1796 sr,vw   1796 sr,vw 1796 sr,vw 1796 sr,w    
v2 (H2O) 1623 w,b 1624 w,b 1624 w,b 1623 w,b 1623 w,b  1647 w,b 1647 w,b 1647 w,b 
CO32- 1489 sr,s 1476 sr,m 1475 sr,m 1475 sr,m 1477 sh 1477 sh 1473 sr,m 1473 sr,m 1473 sr,m 
v (CO32-) 1416 sr,m 1418 sr,m 1419 sr,m 1419 sr,m 1419 sr,m 1421 sr,b 1426 sr,m 1426 sr,m 1426 sr,m 
v (CO32-) 1411 sh         
SO42- 1144 s,sh 1145 s,sh 1140 s,sh 1141 sh 1141 sh 1141 sh 1150 sh 1150 sh 1150 sh 
v3 (SiO42-)    1118 sr,w 1118 sr,w 1121 sr,w    
v3 (SO42-) 1104 sh 1104 sh,w 1104 sh,w   1100 sh 1108 sh 1108 sh 1108 sh 
     997 s,b,sh 997 s,b,sh 994 m,sh 994 s,b,sh 994 s,b,sh 
v3 (Si-O) 929 sr,m 929 sr,m 929 sr,m 926 sr,m 926 sr,m 926 sr,m  948 sr,vw 948 sr,w 
  889 b,sh 893 b,sh 893 b,sh 892 b,sh 892 b,sh 892 b,sh 892 b,sh 892 b,sh 
CO32-     874 sr,w 874 sr,w 874 sr,w 874 w,sh 874 w,sh 874 w,sh 
Si-O 847 vw,b 847 w,b 847 w,b 847 w,sh 848 w,sh 848 w,sh 847 w,sh 848 w,sh 848 w,sh 
CO32- 747 s,b 747 s,b 744 s,b 744 sh,w 744 sh,w 744 sh,w 744 sr,vw 744 sr,vw 744 sr,vw 
v4 (SiO44-) 522 sr,s 522 sr,s 522 sr,s 520 sr,s 520 sr,s 520 sr,s 520 sr,s 520 sr,s 520 sr,s 
v2 (SiO44-) 454 sr,m 454 sr,m 454 sr,m 451 sr,m 454 sr,m 454 sr,m 454 sr,w 454 sr,vw - 
Band intensity; vb: very broad, b: broad, s: strong, sh: shoulder, sr: sharp, m: medium, vw: very weak, w: weak 







Powder 12 min 3 hours 7 days in 
RH 
14 days in 
RH 
28 days in 
RH 
7 days in 
water 
14 days in 
water 
28 days in 
water 
v (OH-)    3644 w,sr 3644 w,sr 3644 w,sr 3644 w,sr 3644 s,sr 3644 s,sr 
v1 + v3 (H2O) 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 3430 s,vb 
v (CO32-)  2511 b,vw 2511 b,vw 2511 b,vw 2511 b,vw 2511 b,vw 2511 b,vw 2511 b,vw 2511 b,vw 
CO32- 1796 sr,vw 1796 sr,vw 1796 sr,vw 1796 sr,vw 1796 sr,vw 1796 sr,vw 1796 sr,vw 1796 sr,vw 1796 sr,vw 
v2 (H2O) 1630 w 1630 m 1630 m 1630 m 1630 m 1630 m 1630 w 1630 m 1630 w 
CO32- 1483 sh  1477 sh 1477 sh 1477 sh 1477 sh 1477 sh 1477 sh 1477 sh 
v (CO32-) 1422 s,b 1435 s,b 1435 s,b 1435 s,b 1435 s,b 1435 s,b 1435 s,b 1435 s,b 1435 s,b 
Si-O 995 sr,m 995 sr,m 995 sr,m 995 sr,vw 995 sr,vw 995 sr,vw 995 sr,vw 995 sr,vw 995 sr,vw 
v3 (Si-O) 979 sh 979 vw 979 vw 979 sh 979 sh 979 sh 978 sh 978 sh 978 sh 
Si-O 950 w 950 w 950 w 950 w 950 w 950 w 950 w 950 w 950 w 
v3 (SiO44-) 938 sr,m 938 sr,m 938 sr,m 938 sr,m 938 sr,vw 938 sr,vw 938 sr,m 938 sr,vw 938 sr,vw 
v3 (Si-O) 920 sh 920 sh 920 sh 920 sh 920 sh 920 sh 920 sh 920 sh 920 sh 
 915 vw 915 vw        
Si-O 905 sr,m 905 sr,m 905 sr,m 905 sr,m 905 sr,w 905 sr,w 905 sr,m 905 sr,w 905 sr,w 
 896 sr,w 896 sr,w 896 sr,w 896 sr,w 896 sr,vw 896 sr,vw 896 sr,w 896 sr,vw 896 sr,vw 
 885 w,b 885 w,b 885 w,b 885 sh 885 sh 885 sh 885 sh 885 sh 885 sh 
CO32-  876 sh 876 sr,w 876 sr,w 876 sr,w 876 sr,w 876 sr,w 876 sr,w 876 sr,w 876 sr,w 
CO32- 856 sr,w 856 sr,w 856 sr,w 856 sh 856 sh 856 sh 856 sh 856 sh 856 sh 
Si-O 847 w 847 w 847 w 848 vw 848 vw 848 vw 848 vw 848 vw 848 vw 
 834 sr,w 834 sr,w 834 sr,w 834 sr,vw 834 sr,vw 834 sr,vw 834 b,vw 834 b,vw 834 b,vw 
 825 b,vw 825 b,vw 825 b,vw       
 816 sr,w 816 sr,w 816 sr,w 816 sr,w 816 sr,w 816 sr,w 818 sr,vw 818 sr,vw 818 sr,vw 
v1 (SiO44-) 811 sr,w 811 sr,w 811 sr,w  811 sr,w 812 sr,vw  811 sr,w 812 sr,vw 
CO32-  713 w 713 w 713 w 713 w 713 w 713 w 713 w 713 w 
v4 (SiO44-) 525 sr,s 530 sr,s 530 sr,s 530 sr,s 530 sr,s 530 sr,s 530 sr,s 530 sr,s 530 sr,s 
v (SiO44-) 513 sh 513 sh 513 sh 513 sh 513 sh 513 sh 513 sh 513 sh 513 sh 
v2 (SiO44-) 453 sr,w 453 sr,w 453 sr,w 453 sr,vw 453 sr,vw 453 sr,vw 456 s, b 456 s, b 456 s, b 
Legend: See table 3.4 





The chemical elements determined with the semi quantitative EDS analyses correspond to the 
basic composition of the three dental cements. Calcium, silicium and oxygen were the common 
elements in all three cements. The composition of ProRoot® white MTA is tricalcium silicate, 
dicalcium silicate, tetracalcium aluminoferrite and calcium sulphate similar to the main compounds 
of Portland cement (Estrela et al., 2000). Compared to Portland cement type 1 (ASTM), the 
ProRoot® white MTA contains less toxic heavy metals (Cu, Mn and Sr), fewer chromophores (Fe, 
Co, Ni, Mn, Cr, Ti or Cu), and less Al species (Dammaschke et al., 2005).  Moreover, a smaller 
amount of gypsum was reported for ProRoot® white MTA but there is an overlap between the 
analytical peak of sulphur and bismuth in the EDS spectra (Camilleri 2008). Therefore, the 
statement that ProRoot® white MTA contains less gypsum could be a result of an over estimation 
of the sulphur concentration obtained with EDS analyses. 
ProRoot® white MTA contains bismuth oxide for radiopacity in a 4 to 1 weight ratio. Earlier reports 
have confirmed that the bismuth oxide concentration is around 20 wt% (Dammaschke et al., 2005, 
Belio-Reyes et al., 2009). However, we obtained a bismuth oxide content of about 7 wt%. Lower 
concentrations of bismuth oxide were also observed by other researchers (Setbon 2014). 
Medcem MTA® is also based on Portland cement but ZrO2 is added as radiopacifier instead of 
bismuth oxide. To the best of our knowledge, there are no reports on the composition of this 
cement. The concentration of zirconium oxide measured with EDS was 27.7wt%. Sulphur is also 
present which can be assigned to the addition of CaSO4 (gypsum). 
In contrast to ProRoot® white MTA and Medcem MTA®, Biodentine™ powder is composed of 
tricalcium silicate, calcium carbonate and zirconia (Setbon et al., 2014). In Biodentine™, high 
purity tricalcium silicate is used which is manufactured using the sol-gel method (Grech et al., 
2013). The zirconium concentration of Biodentine™ powder is 3.1 wt% and is higher than the 
values reported by Setbon et al., However, in this work, carbon is not included in the compositional 
analysis due to reasons stated above. The Zr/Ca (wt%/wt%) ratio in the present study is 0.066 
and in the work of Setbon et al. it is 0.053. Furthermore, in Biodentine™, the concentration of 
trace elements such as aluminium, magnesium and copper are below the detection limit of the 
EDS analysis.   
In the present study, by means of XRD analysis, all the constituent products as per the 
manufacturer’s specifications were identified in ProRoot® white MTA and Medcem MTA®. 




oxide could not be identified in Biodentine™ (Table 3.1). A possible explanation is the reaction of 
calcium oxide with the carbon dioxide in the atmosphere to form calcium carbonate which was 
identified in the Biodentine™ powder. Another reason could be the small quantity of iron oxide 
that makes it undetectable in the X-ray diffractograms. Dicalcium silicate, calcium oxide and iron 
oxide were also not detected in Biodentine™ by previous studies (Camilleri 2013).  
Although ProRoot® white MTA, Medcem MTA® and Biodentine™ are classified as tricalcium 
silicate cements, two different crystalline forms of tricalcium silicate were identified in these 
cements. According to the XRD investigations in the present study, the tricalcium silicate cement 
present in ProRoot® white MTA was ascribed to the Powder Diffraction File (PDF) number 42-
551. This tricalcium silicate is a solid solution containing Mg and Al and is called alite. In the clinker 
it consists of monoclinic form. On the contrary, the tricalcium silicate cement in Biodentine™ was 
ascribed to the Powder Diffraction File (PDF) number 31-301. This tricalcium silicate cement is 
free of Mg and Al and is of the triclinic form. The monoclinic form of tricalcium silicate present in 
ProRoot® white MTA and Medcem MTA®. Camilleri et al., suggested that pure synthetic tricalcium 
silicate manufactured in the laboratory instead of purifying the natural tricalcium silicate is 
advantageous as the mineral content would be constant and not affected by the sintering 
conditions or variations in the chemical composition of the raw materials. The use of pure synthetic 
tricalcium silicate instead of specific clinker could be responsible for enhanced material properties 
of Biodentine™ as compared to ProRoot® white MTA (Camilleri et al., 2013).  
The results of the present FT-IR analysis were in agreement with the study published by Camilleri 
et al., (Camilleri 2013) and other previous literature. A sharp hydroxide peak was found at 3644 
cm-1 which can be attributed to calcium hydroxide (Mollah et al., 2000, Perraki et al., 2003, Ylmén 
et al., 2009, Gandolfi et al., 2010). In accordance with the present study, Mollah et al., identified 
the  gradual  broadening  of  the  water  region toward  lower  frequency (1650 cm-1)  as  indicative  
of  either stronger H-bonding or incorporation of water into crystal  lattice (Mollah et al., 2004). A 
broad peak centred around 3400 cm-1 is due to symmetric and anti-symmetric stretching 
vibrations of adsorbed water molecules (Farmers 1974). The strong band around 1431 cm-1 may 
correspond to the asymmetric stretching of CO32- as it is not possible to prevent incorporation of 
carbon dioxide (CO2) during sample preparation (Mojumdar & Raki 2006).  
The absorptions in the 930–840 cm-1 range as well as the band at 523 cm-1 could reveal the 
presence of poorly polymerised silicate tetrahedra present during hydration of the cement (Taddei 
et al., 2009). Peaks indicative of SiO44- were identified at 525 cm-1 and 453 cm-1 in the three 




identified. Silicon ions are clinically relevant as they have been reported to promote osteoblast 
proliferation and gene expression by involvement in metabolism, collagen synthesis, bone 
mineralization, and connective tissue cross-linking (Hung et al., 2013). Thus, silicon enhances the 
rate of new bone growth and induce remineralisation of demineralised dentin when released from 
bioactive materials (Han & Okiji 2011). 
Although the hydration of these hydraulic cements is quite complex, it is known that poorly 
crystalline C-S-H of variable stoichiometries and calcium hydroxide are the two principal hydration 
products formed (Mollah et al., 1993). C-S-H is a specific annotation where C, S and H stand for 
CaO, SiO2 and H2O, respectively.  The dashes indicate unspecified composition in any 
amorphous or poorly crystalline calcium silicate hydrate (Gougar et al., 1996). C-S-H comprises 
approximately 50 mol% of most cement pastes, which makes it quantitatively the most important 
cement hydrate. C-S-H is an essentially amorphous material, which makes its characterisation 
rather difficult. The type of developing C–S–H phases is influenced by the Ca/Si ratio. The C-S-
H formed by the hydration of tricalcium silicate is a particularly disordered variety. However, the 
exact composition of the C–S–H phases at different Ca/Si ratios remains unclear and can vary.  
The clinical importance of the formation of calcium hydroxide in pulp therapy materials has been 
emphasized repeatedly in the literature (Okiji & Yoshiba 2009, Guerreiro-Tanomaru et al., 2012). 
The calcium hydroxide formed upon hydration may be responsible for the regenerative potential 
of these cements (Faraco & Holland 2001, Rao et al., 2009, Camilleri et al., 2013). At the cellular 
level, calcium ions released from tricalcium silicate cements are known to activate the MAPK 
signalling pathway, thereby inducing the mRNA expression of genes associated with 
odontoblastic differentiation and mineralisation (Peng et al., 2011). It has been speculated that 
calcium and hydroxide ions when in contact with the pulp, promote the nucleation and growth of 
mineralised tissue (Holland et al., 2002). The hydroxide anion is considered to be the most 
important component of calcium hydroxide as it provides an alkaline environment, which 
encourages repair and active calcification (Perraki et al., 2003).  
The calcium hydroxide formed during hydration is directly proportional to the Ca/Si 
(calcium/silicium) molar ratio and modifies the development of the strength and porosity of the 
hardened cement (Gonzalez & Irassar 1997).  Samples with Ca/Si molar ratio > 1.3 contain more 
Ca2+ions than needed to neutralize the non-bridging oxygens.  These excess Ca2+ ions must form 
Calcium-Hydroxide (Ca-OH) bonds.  Ca-OH  bonds  could  also be present  at  lower  Ca/Si  ratios  
for  which  there  is  not enough  Ca2+  for  charge  balance,  and  their  presence would  require  




OH bonds could also occur at Ca/Si ratios greater than 1.3 if there are additional Ca-OH bonds. 
At larger Ca/Si ratios, structural regions with high concentrations of Ca-OH bonds are detectable 
by XRD as Portlandite (Cong & Kirkpatrick 1996). In the present study, Ca/Si molar ratios (3.34, 
3.78 and 3.85) are obtained in ProRoot® white MTA, Medcem MTA® and Biodentine™ 
respectively, which substantiates the fact that there are sufficient Ca2+ ions to form Ca-OH bonds.  
For the XRD analysis, the sharp 2ϴ peak at 18.08 was used for identifying calcium hydroxide as 
this was the only peak of calcium hydroxide without overlap from any other constituents (Lee et 
al., 2004, Camilleri et al., 2013). Calcium hydroxide peaks in ProRoot® white MTA were detected 
only after maturation in water during 7, 14, 21 and 28 days. On the other hand, calcium hydroxide 
peaks were seen irrespective of whether the Biodentine™ samples were stored in 100% RH or in 
water. The intensity of the calcium hydroxide peaks was always higher for Biodentine™ compared 
to that for ProRoot® white MTA and Medcem MTA®. However, higher intensity could not be taken 
as an indication of the concentration without quantification through elimination of other 
confounding factors. The results of the XRD analysis are in accordance to the FT-IR results. It is 
noteworthy that the calcium hydroxide peaks in both XRD and FT-IR analyses indicate the 
formation of calcium hydroxide and not the release of calcium and hydroxide ions in water, 
surrounding the cement. Furthermore, the Calcium and hydroxide ions in the cement itself will 
precipitate and form Ca(OH)2 upon lyophilization.  
In the clinical setting, pulp tissue and dentinal tubules act as a source of moisture, as ProRoot® 
white MTA, Medcem MTA® and Biodentine™ are dental cements used in pulp therapy. Apart from 
these inherent sources of moisture, one should also take into account that manufacturers advice 
the use of a wet cotton pellet (for perforation and root apexification treatment procedures) till the 
final setting of ProRoot® white MTA has been completed and this could be an important source 
of moisture that might have a direct correlation to the formation of calcium hydroxide during the 
setting reaction. In the case of Biodentine™, the cement can be used as a temporary restorative 
material for six months, which would expose the set cement to saliva and moisture within the oral 
cavity (Koubi et al., 2013).  
Conclusion 
Calcium hydroxide is formed during the setting reaction of all three cements when stored in water. 
In ProRoot® white MTA, calcium hydroxide formation was detected only when the set cement 
samples were stored in water whereas in Biodentine™ and Medcem MTA®, calcium hydroxide 




formation of calcium hydroxide and release of calcium and hydroxide ions during and after the 
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Effect of exposed surface area and volume on the calcium ion release of three 
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To analyse the effect of volume and surface area on the calcium ion release of three different 
tricalcium silicate cements (TSCs) viz. ProRoot® white MTA, Medcem MTA® and Biodentine™. 
Methods 
ProRoot®® white MTA (Dentsply, Tulsa dental specialties; Tulsa, OK, USA), Medcem MTA® 
GmbH (Weinfelden, Switzerland) and Biodentine™ (Septodont, Saint Maur des Fosses, France) 
were mixed according to manufacturer’s instructions and randomly allotted to one of four groups 
with different exposed surface area and volume. Each sample was separately immersed in 10 ml 
deionized ultra-pure water. pH and calcium ion release was measured after 3 hours, 1, 3, 7, 14 
and 28 days using a pH glass electrode (Primatrode, Metrohm, Switzerland) and an atomic 
absorption spectrophotometer (Varian SpectrAA-30, Agilent Technologies, Santa Clara, USA).  
Results 
At all the time intervals, there was no significant difference (p > 0.05) in ∆pH and calcium ion 
release between groups with equal surface area. There was no significant difference in pH and 
calcium ion release between the three biomaterials in groups with 1.77 mm2 exposed surface 
area (p > 0.05). In groups with 17.62 mm2 exposed surface area, calcium ion release was in the 
order of Biodentine™ > ProRoot®® white MTA > Medcem MTA® (p < 0.05). 
Conclusions 
∆pH and calcium ion release at each measured time interval were dependent on the exposed 










Tricalcium silicate cements (TSCs) are widely used in endodontics and in dental traumatology for 
pulp capping, pulpotomy, root-end filling, perforation repair, root resorption, apexification and 
obturation of root canals (Gandolfi et al., 2014). These indications are based on the ability of TSCs 
to form calcium hydroxide upon hydration (Massi et al., 2011), which subsequently dissociates 
into calcium ions and hydroxide ions (Ballal et al., 2010). Calcium ions activate a series of 
signalling pathways associated with mineralization (Duarte et al., 2009, Peng et al., 2011) and 
hydroxide ions are responsible for antibacterial and anti-inflammatory activity (Holland et al., 
2002, Shen et al., 2010).  
Numerous tricalcium silicate based cements with subtle variations in composition and 
manufacturing process are commercially available for endodontic applications. In this respect 
ProRoot®® white MTA (Dentsply, Tulsa dental specialties; Tulsa, OK, USA), Medcem MTA® 
GmbH (Weinfelden, Switzerland) and Biodentine™ (Septodont, Saint Maur des Fosses, France) 
are three representative cements. Although tricalcium silicate is the main ingredient, their 
behaviour can be different due to diverse radiopacifiers (Hungaro Duarte et al., 2012), variations 
in the manufacturing process, purity of the constituents and hydration products (Kouzmanova et 
al., 2015). 
Each clinical application requires varying volume of TSC to be used at the site of repair, depending 
on the severity of the infection. Also, the surface area of biomaterial exposed to the surrounding 
oral tissues varies widely. Despite the numerous studies analysing the pH and calcium ion release 
of ProRoot® MTA (Han et al., 2015, Duarte et al., 2003, Amini Ghazvini et al., 2009, Gandolfi et 
al., 2012, Gandolfi et al., 2011, Han & Okiji, 2013, Gandolfi et al., 2013, Gandolfi et al., 2015, 
Gandolfi et al., 2014), there has been no research on the effect of volume and exposed surface 
area on the release of calcium and hydroxide ions. Moreover, studies of the pH and calcium ion 
release of Medcem MTA® are lacking. Hence the aim of the present study was to analyse the 
effect of volume and surface area on the calcium ion release and pH of three TSCs viz. ProRoot® 
white MTA, Medcem MTA® and Biodentine™. 
Materials and Methods  
Sample preparation 
ProRoot® white MTA, Medcem MTA® GmbH and Biodentine™ were mixed according to 




group) with different dimensions. The four groups had varying length (L), diameter (ϕ), exposed 
surface area (ESA) and volume (Vol) as follows: 
Group 1 (G1): L 5 mm, ϕ 1.5 mm, ESA 1.77 mm2 and Vol 8.835 mm3 
Group 2 (G2): L 10 mm, ϕ 1.5 mm, ESA 1.77 mm2 and Vol 17.67 mm3 
Group 3 (G3): L 5 mm, ϕ 3.5 mm, ESA 17.62 mm2 and Vol 48.11 mm3 
Group 4 (G4): L 10 mm, ϕ 3.5 mm, ESA 17.62 mm2 and Vol 96.22 mm3 
ESA and Vol was calculated using the formulae for ´area of circle´ (𝐸𝑆𝐴 = 𝜋𝑟2) and ´volume of a 
cylinder´ (𝑉𝑜𝑙 = 𝜋𝑟2𝐿) respectively; where r is the radius (ϕ/2). The groups were designed in such 
a way that groups 1 and 2 had a smaller ESA compared to groups 3 and 4. The Vol increased 
from groups 1 to 4. The cement was condensed into cylindrical acrylic resin (Plexiglas) vessels. 
The condensed cements were allowed to set in an atmosphere of 100% relative humidity at 37 
oC. After the initial setting time of each cement (12 minutes for Biodentine™ and 180 minutes for 
ProRoot® white MTA and Medcem MTA®) each sample was separately immersed in 10 ml 
deionized ultra-pure water (MilliQ Academic, Millipore, Bedford, USA) and gently shaken at 37 
oC. After 3 hours, 1, 3, 7, 14 and 28 days the samples were taken out of the solution, blotted dry 
with filter paper and transferred to 10 ml of fresh deionized water for further elution.  
pH and calcium ion release measurement  
The pH of the solutions were measured with a pH glass electrode (Primatrode, Metrohm, 
Switzerland). Calcium ion release was measured using an atomic absorption spectrophotometer 
(Varian SpectrAA-30, Agilent technologies, CA, USA) equipped with a specific calcium hollow 
cathode lamp (Agilent technologies, CA, USA). Absorbance was determined at a wavelength of 
422.70 nm, using a slit width of 0.2 nm and lamp current of 10 mA. 
An air/acetylene flame and 0.2 M HCl/4000 mg/L La (LaCl3) as buffer were used. Buffers were 
added to both standard and diluted sample solutions to eliminate interference. The results were 
calculated using a calibration curve established on the basis of standard solutions (1 – 5 ppm 
Ca). Standards were prepared from a 1000 mg/L calcium in HCl solution (as CaCl2, Titrisol, Merck 
Millipore, Darmstadt, Germany). The relative uncertainties at 95% confidence level on the amount 
of calcium was determined as 2%.  
Calcium ion release analysis    
The cumulative release of calcium ions was calculated. Regression analysis, curve fitting and 




Data were subjected to statistical analysis (analysis of variance) and individual comparisons were 
performed by using the Bonferroni method at a significance level of p < 0.05 using Statistical 
Package for Social Sciences (SPSS) v 21.0 (IBM Corp., Armonk, USA). 
 Results  
pH rise (∆pH) and calcium ions released by the TSC during consecutive elutions are summarized 
in Table 1 and Table 2 respectively. At all the time intervals, ∆pH and calcium ion release of each 
TSC did not differ significantly between groups with the same ESA (p > 0.05). However, ∆pH and 
calcium ion release increased significantly with increasing ESA (p < 0.05). The above results 
indicated that ∆pH and calcium ion release were independent of the Vol. As an exception, 3 hours 
after immersion in water, Biodentine™ showed no significant difference in ∆pH between all the 4 
groups.  
At all the time intervals, there was no significant difference in ∆pH and calcium ion release 
between the TSC’s studied in groups with smaller ESA. In groups with larger ESA, Biodentine™ 
showed a significantly higher calcium ion release than ProRoot® MTA and Medcem MTA® (p < 
0.05). Moreover, there was an inconsistent but significant difference in the pH rise of Biodentine™ 
compared to ProRoot® MTA and Medcem MTA® in groups with higher ESA. ProRoot® MTA 
demonstrated a significantly higher ∆pH and calcium ion release (p < 0.05) than Medcem MTA® 
in groups with higher ESA after 7 days.  
The effect of ESA and Vol on calcium ion release as substantiated by the statistical results can 
be seen in Figure 1 where the cumulative calcium release (R in µmoles) plotted versus the 
corresponding time in hours. Non-linear regression analysis of the cumulative calcium ion release 
demonstrated that the data are best represented by Equation [1] on the basis of F statistic, 
corresponding p value, residual sum of squares, correlation coefficient (r2) and standard error of 
estimate.  
R = R∞ (1 - e-βt)δ .....................................................................................................................[1] 
The three parameters characteristic for equation [1], R∞, β and δ are summarized in Table 4.1.3. 
R∞ denotes the maximum amount of calcium ions released at infinity while β is related to the rate 
at which R reaches the maximum. The equation [1] without the exponent ‘δ’ represents a pure 
dissolution controlled process. δ is added to the equation as a correction for the deviation from a 
pure dissolution controlled release indicating a possible combination of dissolution and diffusion 















ProRoot® white MTA 0.75 (0.03) 1.34 (0.45) 1.55 (0.06) 1.89 (0.12) 1.69 (0.10) 1.91 (0.13) 
Medcem MTA® 0.81 (0.07) 1.20 (0.04) 1.17 (0.03) 1.36 (0.04) 1.50 (0.13) 2.06 (0.10) 












ProRoot® white MTA 0.67 (0.03) 1.13 (0.09) 1.31 (0.11) 1.69 (0.08) 1.69 (0.15) 1.63 (0.25) 
Medcem MTA® 0.76 (0.07) 1.04 (0.12) 0.97 (0.11) 1.07 (0.10) 1.07 (0.14) 1.63 (0.12) 











ProRoot® white MTA 3.52 (0.75) 3.52 (0.64) 2.85 (0.76) 6.93 (1.07) 8.92 (0.33) 10.23 (0.52) 
Medcem MTA® 3.25 (0.37) 3.29 (0.50) 2.45 (0.45) 3.89 (1.26) 3.76 (0.99) 4.63 (2.02) 












ProRoot® white MTA 3.19 (0.44) 4.04 (0.45) 1.89 (0.13) 6.42 (0.45) 9.42 (0.38) 9.17 (0.86) 
Medcem MTA® 3.42 (0.36) 3.76 (0.71) 2.54 (0.37) 4.03 (0.72) 4.20 (1.19) 5.94 (2.55) 
Biodentine™ 10.32 (1.02) 7.96 (0.68) 9.18 (0.86) 12.98 (0.89) 12.44 (2.12) 21.21 (0.94) 
 
Table 4.1.1. Amount of calcium ions released (in µmol) in 4 groups with corresponding standard deviation (n=6) between 
















ProRoot® white MTA 0.64 (0.01) 0.76 (0.04) 1.43 (0.02) 1.51 (0.17) 0.56 (0.08) 0.86 (0.10) 
Medcem MTA® 0.27 (0.01) 0.23 (0.12) 1.35 (0.05) 1.31 (0.04) 1.46 (0.05) 1.05 (0.05) 












ProRoot® white MTA 0.96 (0.25) 1.01 (0.17) 1.42 (0.35) 1.32 (0.43) 1.35 (0.12) 1.50 (0.06) 
Medcem MTA® 0.12 (1.24) 0.93 (0.94) 1.35 (0.30) 1.53 (0.57) 1.57 (0.64) 1.32 (1.06) 











ProRoot® white MTA 3.56 (0.65) 4.11 (0.32) 2.53 (0.34) 3.91 (0.64) 4.93 (0.10) 5.18 (0.08) 
Medcem MTA® 2.65 (1.12) 2.99 (0.80) 1.86 (0.81) 3.14 (0.53) 3.95 (0.58) 3.67 (0.94) 












ProRoot® white MTA 4.09 (0.25) 4.27 (0.17) 3.32 (0.35) 4.24 (0.43) 4.89 (0.12) 5.13 (0.05) 
Medcem MTA® 2.99 (1.24) 3.22 (0.94) 2.59 (0.30) 3.35 (0.57) 3.82 (0.64) 4.01 (1.06) 
Biodentine™ 1.10 (0.35) 2.91 (0.70) 4.18 (0.24) 4.67 (0.12) 4.87 (0.32) 5.32 (0.05) 
  
Table 4.1.2. ΔpH in 4 groups with corresponding standard deviation (n=6) between parenthesis of the TSC variants 















ProRoot® white MTA 10.11 (0.25) 2.34 (0.06) 0.54 (0.01) 5.73 (0.18) 0.99 (0.00) 
Medcem MTA® 11.49 (0.42) 0.77 (0.07) 0.44 (0.01) 12.37 (0.99) 0.99 (0.00) 












ProRoot® white MTA 9.04 (0.35) 2.30 (0.09) 0.55 (0.01) 6.12 (0.28) 0.99 (0.00) 
Medcem MTA® 9.61 (0.37) 0.61 (0.10) 0.39 (0.01) 13.24 (2.23) 0.99 (0.00) 












ProRoot® white MTA 70.43 (0.47) 0.43 (0.07) 0.52 (0.01) 30.78 (6.02) 0.99 (0.01) 
Medcem MTA® 37.33 (0.52) 0.43 (0.08) 0.39 (0.02) 18.47  (3.47) 0.93 (0.07) 












ProRoot® white MTA 64.333 (0.52) 0.47 (0.02) 0.52 (0.01) 27.63 (1.32) 0.98 (0.00) 
Medcem MTA® 126.50 (0.55) 0.01 (0.00) 0.36 (0.01) 501.00 (61.99) 0.92 (0.10) 
Biodentine™ 711.49 (0.54) 0.00 (0.00) 0.40 (0.00) 1820.70 (152.02) 0.99 (0.00) 
Legend: Values and corresponding standard deviation in column 3, 4 and 5 are the parameters of the 
cumulative calcium release according to Eq. [1]: R = R∞(1-e−βt) δ. t½ represents the half-life time (days) of the 
calcium release and r2 (correlation coefficient) values represent the goodness of fit of equation [1]. 
  
Table 4.1.3 Values of the parameters of the equation [1], t½ and r2 with corresponding standard deviation (n=6) 





Figure 4.1.1: Cumulative calcium ion release (R) of the TSCs studied (in µmoles) as a function of time. The points represent the measured 
values and the lines show the calculated values according to equation [1] with the values for the parameters given in Table 4.1.3. Bio: 








 Figure 4.1.2: Cumulative calcium ion release rate of the TSCs studied as a function of size. Bio: Biodentine™; MCM: Medcem MTA®; 




Half-life time (t½) is calculated using equation [1] as the time needed to release half of R∞ and 
is an indicator of the longevity of the reaction (in Table 4.1.3). The r2 value gives the goodness 
of fit of the equation (in Table 4.1.3). In figure 4.1.1, the points represent the measured values 
and the full lines show the calculated values according to equation [1]. The release rate of 
each TSC in each pH milieu was calculated as the derivative (dCa/dt) and is illustrated in 
figure 4.1.2. The slope of the curve indicates the decrease in rate of R with respect to time. A 
steep fall in the curve would suggest a high decrease in reaction rate and flattening of the 
curve suggests decreased long-term release rate of calcium ions. 
For each TSC, the R∞ was significantly different between the 4 groups (p < 0.05) indicating 
that R∞ was dependent on the volume of the biomaterial. This also holds true for the t1/2 (p < 
0.05). Likewise, Biodentine™ showed a significantly higher R∞ and t1/2 than ProRoot® MTA (p 
< 0.05) and Medcem MTA® (p < 0.05). However, the rate at which R reaches saturation was 
significantly different between groups with different ESA (p < 0.05). Apparently the volume did 
not play a significant role in the ‘β’ parameter of equation [1]. 
Discussion  
The methodology used in this study included filling standardized vessels with the biomaterial 
to be tested and immersing them in distilled water. The same methodology has been used in 
previous studies (Hungaro Duarte et al., 2012, Jacinto et al., 2015, Linhares Gda et al., 2013, 
Amini Ghazvini et al., 2009, Tanomaru-Filho et al., 2011, Tanomaru-Filho et al., 2009, de 
Vasconcelos et al., 2009, Candeiro et al., 2012, Santos et al., 2005, Massi et al., 2011, 
Gandolfi et al., 2014, Gandolfi et al., 2012, Gandolfi et al., 2013, Dawood et al., 2014) but the 
ESA, volume, pH of distilled water and/or time between manipulation of the cement and 
immersion in distilled water were dissimilar. Hence, a direct comparison of the calcium ion 
release and pH changes found in the present study with those in previous studies was not 
possible.  
At all measured time intervals, ∆pH and calcium ion release was dependent on ESA while 
there was no correlation between the volume and the ∆pH or calcium ion release. ESA also 
determines the rate at which R reaches saturation irrespective of the TSC variant. Compared 
to the present findings, a consistently higher pH and calcium ion release has been observed 
in the previous studies using ProRoot® MTA (Gandolfi et al., 2014, Gandolfi et al., 2013, 
Gandolfi et al., 2012) and Biodentine™ (Dawood et al., 2014). This could be due to the 
increased surface area of the specimens used in these studies: ProRoot® MTA and 
Biodentine™ had an exposed surface area of 50.24 mm2 and 140.74 mm2 respectively. 
Similarly, studies that used a smaller ESA (0.79 mm2) exhibited lower calcium ion release in 




these studies used distilled/deionized water at a pH ranging from 6.8 – 7.0 compared to 5.7 
used in the present study. Besides, the samples were not always immersed in water after the 
setting time. 
The R∞ and the t1/2 was significantly different in all the four groups.  These were the only two 
factors dependent on the volume of the TSC.  The presence of adequate calcium ions for 
dissociation on the exposed surface of the TSC sample might be an explanation. Apparently 
the calcium is leaching from a thin surface layer of the TSC. The effect of the surface on the 
Ca release however increased with increasing volume for ProRoot® MTA and Medcem MTA®.  
On the long-term, diffusion of calcium from deep within the sample might occur for all TSCs, 
as indicated by the R∞ and t1/2. 
In specimens with larger surface area (17.62 mm2), R of Biodentine™ was higher than 
ProRoot® MTA and Medcem MTA® (Table 4.1.3). Increased R of Biodentine™ could be 
responsible for the induction of more rapid calcified tissue deposition compared to MTA 
(Shayegan et al., 2012).  Reasons for increased R with Biodentine™ could be the presence 
of pure synthetic tricalcium silicate (Grech et al., 2013), absence of dicalcium silicate and 
tricalcium aluminate, smaller particle size (Saghiri et al., 2015), increased solubility (Kaup et 
al., 2015, Dawood et al., 2014, Singh et al., 2015) and addition of calcium chloride to the liquid 
component (Camilleri et al., 2012, Linhares Gda et al., 2013).  The use of calcium chloride in 
the liquid component resulting in faster setting of Biodentine™ not only increases the calcium 
ion release by increased calcium hydroxide formation but also contributes to the calcium ion 
release by unreacted calcium chloride. 
Only positive ΔpH values were obtained at all the time intervals irrespective of the TSCs being 
evaluated, showing that the eluted components were of alkaline nature. This is possibly due 
to the formation of calcium hydroxide during the setting of the tricalcium silicate based 
cements. A correlation between ΔpH and Log[Ca] was generally observed for ProRoot® MTA 
and Medcem MTA®. However, such correlation was sporadic in the case of Biodentine™. 
These findings could also be explained by the presence of calcium chloride in the liquid 
component of Biodentine™.   
In vitro studies and animal models evaluating TSCs for calcium release and mineralization 
should consider the exposed surface area and volume of TSC to be used when devising the 
methodology. The present results could be partially translated to a clinical environment, where 
TSCs would release calcium and hydroxide ions when in contact with an aqueous 
environment. However, the results of the present study should be interpreted with caution as 




completely set. This is in contrast to the clinical setting where TSCs come in contact with the 
tissues even before their initial setting time (Fridland and Rosado, 2003).   
The exposed surface in the present study was either 1.77 mm2 or 17.62 mm2. A clinical 
analogy would be that for a maxillary central incisor requiring pulpotomy, the average surface 
area of the pulp tissue exposed to the TSC would be approximately 1.86 mm2. Clinical 
translation of the current results would mean that in pulp capping or pulpotomy procedure, the 
amount of calcium ions released would not be dependent on the TSC variant as the ESA 
would be minimal in these cases. On the other hand, treatment modalities such as root-end 
filling, which possess a large surface area of lesion would benefit from increased calcium ion 
release when using Biodentine™ compared to ProRoot® MTA or Medcem MTA®. 
Mineralization and dentine bridge formation in pulp capping and pulpotomy procedures could 
be promoted by increasing the ESA within the clinical limitations. At the same time, the 
practitioner should be aware of the risks of enlarging pulpal exposure at the cost of introducing 
bacteria into uninflamed, sterile pulp neighbouring the infected pulp. Also, in the era of minimal 
invasive dentistry, removal of any healthy tissue is unwarranted for unless the same could 
improve the prognosis of the treatment. In clinical procedures such as obturation of root canal 
and perforation repair, an increased volume of the TSC would help in sustained long-term 
release of calcium ions.  
Conclusion  
On the short-term, pH and calcium ion release depend on the ESA, whereas the maximum 
amount of calcium ions released at infinity (R∞) is dependent on the volume of TSC. For small 
ESA (1.77 mm2), there was no difference between the three TSCs. In the higher ESA group 













4.2 Effect of pH on the calcium ion release of three tricalcium silicate cements 
Abstract  
Aim To evaluate the calcium ion release of three hydraulic tricalcium silicate cements exposed 
to aqueous solutions with different pH. 
Methods ProRoot® white MTA (Dentsply, Tulsa dental specialties; Tulsa, OK, USA), Medcem 
MTA® GmbH (Weinfelden, Switzerland) and Biodentine™ (Septodont, Saint Maur des Fosses, 
France) were mixed according to manufacturer’s instructions and condensed into cylindrical 
acrylic resin (Plexiglas) tubes of size 10 mm length and 1.5 mm internal diameter. The tubes 
were open only at one end and were randomly immersed in 10 ml of glycine buffer (pH=10.4), 
HEPES buffer (pH=7.4) or butyric acid buffer (pH=4.4). Six cylindrical tubes per material and 
buffer solution were shaken at 37oC. The solutions were collected and renewed after 3, 24, 72 
and 168 hours. Calcium ion release was measured at each time interval using an atomic 
absorption spectrophotometer (Varian SpectrAA-30, Agilent Technologies, Santa Clara, 
USA).  
Results Calcium ion release was highest in acidic environment (pH 4.4) and decreased 
drastically in alkaline environment (pH 10.4) at each time interval. The concentration of 
released calcium ions was in the order of Biodentine™ > ProRoot® white MTA > Medcem 
MTA® in all three pH milieus. 
Conclusions All the TSCs released more calcium ions in the acidic solution when compared 
to the neutral solution which was in turn more than in the alkaline solution. Biodentine™ 
released more calcium ions than ProRoot® white MTA and Medcem MTA® irrespective of the 
pH of the environment. In neutral solution, only Biodentine™ released more than 0.2 mM 
calcium ions at all the time intervals. 0.2 mM calcium ions is considered as a threshold for 












ProRoot® white MTA (Dentsply, Tulsa dental specialties; Tulsa, OK, USA), Medcem MTA® 
GmbH (Weinfelden, Switzerland) and Biodentine™ (Septodont, Saint Maur des Fosses, 
France) are endodontic cements with tricalcium silicate as primary ingredient. Mineral Trioxide 
Aggregate (MTA) as a cement and its clinical applications in endodontics and dental 
traumatology have been studied extensively with positive results. On the other hand, literature 
also mentions several drawbacks such as difficult handling, long setting time, possible 
discoloration, lower compressive and flexural strength compared to dentine (Parirokh and 
Torabinejad, 2010). More recently developed Medcem MTA® is a so-called second generation 
MTA consisting of purified Portland cement and zirconium oxide instead of bismuth oxide as 
radiopacifier as the latter was considered responsible for discoloration. Biodentine™ also 
contains zirconium oxide as radiopacifier and is well-known for its faster setting time and 
superior physical properties (Rajasekharan et al., 2014). 
Tricalcium silicate cements (TSCs) are generally rich in calcium compounds and form calcium 
hydroxide during and after the clinical setting period. Calcium hydroxide has proven properties 
of stimulating mineralization (Holland et al., 1999), protecting the pulp against thermoelectric 
stimuli and favouring antibacterial action (Duarte et al., 2007). However, to exert their 
biological and microbiological action, the calcium and hydroxide ions formed must be released. 
Calcium ions in specific, play a fundamental role in mineralization due to the induction of 
cellular migration and differentiation (Takita et al., 2006, Maeda et al., 2010). However, 
quantification of the formation of calcium hydroxide and subsequent release of calcium ions 
after the setting of these TSCs would provide a better insight into the clinical significance of 
this release (Maeno et al., 2005). In the past, several studies analysed calcium ion release 
from different MTA formulations (Hungaro Duarte et al., 2012, Tanomaru-Filho et al., 2009, 
Linhares Gda et al., 2013, Duarte et al., 2000, de Vasconcelos et al., 2009, Saghiri et al., 
2015) and Biodentine™ (Grech et al., 2013) in water. However, to the best of the author’s 
knowledge, there are no published studies on calcium ion release of Medcem MTA®. 
Moreover, the effect of acidic, neutral and alkaline pH on calcium ion release of TSCs remains 
unexplored. Hence, the aim of the present study was to analyse the effect of pH on the calcium 
ion release of three TSCs (ProRoot® white MTA, Medcem MTA® and Biodentine™). 
Material and Methods  
Sample preparation 
ProRoot® white MTA, Medcem MTA® and Biodentine™ were mixed according to the 
manufacturer’s instructions. The cements were condensed gently in cylindrical Plexiglas 




area of 1.77 mm2 and volume of 17.67 mm3 (n = 18 per cement group). Obturation efficiency 
was verified by radiographs and weight. The cements were allowed to set in an atmosphere 
with 100% relative humidity at 37 oC during their initial setting time of 12 minutes for 
Biodentine™ and 180 minutes for ProRoot® white MTA and Medcem MTA®. Three buffer 
solutions were prepared: 20 mM glycine (Merck Millipore, Darmstadt, Germany) buffered to a 
pH of 10.4, 20 mM HEPES (Fluka, Sigma Aldrich, Diegem, Belgium) buffered to a pH of 7.4 
and 20 mM butyric acid (Merck Millipore, Darmstadt, Germany) buffered to a pH of 4.4. 
Cylindrical vessels were randomly allocated to each group of the pH buffer solutions (n = 6 
per cement group).  Each vessel was placed in 10 ml of respective pH medium in a PE flask 
immediately after their setting time. The sealed flasks were stored at 37 oC on a shaker. The 
amount of calcium released into the pH buffer solution was determined at 3, 24, 72 and 168 
hours. At each specific time interval, the vessels were moved to new flasks with fresh buffer 
solution and the liquid in which they were previously kept was subjected to calcium analysis. 
Calcium ion release measurement  
The release of calcium ions was measured using an atomic absorption spectrophotometer 
(Varian SpectrAA-30, Agilent technologies, CA, USA) equipped with a specific calcium hollow 
cathode lamp (Agilent technologies, CA, USA). The spectrophotometer was operated 
following the manufacturer’s instructions using a wavelength of 422.70 nm, slit width of 0.2 nm 
and a current of 10 mA for the lamp. 
An air/acetylene flame and 0.2 M HCl/4000 mg/L La (LaCl3) as buffer were used. Buffer was 
added to both standard and diluted sample solutions to eliminate interference and to match 
the pH of all solutions. The results were calculated using a calibration curve established on 
the basis of standard solutions (1 – 5 ppm Ca). Standards were prepared from a 1000 mg/L 
calcium in HCl solution (as CaCl2, Titrisol, Merck Millipore, Darmstadt, Germany). The relative 
uncertainties at the 95% confidence level on the amount of calcium was determined as 2%.  
Calcium ion release analysis    
The cumulative release of calcium ions was calculated. Regression analysis, curve fitting and 
graphs were performed using Matlab 8.0 (The Mathworks Inc., Massachusetts, U.S.A) 
software (See Annex 1). Data were subjected to statistical analysis (analysis of variance) and 
individual comparisons were performed by using the Bonferroni method at a significance level 








Table 4.2.1 summarizes the amount of calcium ions released (in µmoles) at each time interval. 
Cumulative calcium release (R in µmoles) is plotted versus time in figure 4.2.1. Non-linear 
regression analysis of the cumulative calcium ion release demonstrated that the data are best 
represented by Equation [1] on the basis of F statistic, corresponding p value, residual sum of 
squares, correlation coefficient (r2) and standard error of estimate. 
R  = R∞ (1 - e-βt) δ………………………………..............…………………………............………..[1] 
The three parameters characteristic for equation [1], R∞, β and δ are summarized in Table 
4.2.2. R∞ denotes the maximum amount of calcium ions released at infinity while β is related 
to the rate at which R reaches saturation. The equation [1] without the exponent ‘δ’ represents 
a pure dissolution controlled process. δ is added to the equation as a correction for the 
deviation from a pure dissolution controlled release indicating a possible combination of 
dissolution and diffusion control process taking place. Half-life time (t½) is calculated using 
equation [1] as the time needed to release half of R∞ and is an indicator of the longevity of the 
reaction (in Table 4.2.2). The r2 value gives the goodness of fit of the equation (in Table 4.2.2). 
In figure 4.2.1, the points represent the measured values and the full lines show the calculated 
values according to equation [1]. The release rate of each TSC in each pH milieu was 
calculated as the derivative (dCa/dt) and is illustrated in figure 4.2.2. The slope of the curve 
indicates the decrease in rate of [Ca2+]cum release with respect to time. A steep fall in the curve 
would suggest a high decrease in reaction rate and flattening of the curve suggests decreased 
long-term release rate of calcium ions. 
General trends in calcium release  
Calcium release profiles of the three TSCs showed certain general trends. Based on the 
parameters of equation [1], the maximal R represented by R∞ was significantly higher in acidic 
solution followed by neutral and alkaline solution (p < 0.05) except for ProRoot® white MTA 
which showed a maximal R∞ in neutral solution (p < 0.05). In acidic and alkaline solution, 
Biodentine™ released the maximum R∞ (p < 0.05) while in a neutral solution, ProRoot® white 
MTA released the maximum R∞ (p < 0.05). 
The t1/2 value indicating the longevity of the calcium ion release was different for the TSCs 
studied and varied with respect to pH. Biodentine™ exhibited the highest t1/2 at acidic and 
neutral pH (p < 0.05) whereas Medcem MTA® showed significantly higher t1/2 at alkaline pH (p 






Table 4.2.1. Amount of calcium ions released (in µmol) with corresponding standard deviation 




Table 4.2.2. Values of the parameters of the equation [1], t½ and r2 with corresponding standard 
deviation (n=6) between parenthesis of the TSC variants studied as a function of pH. 
 






® white MTA 2.41 (0.68) 5.39 (0.71) 6.96 (0.82) 8.69 (0.70) 
Medcem MTA® 2.83 (1.27) 5.39 (0.19) 6.04 (0.19) 7.79 (0.40) 






® white MTA 1.23 (0.09) 2.40 (0.22) 3.31 (0.09) 7.15 (0.50) 
Medcem MTA® 1.38 (0.23) 2.97 (0.30) 3.81 (0.24) 4.97 (0.17) 






 ProRoot® white MTA 0.92 (0.19) 0.39 (0.10) 0.28 (0.05) 0.30 (0.05) 
Medcem MTA® 0.75 (0.12) 0.21 (0.03) 0.34 (0.03) 0.55 (0.09) 
Biodentine™ 2.13 (0.91) 1.07 (0.31) 0.72 (0.65) 1.74 (0.82) 
Legend: pH 4.4, 7.4 and 10.4 indicate the pH of butyric acid buffer, HEPES buffer 
and glycine buffer respectively.  






® white MTA  68.67 (0.58) 0.97 (0.08) 0.58 (0.00) 15.78 (1.20) 0.98 (0.04) 
Medcem MTA® 197.33 (0.51) 0.08 (0.00) 0.51 (0.00) 151.92 (1.77) 0.98 (0.03) 






® white MTA 792.74 (0.73) 0.02 (0.00) 0.73 (0.00) 856.16  (23.31) 0.98 (0.00) 
Medcem MTA® 139.40 (0.57) 0.09 (0.01) 0.57 (0.00) 156.79 (13.77) 0.99 (0.00) 






 ProRoot® white MTA 8.45 (0.21) 0.01 (0.00) 0.21 (0.00) 363.05 (7.10) 0.90 (0.11) 
Medcem MTA® 14.39 (0.26) 0.00 (0.00) 0.26 (0.00) 1668.10 (75.16) 0.93 (0.04) 
Biodentine™ 37.67 (0.26) 0.00 (0.00) 0.26 (0.00) 917.92 (42.99) 0.82 (0.09) 
Legend: Values and corresponding standard deviation in column 3, 4 and 5 are the parameters of 
the cumulative calcium release according to Eq. [1]: R = R∞(1-e−βt) δ. t½ represents the half-life time 







Figure 4.2.1: Cumulative calcium ion release ([Ca2+]cum) of the TSCs studied (in µmoles) as a function of time. The points represent the measured 
values and the lines show the calculated values according to equation [1] with the values for the parameters given in Table 2. Bio: Biodentine™; 











The biological effects of TSCs are mostly attributed to the formation of calcium hydroxide during 
and after the setting of these hydraulic cements. The clinical importance of the formation of 
calcium hydroxide during the setting of endodontic materials has been emphasized repeatedly in 
the literature (Okiji and Yoshiba, 2009, Guerreiro-Tanomaru et al., 2012). An increase in 
extracellular calcium ion concentration by 0.2 – 0.7 mM in cell culture media could elevate bone 
related gene expression in human dental pulp cells (Rashid et al., 2003). In the present study 
more than 0.2 mM calcium ion release was seen for all cements in acidic solution. However, in 
neutral solution, only Biodentine™ released more than 0.2 mM calcium ions at all the time 
intervals. All the cements released less than 0.2 mM calcium ions at an alkaline solution. 
The presence of calcium compounds in a dental material does not imply their dissociation and 
release by the materials after setting, because the setting reaction and the presence of other 
constituents can inhibit the release of calcium ions (Staehle et al., 1995). Another factor which 
could inhibit/promote calcium ion release from the materials is a change of the pH of the 
environment during and after the setting of TSCs. An acidic pH in the root canal could be due to 
the ingress of tissue fluids from dentinal tubules, exudate/pus from periapical area and from the 
acidification process caused by inflammatory cells. On the other hand, endodontic medication 
(calcium hydroxide with pH 12.4) and irrigants (5% sodium hypochlorite with pH 11) and irrigants 
with high pH can lead to a sustained high alkalinity in the root canal between appointments 
(Tronstad et al., 1981).  
An acidic or alkaline pH has been known to alter the physical and chemical properties of TSCs 
(Lee et al., 2004). In acidic pH, inability to set (Watts et al., 2007, Namazikhah et al., 2008), 
impaired sealing ability (Saghiri et al., 2008), reduced surface hardness (Namazikhah et al., 
2008), decreased push-out bond strength (Shokouhinejad et al., 2010) and diminished diametrical 
tensile strength (Shie et al., 2009) of MTA have been reported. Similarly, in alkaline pH, decreased 
push-out bond strength (Saghiri et al., 2010), low surface hardness and increased porosity of 
white MTA has been reported in the literature (Saghiri et al., 2009). In certain clinical applications, 
TSCs could be placed in an environment where inflammation may be present and consequently, 
the surface of the material will be exposed to low pH environment.  
Different pH buffers and different types of acids have diverse effects on the calcium ion release 
due to the varying chelation effect. In the present study, we used butyric acid buffer, as butyric 




the conditions of periradicular infections (Namazikhah et al., 2008). Also, in situations where the 
initiating and perpetuating factors of an inflammatory process are removed by appropriate 
treatment, the pH of the environment returns to normal within 168 hours (Namazikhah et al., 2008)  
justifying the duration of the present study. 
The increase of the calcium ion release observed in a solution of pH 4.4 could be due to increased 
solubility (Yavari et al., 2013) at highly acidic pH (Namazikhah et al., 2008, Lee et al., 2004). This 
leads to increased porosity of the cements and consequently diminished physical characteristics 
of the restorative material. In acid medium H+ ions could cleave Ca-O bonds in the cement, 
leading to erosion of the cement and dissolution of calcium hydroxide and consequent leaching 
of calcium ions. Calcium hydroxide is easier to dissolve in acid medium resulting in cleavage of 
the Ca-O bond of calcium hydroxide by H+, thus formation of H2O and free calcium ions.  In 
alkaline medium the solubility of calcium hydroxide is decreased due to the common ion effect 
(OH-), resulting in the lower calcium ion release. 
Translation of these in vitro results clinically would imply the necessity to decrease inflammation 
and if possible, perform a two session treatment with placement of an alkaline medication such 
as calcium hydroxide between the appointments (Yavari et al., 2013). Furthermore, these results 
also signify that highly alkaline pH is harmful to calcium ion release and thorough irrigation of the 
root canal space between the usage of alkaline calcium hydroxide and the endodontic filling 
material is an absolute necessity to neutralize the pH of the root canal. Obturation of root canal 
space with TSCs is best preceded with thorough saline irrigation to neutralize the effect of other 
root canal irrigants. 
Calcium ion released by Biodentine™ was generally higher than that of ProRoot® white MTA and 
Medcem MTA® at every time interval irrespective of the pH of the solution. Also, the t1/2 of 
Biodentine™ was higher at acidic and neutral pH. The presence of pure synthetic tricalcium 
silicate (Grech et al., 2013), absence of dicalcium silicate and tricalcium aluminate and addition 
of calcium chloride to the liquid component (Camilleri et al., 2012) could cause the increased 
calcium ion release with Biodentine™.  Moreover, the use of calcium chloride in the liquid 
component of Biodentine™ not only increases the calcium ion release by increased calcium 
hydroxide formation but also contributes to the calcium ion release by unreacted calcium chloride. 
The results of the present study must be interpreted with caution as the effect of pH on calcium 
ion release was not evaluated during the setting but after the initial setting times of the materials. 




and Inductively coupled plasma atomic emission spectrometry are other techniques that could be 
used in the future studies to validate the current findings. The evaluation of such properties of the 
recently developed materials is fundamental (de Vasconcelos et al., 2009), because the effect of 
compositional differences of each TSC variant on its calcium ion release properties is still not 
precisely known. Also, the relationship between extracellular calcium ion concentration and cell 
behaviour need to be studied extensively. 
Conclusion  
All the three TSCs released more calcium ions in acidic solution when compared to neutral 
solution which in turn resulted in more calcium release than alkaline solution. Biodentine™ 
released more calcium ions than ProRoot® white MTA and Medcem MTA® irrespective of the pH 
of the environment. An alkaline pH in the root canal would be detrimental to the calcium ion 
release of the tricalcium silicate based endodontic cements. In neutral solution, only Biodentine™ 
released more than 0.2 mM calcium ions at all the time intervals. 0.2 mM calcium ions is 























SURFACE TOPOGRAPHY AND CYTOTOXICITY 
















































































Surface topography and cytotoxicity analysis of three tricalcium silicate cements on 
fibroblasts and osteoblasts – an explorative study 
Abstract  
Introduction 
Endodontic cements in contact with periapical tissues may result in bone tissue reaction either 
directly or by release of soluble components. The aim of the present study was to evaluate in 
vitro cytotoxicity of three different commercially available tricalcium silicate based endodontic 
cements on MG-63 osteosarcoma and Human foreskin fibroblast (HFF) cell lines. 
Materials and methods 
ProRoot® white MTA (Dentsply, Tulsa Dental Specialties, Tulsa, OK, USA), Medcem MTA® 
GmbH (Weinfelden, Switzerland) and Biodentine™ (Septodont, Saint Maur des Fosses, France) 
were mixed and extract cytotoxicity was tested in HFF-1 cells. Direct contact effects on viability 
and cell adhesion was evaluated in MG-63 osteosarcoma cell line. Qualitative analysis was 
done using live/dead staining and MTT assay was used for quantitative viability analysis. 
Scanning electron microscopy, energy dispersive spectroscopy and optical profilometry was 
performed to evaluate surface microtopography, surface composition and surface roughness, 
respectively. 
Results 
Surface roughness was in the order of ProRoot® MTA > Medcem MTA® > Biodentine™. Extract 
cytotoxicity demonstrated that the cytotoxicity of tested materials was dose dependent. 
Live/dead staining after direct cytotoxicity revealed that Biodentine™ showed high cytotoxicity 
before and low cytotoxicity after extraction for 28 days in medium. There was no significant 
difference between the three tricalcium silicate cements with regard to cell adhesion (p > 0.05) 
after extraction for 28 days in medium, Biodentine™ showing significantly higher cell viability 
than positive control (p < 0.05). 
Conclusion 
No correlation can be established between surface roughness and cell adhesion in the tested 
cements. The cytotoxic effects of all three tricalcium silicate cements tested were dose 






Mineral trioxide aggregate (MTA) is a widely researched tricalcium silicate based cement that 
provides exceptional results in various endodontic indications. Newer cements are being 
developed to overcome the drawbacks of MTA such as a long setting time, risk of coronal 
discoloration, difficult handling and low compressive strength. Biodentine™ (Septodont, Saint 
Maur des Fosses, France) was developed to overcome these limitations by using zirconium oxide 
as a radiopacifier, reduction of the particle size and addition of calcium chloride. Medcem MTA® 
GmbH (Weinfelden, Switzerland) is referred to as a second generation MTA by the manufacturer 
and also uses zirconium oxide instead of bismuth oxide as in the original formula. 
Endodontic cements in contact with periapical tissues may result in bone tissue reaction either 
directly or by release of soluble components. Fibroblasts and osteoblasts are the major 
responsive host cells involved in periapical tissue regeneration induced by root-end filling 
materials (Yan et al., 2010). These cells are in intimate contact with the biomaterial and are 
responsible for the repair, remodelling, and regeneration of the adjacent periodontal ligament, 
alveolar bone and cementum (Boyko et al., 1981). Hence, it is important to evaluate the 
cytotoxicity of root-end filling material on these cells (Chen et al., 2009).  
Extract tests, direct contact and indirect contact tests are the three types of cytotoxicity tests 
stated in ISO 10993-5. The extract test is suitable for detecting the toxicity of eluted substances 
and it could be correlated with the results of animal toxicity tests. Assessing the toxicity of elutes 
simulates the clinical situation where soluble components released from tricalcium silicate 
cements are diluted by tissue fluids and carried to the surrounding cells and tissues (Yoshino et 
al., 2013, Bin et al., 2012, Ma et al., 2011). The direct contact assay is a very sensitive test for 
cytotoxicity of endodontic cements as it helps to observe even weak cytotoxicity (De Melo et al., 
2013).  
In a study conducted on human alveolar bone marrow stem cells, Margunato et. al. concluded 
that ProRoot® MTA is less toxic and more efficient to stimulate mineralisation processes compared 
to Biodentine™ (Margunato et. al., 2015). Jung et. al. established that Biodentine™ and MTA 
induce differentiation and mineralisation of human dental pulp cells in a similar manner (Jung et. 
al., 2015). In another study with fibroblasts of periodontal ligament, Escobar-Garcia et.al., 
declared that neither Biodentine™ nor MTA was cytotoxic in incubation periods of up to 5 days 
(Escobar-Garcia et.al., 2016).These contrasting results could be explained by the difference in 




ingredient in all the three cements, their cytotoxicity behaviour could be different owing to, for 
instance, diverse radiopacifiers (Hungaro Duarte et al., 2012), variations in the manufacturing 
process, purity of the constituents and hydration products (Kouzmanova et al., 2015). Hence, the 
aim of this study was to quantitatively and qualitatively analyse the cytotoxicity of ProRoot® White 
MTA, Biodentine™ and Medcem MTA® by means of extract tests and direct contact tests.  
Materials and Methods  
Cell culture preparation 
MG-63 osteosarcoma cells (American Type Culture Collection, ATCC, USA) and Human foreskin 
fibroblasts (HFF-1) (American Type Culture Collection, ATCC, USA) were cultured in MEM alpha 
medium and DMEM GlutaMAX respectively. The medium was supplemented with 20% foetal 
bovine serum (Gibco, Invitrogen, USA), 1% sodium pyruvate (Gibco, Invitrogen, USA) and 0.5% 
penicillin-streptomycin (Gibco, Invitrogen, USA). Cells were cultured at 37oC in a humidified 
atmosphere with 5% carbon-dioxide. MG-63 cells were used for the purpose of direct contact 
effects on viability and cell adhesion tests while fibroblasts were used for extract cytotoxicity 
analysis. 
Preparation of test materials 
ProRoot® white MTA (Dentsply, Tulsa Dental Specialties, Tulsa, OK, USA), Medcem MTA® 
(Weinfelden, Switzerland) and Biodentine™ (Septodont, Saint Maur des Fosses, France) were 
mixed according to the manufacturer’s instructions and allowed to set in cylindrical discs (1 mm 
high by 5 mm diameter) in a sterile environment. After the initial setting time of 12 minutes for 
Biodentine™ and 3 hours for ProRoot® MTA and Medcem MTA®, all samples were subjected to 
ultraviolet radiation for one hour. Cytotoxicity and cell viability assays were performed either as 
such or after extraction of the cements before seeding the cells. Extraction of cement samples 
were performed by immersion in 2ml MEM alpha medium at 37oC for 1 or 28 days. All tests were 
performed in triplicate. 
Surface topography analysis 
Scanning electron microscope (SEM) analysis was performed using a JEOL JSM-5600 (Jeol Ltd., 
Tokyo, Japan). The apparatus was used in the secondary electron mode (SE) or in the 
backscattered compositional contrast mode (BEC). This SEM apparatus was equipped with an 
electron microprobe JED 2300 (Jeol Ltd., Tokyo, Japan and an energy dispersive spectroscopy 




weight % for most elements. All samples were prepared for analyses by transferring to a carbon 
tape and subsequently coated with a thin carbon layer via flash evaporation. The EDS analyses 
were performed in the mapping mode. Three areas (123 µm by 93 µm) were analysed for each 
sample. In the elemental composition analysis, carbon was excluded because the evaporated 
carbon on the surface would lead to a bias in the total carbon content. Three-dimensional images 
and surface roughness were obtained from a NT3300 WYKO (non-contact optical profilometer). 
Each analysed area consists of a rectangular spot of 111 µm x 147 µm. 
Extract cytotoxicity 
Extracts  were  prepared  in  accordance  with  the  international  ISO  10993–Part  12  standard 
using HFF medium as the extraction medium. The initial surface area-to-volume extraction ratio 
was 1.2 cm2/ml. The cements were immersed in medium and incubated at 37 °C for 7, 14 and 21 
days under dynamic conditions (gyratory shaker).  HFF cells were seeded in 96-well culture plates 
at a density of 20000 cells/well in 200 µl of HFF medium. The  medium  was  withdrawn  and  200  
µl  extraction  medium (corresponding to 1.2 cm2/ml, 0.6 cm2/ml, 0.3 cm2/ml, 0.1 cm2/ml, 0.05 
cm2/ml and 0.01 cm2/ml ratio of surface area to culture medium) was  added  and  incubated  for  
2  days.   
Direct contact effects on viability 
The samples were placed on top of a monolayer of MG-63 cells, which were seeded before 1 day 
at a concentration of 100000 cells/ well in a 24-well culture plate. Cells cultured on tissue culture 
polystyrene were taken as positive control. Live/dead staining and MTT assays were performed 
after 1 day.  
Cell adhesion 
Cements were placed in 96 well plates and 20,000 cells/ well were seeded on top of the samples. 
For MTT assay, cement samples immersed in medium without cells were used as negative 
control.  Live/dead staining and MTT assays were performed post-seeding after 1 day. In 
accordance with ISO 10993-5 standards, all tests were performed in triplicate. 
MTT assay 
To  quantify  cell  viability, the  colorimetric 3-(4,5-dimethyl-2-thiazolyl)- 2,5-diphenyl-2H-
tetrazolium bromide (methyl thiazolyl tetrazolium; MTT) assay was  performed. The tetrazolium 
component is reduced in living cells by mitochondrial dehydrogenase enzymes to a water-




and measured using spectrophotometry. The cell culture medium was replaced by 0.5 mg/ml MTT 
reagent and cells were incubated for 4 hours at 37°C. After removal of the MTT reagent, lysis 
buffer (1% Triton X-100 in isopropanol/0.04 N HCl) was added  and  incubated  for  30  min  at  
37°C  on  a  gyratory  shaker  (70  rpm).  The  dissolved  formazan  solution  was  transferred  into  
a  96-well  plate  and  the  optical  densities  (OD)  were  measured spectrosphotometrically  at  
580  nm  (Universal  Microplate  Reader  EL  800,  Biotek  Instruments, Vermont, USA)  in triplicate. 
Cell viability was calculated according to the following equation:  
Cell viability (%) = 100 x OD (mean of sample) / OD (mean of control).                      
Live/dead staining 
Live/dead staining was performed using calcein acetoxymethyl (AM) ester (Tebu-Bio, Belgium) / 
propidium iodide (PI; Sigma-Aldrich). Calcein AM is a non-fluorescent membrane-permeable dye. 
The dye converts into a membrane-impermeable, green fluorescent compound under intracellular 
esterase activity (excitation: 490 nm, emission 515 nm). PI enters dead cells through 
compromised cell membranes where it intercalates into double-stranded DNA thereby emitting 
red fluorescence (excitation: 535 nm, emission: 617 nm). The samples were rinsed with 500 µL 
phosphate buffered saline (PBS). Subsequently, 500 µL PBS; 1 µL PI (1mg/ml) and 1µL calcein 
AM (1mg/ml) was added to each well. After 10 minutes incubation in a dark room, samples were 
evaluated with a fluorescence microscope (Type U-RFL-T, Olympus, Belgium). 
Statistical analysis 
Statistical analyses was performed by Kruskal-Wallis and Mann-Whitney U tests using the SPSS 
v21.0 (IBM Corp., Armonk, New York, USA). The level of significance was set at 0.05. 
Results 
Surface topography 
The surface roughness of each material was measured with an optical profilometer and expressed 
as RRMS. RMS is the root mean square average of the profile height deviations from the mean 
line, recorded within the evaluation length. The RRMS for ProRoot® MTA (5.04 µm) were higher 
than Medcem MTA® (3.26 µm), followed by those of Biodentine™ (2.02 µm) (figure 5.1a).  
SEM analysis of the powder component indicated that the particle size varied from 1 to 30 µm for 
ProRoot® MTA and Medcem MTA®, whereas the maximum diameter for Biodentine™ was only 




bismuth oxide and zirconia was evident. More spots with zirconia were present in Medcem MTA® 
compared to Biodentine™ as also confirmed by the scanning electron microprobe analyses 
(Figure 5.1.b-h). EDS analyses showed the chemical composition (wt%) of each species (Table 
5.1).  
SEM images of the cement samples immersed in medium for 1, 7, 14, 21 and 28 days showed 
that the surface evolved smoother with increase in time and deposition of sodium, chloride and 
phosphate on the surface was observed. The presence of cauliflower like structures on ProRoot 
MTA® after 7 days immersion in medium (Figure 5.1e) could indicate the formation of calcium 
phosphate and/or calcium carbonate. This was also in correlation with the EDS analysis, where 
the elemental composition of silica decreased drastically, denoting the formation of a silica-free 
layer on top of the cement sample. This phenomenon occurs at 28 days in Biodentine™ and 
Medcem MTA® but in ProRoot MTA®, the same was observed after 1 day (Table 5.1). Also from 
the EDS analysis of ProRoot MTA®, we could see that the weight percentage of calcium is very 
high compared to that of phosphorous and this could mean that other calcium compounds such 
as calcium hydroxide and calcium carbonate are formed in addition to the calcium phosphate on 
the surface. The presence of phosphorous could not be identified in Biodentine™ and Medcem 
MTA® due to the overlap with zirconium. The formation of calcium carbonate could also not be 
verified by EDS analysis as the samples were carbon coated. The difference in the SEM images 
seen between the three cements at day 1, 7, 14, 21 and 28 could be due to the rate of formation 
of calcium phosphate and/or calcium carbonate on the surface. Extract cytotoxicity 
Cell viability was classified as non-cytotoxic (>90%), slightly cytotoxic (60 – 90%), moderately 
cytotoxic (30 – 59%) and severely cytotoxic (<30%) (Sjogren et al., 2000). All the three materials 
were severely cytotoxic at all time limits when undiluted, and non-cytotoxic at 1/8 and 1/16 dilution. 
Non-diluted extracts of all three materials were significantly more cytotoxic than the positive 
control (p < 0.05). At 1/2 dilution, only Biodentine™ was significantly more cytotoxic than positive 
control (p < 0.05). On the contrary, at 1/16 dilution only Biodentine™ showed significantly higher 
cell viability than positive control (p < 0.05). Results of extract cytotoxicity indicated that the 
cytotoxic effect of the tricalcium silicate cements under investigation were dose dependent (Figure 
5.2). 
Direct contact effects on viability 
MTT assay did not show any statistically significant difference between the materials in the direct 




to extract cytotoxicity (Figure 5.3.a-c). It was seen that unextracted Biodentine™ sample was 
severely cytotoxic but extracted Biodentine™ samples showed high cell viability. On the other 
hand, Medcem MTA® and ProRoot® MTA cytotoxicity results did not show significant difference 
between extracted and unextracted samples (p < 0.05). 
Cell adhesion  
When using unextracted samples, cell viability was significantly higher in Medcem MTA® than 
Biodentine™ (p < 0.05).  After extraction (1 or 28 days), there was no significant difference 
between the three tricalcium silicate cements. After 1 day extraction only Medcem MTA® showed 
significantly more cell adhesion than positive control (p < 0.05), and after 28 days extraction only 
Biodentine™ was significantly better than positive control (p < 0.05). Qualitative live/dead staining 

















Table 5.1: Chemical composition (wt%) determined with EDS analyses (n=3). The corresponding 
standard deviation is given within the parenthesis.  
Biomaterial Element Powder 1 day 28 days 
Biodentine™ Oxygen 42.60 (1.02) 40.14 (0.29) 38.86 (1.95) 
Calcium 46.03 (1.35) 48.53 (0.13) 32.35 (1.64) 
Silicon 8.37 (0.12) 8.91 (0.17) 0.09 (0.03) 
Zirconium 3.07 (0.45) 2.43 (0.01) 0.44 (0.02) 
Sodium   15.06 (1.71) 
Chloride   12.28 (1.95) 
Potassium   0.50 (0.02) 
Sulfur   0.44 (0.05) 
ProRoot® MTA Oxygen 40.10 (2.70) 47.10 (0.32) 40.95 (0.64) 
Calcium 42.47 (2.32) 48.30 (0.52) 34.29 (1.69) 
Silicon 8.97 (0.26) 1.16 (0.24) 2.15 (0.73) 
Bismuth 7.07 (0.96) 0.97 (0.76) 3.45 (0.95) 
Aluminium 1.10 (0.08)  0.35 (0.11) 
Magnesium 0.37 (0.05)  0.31 (0.00) 
Sodium  1.15 (0.12) 12.53 (0.92) 
Chloride  0.75 (0.01) 3.71 (0.19) 
Potassium    0.49 (0.02) 
Phosphorous  0.59 (0.02) 1.77 (0.43) 
Medcem MTA® Oxygen 38.07 (0.70) 33.64 (0.22) 40.56 (0.35) 
Calcium 32.23 (1.43) 34.08 (0.86) 29.30 (0.01) 
Silicon 6.00 (0.28) 5.19 (0.17) 1.43 (0.08) 
Zirconium 23.00 (1.79) 22.77 (0.89) 10.31 (0.12) 
Aluminium 0.70 (0.00) 0.62 (0.04)  
Sodium  1.55 (0.20) 11.53 (0.31) 






Figure 5.1.a: Two-dimensional (left) and three-dimensional (right) images of the surface of 
Biodentine™, Medcem MTA® and ProRoot® MTA (from top to bottom) as assessed with an optical 
profilometer. The colour scale bar on the right of each image shows that the images are 
characterized by three colours (blue, green and red). Each colour indicates a range of surface 
roughness; blue (0 to -10 µm), green (0 to10 µm) and red (10 to 20 µm). Hence, the presence of 
red areas indicate increased surface roughness as compared to blue and green regions. The 






Figure 5.1.b: SEM analysis of the powder component of Biodentine™, Medcem MTA® and 







Figure 5.1.c: BEC images of the powder component of Biodentine™, Medcem MTA® and 
ProRoot® MTA (from top to bottom). The arrows indicate the presence of radiopacifier (zirconium 
oxide in Biodentine™ and Medcem MTA®; and bismuth oxide in ProRoot® MTA). Green indicates 





Figure 5.1.d: SEM images of the set cement samples of Biodentine™, Medcem MTA® and 
ProRoot® MTA (from top to bottom) at 500x (left) and 2000x (right) magnification after 1 day 







Figure 5.1.e: SEM images of the set cement samples of Biodentine™, Medcem MTA® and 
ProRoot® MTA (from top to bottom) at 500x (left) and 2000x (right) magnification after 7 days 







Figure 5.1.f: SEM images of the set cement samples of Biodentine™, Medcem MTA® and 
ProRoot® MTA (from top to bottom) at 500x (left) and 2000x (right) magnification after 14 days 






Figure 5.1.g: SEM images of the set cement samples of Biodentine™, Medcem MTA® and 
ProRoot® MTA (from top to bottom) at 500x (left) and 2000x (right) magnification after 21 days 






Figure 5.1.h: SEM images of the set cement samples of Biodentine™, Medcem MTA® and 
ProRoot® MTA (from top to bottom) at 500x (left) and 2000x (right) magnification after 28 days 






Figure 5.2: Cell viability (%) after extraction cytotoxicity as analysed by MTT assay. v0, v1, v2, 
v3 and v4 represent undiluted, 1/2, 1/4, 1/8 and 1/16 dilution. The MTT assay was performed after 
7, 14 and 21 days (from top to bottom). Similar alphabets represent significant difference (p < 





In the present study the cytotoxicity of Biodentine™ reduced significantly after extraction in 
medium (Figure 5.4a). These results were similar to a previous study using human dental pulp 
stem cells (Bortoluzzi et al., 2015b). In the present study, unextracted/undiluted Biodentine™ 
showed less cell viability as compared to ProRoot® MTA in both fibroblasts and osteoblasts 
(Figure 5.2 and 5.4a). Inconsistent results were seen in the literature where Biodentine™ 
performed better (Jung et al., 2014), similar (Corral Nunez et al., 2014, Cornelio et al., 2015, Jung 
et al., 2015, Silva et al., 2016) or worse (Samyuktha et al., 2014) than MTA. Such controversial 
results may be related to the type of target cells, method of cytotoxicity assessment, direct contact 
of cells with the materials, concentration of materials and assessment time points. 
The surface characteristics of biomaterials, such as their roughness and chemical composition, 
regulate in vitro and in vivo cellular responses, such as cell adhesion, cell survival, cell cycle 
progression, cell differentiation, and bony tissue formation and deposition (Biela et al., 2009, 
Perez et al., 2003). Scanning electron microscopy allowed observation of material microstructure 
and surface topography. Characterisation with EDS provided qualitative and semi-quantitative 
information about the elemental constitution of the material surface under study.  
Although research has shown that cells are affected by the surface topography (Boyan et al., 
1999, Schwartz et al., 1999), the smallest dimension that these cells may sense in early phases 
of interaction has not yet been accurately determined (Saldana et al., 2007). It follows that no 
correlation can be established between surface roughness and cell adhesion in the tested 
cements. In the present study, surface roughness was in the order of ProRoot® MTA > Medcem 
MTA® > Biodentine™. This could be because of the finer and more homogenous particle size of 
Biodentine™ when compared to the other cements as reported in the literature and confirmed in 
the present study (Camilleri et al., 2013, Nagas et al., 2016, Han & Okiji, 2011) 
On the other hand, the high correlation observed between the results of extract cytotoxicity and 
cell adhesion could suggest that the results of the cytotoxicity profiles of the cements analysed 
were more dependent on the surface chemistry of the cement rather than on the surface 
topography of the sample itself. The proportions of silicon or calcium in the calcium silicate cement 
may play a dose-dependent role in increasing cell growth on the material (Shie et al., 2012). The 
calcium/silicon molar ratio in the powder of Biodentine™, Medcem MTA® and ProRoot® MTA was 




A significant difference in cell viability was observed between unextracted Biodentine™ and 
Biodentine™ after 28 days extraction (p < 0.05). Cell viability strongly increased to up to 300% 
after 28 days extraction. This could be due to the extraction of initial cytotoxic components formed 
in Biodentine™ immediately after the setting or due to the formation of a hydroxyapatite layer or 
both. This phenomenon was observed in all the three tricalcium silicate cements but only 
Biodentine™ and Medcem MTA® showed a significant difference in viability between unextracted 
samples and samples after 28days extraction.   
 
Figure 5.3.a: Brightfield and immunofluorescence images after tests assessing direct contact 
effects on viability (without extraction in medium) of positive control, Biodentine™, Medcem MTA® 





Figure 5.3.b: Brightfield and immunofluorescence images after tests assessing direct contact 
effects on viability (after extraction in medium) of positive control, Biodentine™, Medcem MTA® 







Figure 5.3.c: Cell viability (%) after direct contact as analysed by MTT assay. There was no 
significant difference between the groups studied.  
                                                                             
Figure 5.4.a: Cell viability (%) after cell adhesion cytotoxicity as analysed by MTT assay. Similar 
alphabets represent significant difference (p < 0.05) between the two groups.  





Figure 5.4.b: Immunofluorescence imaging after cell adhesion test. Rows 1, 2, 3 and 4 show 
positive control, Biodentine™, Medcem MTA® and ProRoot® MTA respectively. Columns 1, 2 and 
3 represent cell adhesion without extraction, after 1 day extraction in medium and after 28 days 








Extracted Biodentine™ showed an increased cell viability compared to ProRoot® MTA (Figure 
5.4a). This could be explained by the difference in composition between Biodentine™ and 
ProRoot® MTA. While the use of bismuth oxide in ProRoot® MTA has been previously questioned 
since it does not promote cell growth (Camilleri et al., 2004, Corral Nunez et al., 2014), the use of 
zirconium oxide as a radiopacifier (Kucukkaya et al., 2016) could have attributed to the non-
cytotoxic effect of Biodentine™. Cytotoxicity of bismuth oxide assessed using several cell line 
models revealed it to be cytotoxic in short-term culture (1 day), but after 2 days the cells were 
able to repair damage (Kim et al., 2008). Conversely, studies assessing the toxicity of zirconium 
oxide have shown more favourable results. Zirconium oxide has been shown to have a non-
cytotoxic effect on mouse fibroblast cells and human differentiated cells (Dion et al., 1997, Corral 
Nunez et al., 2014, Gomes Cornelio et al., 2011, Silva et al., 2014). 
Rapid production and dissolution of calcium hydroxide could explain the severe cytotoxicity 
exhibited without extraction (Kim et al., 2015). A high pH due to the gradual release of hydroxyl 
ions may decrease cell viability in vitro and could be responsible for the initially high cytotoxicity 
of non-extracted Biodentine™. (Mozayeni et al., 2012). The initial rise in surface pH can cause 
denaturation of proteins in both adjacent cells and the medium (Bortoluzzi et al., 2015a). However, 
under in vivo conditions a high pH due to alkaline hydroxyl ions may be neutralized by the body 
tissue fluid and may not cause significant effects on cell viability (Kucukkaya et al., 2016). The 
occurrence of chemical irritation by endodontic cements following the formation of calcium 
hydroxide is cytotoxic, although not at a detrimental level, because the presence of a thin necrotic 
zone is known to initiate a non-extensive inflammatory process leading to cell migration, 
proliferation and new collagen deposition (Yoshino et al., 2013).  
Elution substances from tricalcium silicate cements can induce cytotoxicity and hence the 
presence of heavy metals in the cement could play a role in the elute composition (Gomes 
Cornelio et al., 2011). The use of pure synthetic tricalcium silicate in Biodentine™ is in contrast 
to other tricalcium silicate cements based on Portland cement, such as MTA, which intrinsically 
contain unpurifiable blends with low concentrations of metallic impurities. Moreover, the mineral 
content in Biodentine™ would be constant and not affected by the sintering conditions or 
variations in the chemical composition of the raw materials (Camilleri et al., 2013). This could also 
be responsible for the significantly better cell viability after longer extraction periods. 
Finally, in all laboratory studies limitations to simulate the complex biological conditions of the 
clinical status exist and hence the results obtained from the present study must be observed with 




reliable means for comparing and testing new materials. Future research should analyse the 
chemical composition of the extraction fluid (elute) which could throw more light to the cytotoxicity 
profiles of the tested cements. 
Conclusion 
The cytotoxic effects of all three tricalcium silicate cements tested were dose dependent and 
extraction in medium enhanced the overall cell viability. All the TSCs tested were well-tolerated 
by the cells despite an initially high cytotoxicity owing to increased pH. Specific reasons for 
differences in cytotoxic behaviour within the TSCs with respect to calcium release, surface 
chemistry and elute composition should be analysed in the future to improve the currently 


































































Part of this chapter has been published as: 
 
Efficacy of three different pulpotomy agents in primary molars: a randomized control 
trial.  
S Rajasekharan, L Martens, J Vandenbulcke, W Jacquet, P Bottenberg, R Cauwels.  




















































To compare the clinical and radiographic efficacy of Biodentine™, ProRoot® White Mineral 
Trioxide Aggregate (WMTA) and Tempophore as pulpotomy medications in the treatment of 
carious deciduous molars. 
Methodology  
A parallel design, randomised controlled trial was developed. Patients above three years of age 
with carious primary teeth with vital pulp without spontaneous pain or history of swelling were 
included. Fifty eight patients (81 teeth) with a mean age of 4.79 ± 1.23 years were included. The 
teeth were randomised, and allocated to one of the three groups (Biodentine™, ProRoot® WMTA 
or TempophoreTM) for pulpotomy treatment. All teeth were followed up clinically and 
radiographically (after 6, 12 and 18 months) by two blinded calibrated investigators. A generalised 
estimating equation (GEE), Wald chi-square test and an intention to treat analysis (ITT) with ´last 
carried forward´ approach was performed using Statistical Package for Social Sciences v 21.0 
(IBM Corp., Armonk, USA). 
Results  
Forty six patients and 69 teeth were available for follow-up after 18 months. Clinical success 
(radiographic success in parenthesis) was 95.24% (94.4%), 100% (90.9%) and 95.65% (82.4%) 
in the Biodentine™, ProRoot® MTA and Tempophore groups respectively, but the difference was 
not significant. Pulp canal obliteration was significantly different among the experimental groups 
as the Biodentine™ group exhibited significantly more pulp canal obliteration when compared to 
the ProRoot® MTA group at 6 months (p = 0.008) and 18 months (p = 0.003).  
Conclusions  
After 18 months follow-up, there was no significant difference in the clinical and radiographic 









The most widely used vital pulp therapy technique for treatment of deciduous teeth with carious 
pulp exposure is pulpotomy. According to the American Academy of Paediatric Dentistry, 
pulpotomy is defined as the ablation of infected or affected pulp tissues leaving the residual vital 
pulp tissues intact, thus preserving vitality and function (totally or partially) of the radicular pulp, 
while the remaining pulp stump is covered with a medication (American Academy on Paediatric 
Dentistry Clinical Affairs Committee-Pulp Therapy et al., 2008). The rationale for pulpotomy is 
based on the assumption that inflammation and impaired vascularity caused by the bacterial 
invasion are confined to the superficial part of the coronal pulp, while the radicular pulp tissue 
remains functional. The primary objective in treatment of the pulpally involved tooth is to retain it 
in a functional state (mastication, phonation, swallowing and aesthetics) so that it may fulfil its role 
as a useful component of the primary and young permanent dentition (Fuks 2000).  
 
Iodoform-based pastes has been advised for pulpotomy in primary teeth (Cerqueira et al., 2008) 
because of their antibacterial activity and ability to resorb. In the past, Tempophore has been 
reported to show a success rate of 87% (Boeve and Dermaut, 1982). MTA was developed as a 
bioactive and biocompatible cement for the purposes of root-end filling and furcation perforation 
repair and is currently marketed in several forms. White MTA is currently used for direct pulp 
capping, apexogenesis and apexification in immature teeth with necrotic pulps, filling of root 
canals, treatment of horizontal root fractures, internal and external resorption, and repair of 
perforations ( Parirokh & Torabinejad 2010, Anthonappa et al., 2013).  
 
Biodentine™ is a tricalcium silicate (Ca3SiO5) based inorganic non-metallic restorative cement 
commercialised and advertised as a “bioactive dentine substitute” (Zanini et al., 2012). The 
material is claimed to possess far better physical and biological properties such as material 
handling, faster setting time, increased compressive strength, increased density, decreased 
porosity and induction of reparative dentine synthesis when compared to its competitors 
(Rajasekharan et al., 2014). Despite the limited clinical evidence, Biodentine™ appears to be a 
potential substitute for other tricalcium silicate based cements.  
 
An ideal pulpotomy agent must be bactericidal, promote healing of the radicular pulp, be 
biocompatible, offer the dentine-pulp complex a relative stable environment, support the 
regeneration of dentine-pulp complex and not interfere with the physiological process of root 




alternative to formocresol and have a long-term bactericidal effect. However, Iodoform based 
pastes do not induce tissue regeneration and are not bioinductive. Regeneration approaches 
include pulpotomy agents that have cell-inductive capacity to either replace lost cells or induce 
existing cells to differentiate into hard tissue–forming elements. The regenerative materials that 
are widely used in pulpotomy procedures are calcium hydroxide and calcium based materials 
(Bergenholtz 2005) such as Calcium Enriched Mixture, Portland cement, Mineral trioxide 
aggregate (MTA), Biodentine™ and Bioaggregate. 
 
The objective of the present study was to compare the clinical and radiographic efficacy of two 
calcium silicate based cements (Biodentine™ and ProRoot® WMTA) to a Iodoform-based paste 
(Tempophore) used as pulpotomy agents in primary teeth of children treated under general 
anaesthesia. The null hypothesis was that “In carious primary molars, the outcome of pulpotomy 
treatment with Biodentine™ and ProRoot WMTA is not inferior to pulpotomy treatment with 
Tempophore”.  
Materials and Methods 
Study design 
A parallel design, randomised controlled clinical trial was set up and is reported according to the 
CONSORT statement. The PICOT question was: Did patients receiving pulpotomy treatment for 
extensive decay in primary molars under general anaesthesia (Population;P) using Biodentine™ 
or ProRoot® WMTA (Intervention;I) in comparison to pulpotomy using Tempophore (Control;C) 
show increased clinical and radiographic success based on a set of specified criteria (Outcome;O) 
when followed up for 18 months (Time;T).  
Sample size and power calculation 
The success percentage of the treatment groups (99% for ProRoot® WMTA and 87% for 
Tempophore) were derived from the literature with similar methodology (Boeve & Dermaut 1982, 
Simancas-Pallares et al., 2010). No published clinical studies could be identified for the 
Biodentine™ group. The sample size was calculated for binary primary outcome measures for a 
non-inferiority trial (non-inferiority limit of 12%) with the above parameters using 
Sealedenvelope™ (Sealed Envelope Ltd, London, UK) and 19 teeth per group were required to 
detect a significant difference for a two sided type I error 5% and 80% power. The sample size 
was increased by 30% to compensate for loss during follow-up or other causes of attrition. 





The study was approved by the Ethical Committee of University hospital, Ghent, Belgium 
according to laws of ICH Good Clinical Practice (B670201111951) (See Annex 2). All procedures 
performed were in accordance with the ethical standards of the institutional and national research 
committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical 
standards. The study protocol was also enrolled and the full trial protocol can be accessed at 
clinicaltrials.gov (NCT01733420) (See Annex 3). A detailed information pamphlet in simple non-
technical language was provided beforehand (See Annex 4) and parents/guardians of all patients 
included in the study were requested to sign an informed consent (See Annex 5). No remuneration 
was provided for participating patients. The patients and parents were blinded by not providing 
any information about the treatment group to which they were allotted. 
Participants 
All patients were selected and treated in the Department of Paediatric Dentistry and Special Care, 
University Hospital, Ghent University, Belgium. Healthy patients (aged 3 to 8 years) belonging to 
the category of ASA I according to the ‘American Society of Anaesthesiologists' with at least one 
carious deciduous molar indicated for pulpotomy were recruited. The minimum age limit was set 
at 3 years as Tempophore is contradicted for use in children below 3 years of age. The teeth of 
selected patients were initially evaluated clinically and radiographically for vital pulpotomy but final 
case selection was based on direct evaluation of pulp tissue after coronal amputation. Clinical 
exclusion criteria were teeth with necrotic pulps, spontaneous pain, history of swelling / abscess 
/ fistula / sinus tract and when final restoration with stainless steel crown was not possible. 
Radiographically, teeth with internal / external pathologic root resorption, periapical / furcal 
radiolucency and more than one-third root resorption were excluded. The clinical and radiographic 
exclusion was performed by the operators themselves. Radiographic assessment of tooth 
inclusion was performed on a pre-operative digital radiograph. 
Randomisation and Blinding 
After tooth inclusion, they were randomised by an independent individual to one of the three 
parallel groups depending on a set of randomised numbers generated by a computer using Matlab 
8.0 (The Mathworks Inc., Natick, Massachusetts, U.S.A) software (See Annex 6). Simple 
randomisation was performed per tooth and not per patient, similar to previously reported studies 
(Huth et al., 2005, Huth et al., 2012). A sealed envelope was used to conceal the randomisation. 




Septodont Ltd., Saint Maur des Faussés, France, Lot no. B02049; ProRoot® WMTA, Dentsply, 
Tulsa Dental, USA, Lot no. 10003596; or Group-3. Tempophore™, Septodont Ltd., Maidstone, 
UK, Lot no. 47458AF). Allocation was performed by a trial independent individual and the 
allocation ratio was intended to be equal. All treated teeth received a unique five digit code to 
which it would be mapped till the end of the study. This five digit code noted in all the patient files 
ensured blinding both at the patient and the investigator level. The five digit codes were generated 
by the computer using Matlab 8.0 software (See Annex 7). 
Intervention 
Five operators, with different educational qualification and experience level (professor, doctoral 
graduate, doctoral student, master graduate and master student) were involved in this trial. All 
operators were calibrated using typodont teeth for mixing the product according to manufacturer’s 
instructions and condensing them in a pulp chamber. Operators could not be blinded, as each 
pulpotomy agent had to be mixed and carried to the pulp chamber in a unique way.  
All interventions were performed under general anaesthesia and identical protocols were followed 
for all the treatment groups except for the pulpotomy agent used. No additional local anaesthesia 
was administered. Caries removal and coronal access was obtained with a high speed cylindrical 
diamond bur with ample water spray. Coronal pulp was removed with a sterile spoon excavator. 
Normal haemostasis was obtained after removal of infected pulp by application of light pressure 
with a cotton pellet. If haemostasis was not obtained after 4 minutes, pulp tissue in the canal was 
assumed to be infected and the tooth was excluded from the study. In each group, a minimum of 
2 mm layer of the pulpotomy agent was applied according to the manufacturer’s instructions and 
then covered with glass ionomer cement (Ketac™ Bond AplicapTM, 3M™ ESPE™, Seefeld, 
Germany) up to the occlusal level. After crown preparation, pre-fabricated stainless steel crowns 
(3M™ ESPE™, Seefeld, Germany) were placed on all the pulpotomy treated teeth using resin 
modified glass ionomer luting cement (Rely-X TM, 3M™ ESPE™, Seefeld, Germany). 
Subsequently, the occlusion was checked to prevent abnormal occlusal contact. Post-operative 
periapical digital radiograph (Dürr Dental Ag™ and VistaScan Perio™, Bietigheim-Bissingen, 
Germany) was taken immediately after the treatment to establish the baseline. 
Parents and children were provided with all the general oral hygiene instructions and specific 
instructions in relation to the treated tooth. All possible outcomes were explained to the parents 
and they were asked to report immediately in case of any post-operative pain, swelling, pus 





All patients were followed up clinically after 1 month. Clinical and radiographic evaluations were 
performed at 6, 12 and 18 months (See Annex 8). At the 1 month follow-up visit all patients were 
provided with oral hygiene instructions and a toothbrush to motivate brushing twice a day. Clinical 
examinations were performed by two experienced, independent, blinded clinicians (not the 
operators) who did not have any information about the treatment group. Clinical calibration was 
performed for outcome in twenty pulpotomy treated teeth at various stages of follow-up. 
Radiographic examinations were also performed by two experienced, independent, blinded 
investigators (neither the operators nor the clinical examiners) and no clinical data was available 
to the radiographic examiners. Pre-operative, baseline and radiographs from previous follow-up 
were provided to assess changes in periapical or periradicular region. Radiographic calibration 
was performed by evaluation of 25 digital radiographs (10 for tooth inclusion and 15 for outcome 
evaluation). All digital radiographs were assessed on a 24” LCD screen where image brightness 
and contrast could be changed using the software Mediadent™ (Imagelevel©, Kruibeke, 
Belgium). All 25 radiographs were evaluated again after three months to assess intra-rater 
reliability. Clinical and radiographic calibration was performed on patients and radiographs not 
participating in the study. 
An alteration was made to the intervention design in the middle of the recruitment phase. After 
evaluating a selection of post-operative x-rays, the radiographic examiners found it difficult to 
evaluate the condensation of pulpotomy material in the treated tooth after stainless steel crown 
placement. So after consensus with the operators, it was decided that the post-operative x-ray 
would be taken immediately after the placement of the pulpotomy agent and specifically before 
the placement of the stainless steel crown for the purpose of easier evaluation. 
Hypothesis and outcome assessment 
Clinical and radiographic scores were based on the criteria for clinical and radiographic scoring 
adapted from Zurn & Seale (2008) (Table 6.1). This scoring system is devised to represent 
severity of changes but not to label an individual tooth as ‘success’ or ‘failure’. As the score gets 
larger (1 to 4), the disease gets progressively more invasive and requires more frequent recall. In 
order to compare the present results with previous literature, the present study also estimated 
score 1 and 2 as success and score 3 and 4 as failure in both clinical as well as radiographic 




most severe score was recorded. The outcome criteria were pre-determined and were not 
changed after trial commencement.  
Clinical scoring criteria 
Clinical score Description 
1  Asymptomatic 
 6 month recall 
 Pathology: Absent 
 Normal functioning 
 Naturally exfoliated 
 Exfoliation prematurely due to ectopic eruption 
 Mobility (physiological) ≤1 mm 
2  Slight discomfort 
 Short-lived 
 3 month recall 
 Pathology: Questionable  
 Percussion sensitivity 
 Chewing sensitivity, short-lasting 
 Gingival inflammation (due to poor oral hygiene) 
 Mobility (physiological) >1 mm but <2 mm 
3  Minor discomfort 
 Short-lived 
 1 month recall 
 Pathology: Initial changes present 
 Chewing sensitivity, long-lasting 
 Gingival swelling (not due to poor oral hygiene) 
 Periodontal pocket formation (no exudate) 
 Mobility >2 mm but <3 mm 




 Pathology: Late changes present 
 Spontaneous pain 
 Gingival swelling (not due to poor oral hygiene) 
 Periodontal pocket formation (exudate) 
 Sinus tract present 
 Mobility ≥ 3 mm 
 Premature tooth loss, due to pathology 
 
Radiographic scoring criteria 
Radiographic score Description 
1  No changes 
present 
 6 month follow-up 
 Internal root canal form tapering from chamber to the 
apex 
 PDL/periapical regions; normal width and 
trabeculation 
2  Pathological 




 3 month follow-up 
 External changes are not allowed (widened 
periodontal ligament widening (PDL),  
 Abnormal inter-radicular trabeculation or variation in 
radiodensity 
 Internal resorption acceptable (non-perforated) 
 Calcific metamorphosis is acceptable and defined as: 
uniformly thin root canal; shape (non-tapering); 
variation in radiodensity from canal to canal (one 
cloudier than the other) 
 Dentin bridge formation (one or more canals) 
3  Pathological 
changes present 
 External changes are present, but not large  




 1month follow-up  Minor inter-radicular radiolucency with trabeculation 
still present  
 Minor external root resorption 
 Internal resorption changes are acceptable, but not if 
external change is also present (perforated form) 




 Frank osseous radiolucency present, endangering 
permanent successor 
 
Table 6.1: Clinical and Radiographic scoring criteria adapted from Zurn and Seale (2008). 
Statistical analysis 
The Gwet’s AC1 inter- and intra-rater reliability was calculated using Agreestat 2011.1 (Advanced 
analytics LLC, Gaithersburg, Maryland, USA). Data was analysed using the Statistical Package 
for Social Sciences v 21.0 (IBM Corp., Armonk, New York, USA). An intention to treat analysis 
(ITT) with ´last carried forward´ approach was performed to account for follow-up loss during the 
trial. Multiplicity and therefore dependence of more than one pulpotomy within a patient was 
accounted for within the statistical analysis by using a generalised estimating equation (GEE) 
(Tate 2011). An exchangeable correlation structure was used because the correlation between 
any two pulpotomies was assumed to be the same across patients (Huth et al., 2012). A binary 
logistic GEE model was used to analyse the differences in effectiveness among the experimental 
groups (α level = 0.05). The Wald chi-square test was applied to test the differences in overall 
effectiveness between the treatment groups. The difference in treatment groups with respect to 
individual clinical and radiographic criteria were also performed where possible. The level of 
significance for all tests was set at 0.05. 
Results  
The recruitment of patients started on 30/09/2011 and the final sample size (n = 81) was achieved 
on 21/08/2012, after which the trial was stopped. The flowchart of participants during each phase 
of the trial, namely, enrolment, allocation, follow-up at 1, 6, 12 and 18 months and data analysis 
is depicted in Figure 6.1.  
Baseline clinical characteristics of the study sample is shown in Table 6.2. The Gwet’s AC1 inter- 
and intra- rater reliability coefficients are summarised in Table 6.3. Clinical and radiographic 
success rates after 6, 12 and 18 months are mentioned in Table 6.4 and the clinical as well as 




on individual radiographic observations within a score. A set of radiographs representative of the 
radiographic changes has been compiled in Figure 6.2. Notable failures included one teeth 
requiring extraction due to abscess formation after 6 months in the Biodentine™ group and one 
teeth in the Tempophore group showing premature asymmetric exfoliation. In the Tempophore 
group, three other teeth were close to asymmetric premature exfoliation after 18 months. 
However, all exfoliations were reported to be asymptomatic. 
Pulp canal obliteration was significantly different among the experimental groups (χ2 = 6.901; df 
= 2; p = 0.032). Further tests between groups at different individual follow-up times revealed that 
Biodentine™ group exhibited significantly more pulp canal obliteration when compared to the 
ProRoot® MTA group at 6 months (χ2 = 7.011; df = 1; p = 0.008) and 18 months (χ2 = 8.820; df = 
1; p = 0.003). There was no significant difference between the groups at 12 months follow-up (χ2 
= 3.367; df = 1; p = 0.067). No other clinical or radiographic criteria showed a significant difference 
between the experimental groups.  
The correlation between the type of intervention (pulpotomy agent) and the clinical success, 
radiographic success, clinical score or radiographic score was not significant (p > 0.05). 
Confounding factors such as age, gender, tooth treated, arch, molar treated, side of the oral 
cavity, gender and qualification of the operator were not significant with either the type of 
intervention or the clinical and radiographic success (p > 0.05).  
The failure rate was extremely low to perform GEE analysis. Therefore, the radiographic 
evaluation was re-coded by recombining radiographic scores of 2, 3 and 4. As radiographic score 
1 indicated asymptomatic tooth, the rest of the radiographic scores were assumed to be an 
indicator for possible failure in the future. The GEE analysis showed no significant effect of the 
used material on re-coded radiographic score at 6-, 12-, and 18 months follow-up (p = 0.135). 
The dependency between the re-coded radiographic score at 18 months and the treatment group 
was not significant (p = 0.085).  
Intention to treat analysis revealed that the allocation strategy consisted of random allocation of 
teeth to the three treatments independent of whether or not they belonged to one patient. This 
approach mimics the clinical practice of teeth being presented for treatment. No protocol violations 
have been reported. The treatment differences are such that there is no need for clinicians to 
divert from protocol on the bases of individual patients or teeth. Sources of the absence of data 
are exfoliation and the failure to follow-up due to patient drop out. The exfoliation process, when 




of physiologic exfoliation can be considered to be completely at random and were excluded from 
the analysis. The patient drop out is thought of as being related to practical considerations of the 
patient more than treatment related aspects such as treatment failure. The latter cannot be tested 
with current study design. Therefore, the relation between patient deviation from practice and 
failure to follow-up was tested using a Mann-Whitney U test. No significant difference in the follow-
up period was found between referred and non-referred patients (U = 780.0, p = 0.703). 
 









Number of teeth 25 29 27 81 
Number of patients 21 17 20 58 
Mean age in years 5.18 ± 1.15 4.65 ± 1.13 4.73 ± 1.27 4.79 ± 1.23 
Mean age in months 67.14 ± 13.77 61.06 ± 12.01 60.42 ± 15.64 63.16 ± 14.28 
First molar 6 9 13 28 
Second molar 19 20 14 53 
Maxillary 8 10 12 30 
Mandibular 17 19 15 51 
Tooth treated (54) 2 1 5 8 
Tooth treated (55) 4 4 4 12 
Tooth treated (64) 0 0 1 1 
Tooth treated (65) 2 5 2 9 
Tooth treated (74) 1 3 4 8 
Tooth treated (75) 5 5 3 13 
Tooth treated (84) 3 5 3 11 
Tooth treated (85) 8 6 5 18 
Operator 1 (Professor) 5 4 11 20 
Operator 2(Doctoral graduate) 11 11 5 27 
Operator 3 (Doctoral student) 3 8 5 16 
Operator 4 (Master graduate) 3 3 4 10 
Operator 5 (Master student) 3 3 2 8 
Male 4 7 11 22 
Female 21 22 16 59 
Referred from private practice 12 12 11 35 
Recruited from university 
hospital 
13 17 16 46 
 







 Inter rater 
reliability 
Intra rater reliability 
(Examiner 1) 
Intra rater reliability 
(Examiner 2) 
Radiographic 
criteria for tooth 
inclusion 




0.96 (Excellent) 0.73 (Fair to good) 0.81 (Excellent) 
Clinical criteria 
for evaluation 
0.98 (Excellent) Classification of scores based on Fleiss’s guidelines for 
characterizing Kappa values. 
 
Table 6.3: Gwet’s AC1 inter rater and intra rater reliability co-efficient 
 
Clinical (C) and Radiographic (Rx) 
success rate (%) 




C Rx C Rx C Rx 
6 months 96  96 100 100 100 85 
12 months 96  96 100 92  96 75 
18 months 95 94 100 91 96 82 
*All percentages mentioned are rounded off to the nearest integer. 
 
Table 6.4: Clinical and radiographic success rate at 6, 12 and 18 months follow-up 
 
Clinical score (% of teeth) Radiographic score (% of teeth) 
 1 2 3 4 Total  1 2 3 4 Total 
6 months      6 months      
Biodentine™ 96   4 100 Biodentine™ 52 40 4 4 100 
ProRoot® White 
MTA 
93 7   100 ProRoot® White 
MTA 
82 18   100 
Tempophore 88 8  4 100 Tempophore 62 23 15  100 
12 months      12 months      





   100 ProRoot® White 
MTA 
52 40 8  100 
Tempophore 96   4 100 Tempophore 29 54 13 4 100 
18 months      18 months      





   100 ProRoot® White 
MTA 
43 48 9  100 
Tempophore 96   4 100 Tempophore 25 57 14 4 100 
*All percentages mentioned are rounded off to the nearest integer. 
 





Radiographic characteristics (% of teeth) 
Radiographic score 1 2 3 4 
Radiographic 
criteria 
NC DB PCO IRR-NP PDL ERR IRR-P PRL 
         
6 months         
Biodentine™ 52  36 8 4   4 
ProRoot® White MTA 82 11 7 4     
Tempophore 61  27 8 4 4 12  
         
12 months         
Biodentine™ 35 22 48 4     
ProRoot® White MTA 52 24 28  8 4 4  
Tempophore 29  46 8 13 8 13 4 
         
18 months         
Biodentine™ 15 20 65    5  
ProRoot® White MTA 43 35 26  9 4 4  
Tempophore 27  41 5 9 9 9  
         
Legend: NC: No changes; DB: Dentine bridge; PCO: Pulp canal obliteration; IRR-NP: 
Internal root resorption (non-perforated); PDL: Periodontal ligament widening; ERR: 
External root resorption; IRR-P: Internal root resorption (perforated); PRL: Periradicular 
lesion. 
*All percentages mentioned are rounded off to the nearest integer. Percentages may add 
up to more than 100% as the same tooth could present multiple radiographic symptoms. 
 






Figure 6.2. Sample radiographs representative of radiographic changes during the follow-up. 
Arrows indicate the region of interest (a) pre-operative radiograph (b) immediate post-operative 
(c) dentine bridge formation (d) pulp canal obliteration (e) internal root resorption without 
perforation (f) internal root resorption with perforation (g) external root resorption (h) tooth too 
close to exfoliation (i) clinical image after 18 months follow-up. 
Discussion  
Not every pathological finding in a primary tooth requires intervention, since primary tooth survival 
or the permanent successor may not necessarily be affected (Peng et al., 2006). The criteria for 
evaluating success or failure are also dependent on the objective of performing a pulpotomy on 
the primary teeth with pulp exposure due to caries (Holan et al., 2005). Based on the primary 
objective of retaining the treated tooth asymptomatically until exfoliation, only those teeth which 
require re-treatment were considered as a failure. In the present study, only grade three and  four 
of the Zurn & Seale (2008) scale were considered failures, which includes periodontal pocket 
formation with exudate, gingival swelling, sinus, widened periodontal ligament, perforated form of 
internal root resorption, external root resorption or frank osseous radiolucency endangering the 




After 18 months follow-up, 95.24%, 100% and 95.65% clinical success were observed in the 
Biodentine™, ProRoot® MTA and Tempophore groups respectively. The 100% clinical success 
of MTA after 6 months is in accordance with many other studies with both short and long-term 
follow-up (Rocha et al., 1999, Farsi et al., 2005, Naik & Hegde 2005, Aeinehchi et al., 2007, 
Moretti et al., 2008, Sakai et al., 2009, Hugar & Deshpande 2010;). To date, there have been no 
prospective trials using Biodentine™ as a pulpotomy agent in carious primary molars. 
Tempophore was employed in the present study as the treatment of choice for the control group 
because it has been used for many years with successful outcomes. Moreover, Tempophore was 
considered to be a biologically better choice when compared to formocresol (Boeve and Dermaut, 
1982, Ranly and Garcia-Godoy, 2000). Increased premature exfoliation or mobility in the 
Tempophore group could be due to rapid elimination of iodoform paste, leaving behind voids 
inside the pulp chamber (Kubota et al., 1992, Silva et al., 2010).  
In Biodentine™, ProRoot® MTA and Tempophore groups, radiographic success of 94.4%, 90.9% 
and 82.4% were observed after 18 months.  Grading a pulpotomy treatment as success or failure 
is dependent on a variety of factors and has always been subjective. While most authors agree 
unanimously for scoring a tooth clinically as a success, there have been different opinions 
regarding the grading a tooth as a radiographic success. Internal root resorption, pulp canal 
obliteration (PCO) and dentine bridge formation have been approached with contradicting 
theories. Hence, comparison of radiographic success as a whole with previous literature must be 
done with caution ensuring that similar criteria have been used. Therefore, this study does not 
compare radiographic failure as a whole with previous literature, but instead each radiographic 
criteria was compared to previously published literature. 
Internal root resorption was considered by others as a failure and as an indication of chronic 
inflammation of the residual pulp (Magnusson 1970, Kalaskar & Damle 2004) while others (Smith 
et al., 2000, Holan et al., 2005, Maroto et al., 2005) did not consider radiographic evidence of 
internal root resorption as a failure. In the present study, the non-perforated form of internal root 
resorption was observed only in the Tempophore group in 4.55% teeth. The perforated form of 
internal root resorption was observed in Biodentine™ (5%) ProRoot® WMTA (4.35%) and 
Tempophore (9.09%) treated teeth. The teeth were followed-up once in every three months. 
Some authors also speculate that when a tooth has a non-perforated form of internal resorption 
on the radiograph, it could clinically be perforated (Camp, 2008, Odabas et al., 2012) and it is 
impossible to determine the extent of such a defect with two dimensional radiographs. The 




accordance with previous studies (Naik & Hegde 2005, Moretti et al., 2008, Sonmez et al., 2008, 
Sakai et al., 2009, Ansari & Ranjpour 2010, Hugar & Deshpande 2010,; Odabas et al., 2012;).  
Another controversial radiographic outcome with different schools of thought is PCO. Some 
(Waterhouse et al., 2000) categorise PCO as a radiographic failure since it demonstrates a 
deviation from a normal pulp. Others (Willard 1976, Tziafas et al., 2000, Subramaniam et al., 
2009) argue that the extensive activity of odontoblast-like cells demonstrate that the pulp has 
retained some degree of vitality and hence PCO should be considered as a success.  
In the present study PCO was not considered as a radiographic failure (radiographic score 2) and 
was the most commonly observed radiographic outcome. After 18 months follow-up, PCO was 
observed in 65%, 26.09% and 40.91% teeth in the Biodentine™, ProRoot® WMTA and 
Tempophore groups respectively. The Biodentine™ group exhibited significantly more PCO than 
ProRoot® WMTA group at 6 and 18 months follow-up, which is in accordance with recently 
published animal studies (Tziafa et al., 2014). In a miniature swine model, pulp canal obliteration 
or ectopic formation of osteodentine at a distance from the pulp capping materials was reported 
to be higher with the use Biodentine™ than white MTA Angelus (Tziafa et al., 2014). Biodentine™ 
is also known to cause thicker mineralized tissue during pulpal repair, probably due to the quicker 
setting time (De Rossi et al., 2014). Biodentine™ releases a substantial amount of calcium ions 
during the initial setting time and reduces long-term ion release thereby producing favourable 
conditions for pulp repair (De Rossi et al., 2014). PCO has been reported in the literature to be 
0% (Naik & Hegde 2005), 2.5% (Ansari & Ranjpour 2010), 10 % (Subramaniam et al., 2009), 
24.7% (Holland et al., 1999), 41% (Eidelman et al., 2001) or 57.14% (Sakai et al., 2009) after 
using MTA.  
The concept of dentine bridging is controversial because it can be viewed as either a healing 
response or a pulp reaction to irritation (Moretti et al., 2008). Furthermore, the formation of a 
dentine bridge does not imply that the pulp will be sealed completely from the environment. The 
bridges that are formed are initially permeable and as time progresses their permeability 
decreases (Dominguez et al., 2003, Chacko & Kurikose 2006). It is also possible that the pre-
operative state of the pulp may play a role in determining whether a dentine bridge occurs after 
treatment, but this aspect has never been investigated. In the present study dentine bridge 
formation was considered as a success (radiographic score 2) and was observed in 20% of 
Biodentine™ and 34.78% in ProRoot® WMTA treated teeth after 18 months follow-up. Dentine 
bridge formation after using MTA as a pulpotomy agent has been reported as 5% (Subramaniam 




et al., 2011). This was higher than in the present study and could be because all teeth were 
treated under general anaesthesia and thus, pulpotomy procedures could have been facilitated 
enabling better prognosis teeth to be included in the sample.  
Healing of the dental pulp is not exclusively dependent on the supposed stimulatory effect of a 
particular type of agent but is also directly related to the capacity of both the dressing and 
permanent restorative material to provide a biological seal against immediate and long-term 
microleakage along the entire restoration interface (Holland et al., 1999, Jabbarifar et al., 2004, 
Percinoto et al., 2006). Stainless steel crowns protect the underlying pulp against leakage and 
are a necessity for long-term success of vital pulp therapy in cariously exposed teeth (Croll  & 
Killian 1992, Sonmez & Duruturk 2010). The use of stainless steel crowns in the present study 
was aimed to increase the success rate of pulpotomy, considering that most of the patients had 
very poor oral hygiene and high dmft/DMFT scores. The success rate observed in this study could 
also be attributed to the fact that all patients were treated under general anaesthesia thereby 
eliminating the patient’s co-operation factor. Similar to previous literature (Zealand et al., 2010), 
in the present study, the authors did not find any significant relation between these variables and 
overall success of the treatment.  
Trial limitations 
Periapical radiograph procedures at six month follow-up was laborious and impossible using film 
holding devices in young patients with fear and /or anxiety. This resulted in some cases where 
the pre-operative and follow-up x-rays could not be taken with the same angulation.  In the present 
study, although all treated patients were Belgian (Flemish) residents, the fluoride background of 
each patient could not be assessed owing to the considerable amount of immigrant patients 
included in the study. Also, blinding the operator was impossible in this trial as each material had 
different methods of mixing and condensation. Blinding the evaluator for the radiographic 
examination was not fail proof as the difference in radiopacity of each material was conspicuous 
to experienced examiners who were familiar with all the three pulpotomy agents.  
Follow-up loss increased gradually over time, with only 69 teeth (46 patients) of the initial 81 teeth 
(58 patients) available for follow-up at 18 months. However, the follow-up loss was only 15% 
compared to the 30% accounted for during sample size calculation. In the Tempophore group, 
the final sample comprised of only 17 teeth, which was two teeth less than the initially calculated 
sample size for each group. Of the 12 patients lost to follow-up, 4 of them expressed their 




their private dentist after general anaesthesia. The remainder of the 5 patients could not be 
contacted either by telephone or by repeated letters.  
Sample size was neither calculated on the basis of individual primary clinical and radiographic 
outcomes nor secondary outcomes. Sample size calculation was based only on the overall 
success or failure percentage of the treatment groups. Power calculation on secondary outcomes 
were not performed due to lack of previous literature that measured these secondary outcomes 
with either Biodentine™ or Tempophore. This could also have been a reason for the absence of 
significant differences in the secondary outcomes.  
Generalizability 
All patients in this study were treated under optimal clinical conditions regarding child co-operation 
(general anaesthesia) and hence, direct applicability of these results to the patients treated in 
clinical conditions should be exercised with caution. It is notable that the qualification of the 
operator did not have any significant influence on the treatment outcome but all operators were 
trained and calibrated beforehand, eliminating the learning curve associated with the use of a new 
material. Also, all treated teeth were restored with stainless steel crowns, hence eliminating the 
chance of restoration failure. Although, stainless steel crowns have been reported to be the best 
choice of restoration after pulpotomy of primary molars, they are not popular in many countries 
due to aesthetic factors (Sonmez & Duruturk 2010). 
Conclusion 
There was no significant difference between the materials used and the clinical or radiographic 
success after 6, 12 or 18 months and the null hypothesis was accepted. None of the confounding 
factors such as age, gender, tooth treated, arch, molar treated, side of the mouth, gender and 
qualification of the operator had a significant influence on clinical or radiographic success. 
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7a. Pulp management after traumatic injuries with a tricalcium silicate based cement 
(Biodentine™) – A report of two cases, up to 48 months follow-up 
Abstract 
 
Background   
Apexogenesis after traumatic exposure in vital young permanent teeth can be accomplished by 
implementing the appropriate vital pulp therapy such as pulp capping (direct or indirect) or 
pulpotomy (partial or complete) depending on the time between the trauma and treatment of the 
patient, degree of root development, and size of the pulp exposure. 
 
Case report 
Two cases (three teeth) of complicated enamel dentine fracture in immature permanent teeth 
were treated with a new tricalcium silicate cement (Biodentine™). The treatment plan in these 
cases was to maintain pulp vitality aiming for apexogenesis which allows continued root 
development along the entire root length. Endodontic management included partial pulpotomy or 
pulpotomy using Biodentine™. Clinical and radiographical follow-up (up to 48 months) showed 
continual apexogenesis with no periodontal or periapical pathology. The appropriate restorations 
were functionally acceptable and aesthetically satisfying. The three traumatized teeth showed 
complete success both clinically (vitality and aesthetic outcome) as well as radiographically 
(apexogenesis and absence of pathological findings) after up to 48 months follow-up.  
Conclusion  
Biodentine™ is a suitable alternative to MTA for vital pulpotomy in traumatized permanent 













Crown fractures with pulp exposure represent 18% to 20% of traumatic injuries involving the teeth, 
the majority being in young permanent central incisors (De Blanco 1996). These injuries produce 
changes in the exposed pulp tissues, and a biological and functional restoration of immature 
young permanent teeth represents an important clinical challenge (Ojeda-Gutierrez et al., 2013). 
The treatment plan in such cases is to maintain pulp vitality via apexogenesis which allows 
continued root development along the entire root length (Shabahang 2013). 
Apexogenesis after traumatic exposure in vital young permanent teeth can be accomplished by 
implementing the appropriate vital pulp therapy such as pulp capping (direct or indirect) or 
pulpotomy (partial or complete) depending on the time between the trauma and treatment of the 
patient, degree of root development, and size of the pulp exposure (American Academy on 
Pediatric Dentistry Clinical Affairs Committee-Pulp Therapy, American Academy on Pediatric 
Dentistry Council on Clinical 2008). Histologic examination of traumatized pulp shows that the 
depth of inflammatory reaction does not exceed 2 mm from the exposed surface within 48 h 
(Karabucak et al., 2005). Therefore, if treated within 48h, 2mm of injured pulp can be successfully 
removed, leaving the non-inflamed healthy radicular pulp to reorganize.  
 
Calcium silicate-based materials are hydraulic self-setting materials with intrinsic physico-
chemical properties suitable for pulp therapy. Biodentine™ (Septodont Ltd., Saint Maur des 
Fausse´s, France) possesses superior clinical properties such as good sealing, increased 
compressive strength, decreased porosity, higher density, bioactivity, release of ions acting as 
epigenetic signals, immediate formation of calcium hydroxide, biomineralization ability, 
biointeractivity and colour stability compared to mineral trioxide aggregate (MTA) (Gandolfi et al., 
2013; Rajasekharan et al., 2014).  
 
Case report   
Two patients with three traumatized teeth without luxation were treated with pulpotomy using 
Biodentine™ after Traumatic Dental Injury (TDI) and documented for up to 48 months follow-up 
period. Both patients reported were treated according to the standard protocol of the Department 
of Paediatric Dentistry of the University Hospital at Ghent, Belgium. All treatments were performed 




Patient one (2 injuries) 
An 8 year old Caucasian male visited the dental hospital suffering from a complicated crown 
fracture (fracture involving enamel, dentine and pulp) of tooth 21 during sports activity two days 
ago. Medical history of the patient did not reveal any relevant information. The diagnostic 
radiograph revealed the immaturity of the tooth with wide open apex (Figure 7a.1.1). The tooth 
was sensitive to percussion and palpation with a visible pin-point exposure of the pulp (Figure 
7a.1.2). The tooth was prepared for a partial pulpotomy with a high speed diamond bur and 
copious irrigation with water under local anaesthesia. The pulp exposure was rinsed with saline 
and dried with a sterile cotton pellet. The pulp tissue seemed healthy as the bleeding had stopped 
and the pulp appeared bright red. The open pulp was gently covered with an initial layer of 
Biodentine™. The Biodentine™ was further placed in layers up to the occlusal level to function 
as a temporary filling material (Figure 7a.1.3).  
Figure 7a.1.1 Immature, wide open apex of tooth 21 
Figure 7a.1.2 Visible pin point exposure of the pulp 
Figure 7a.1.3 Biodentine™ as a temporary filling material 
 Four weeks later, there were no pain symptoms after the initial treatment. Tooth vitality was 
followed up clinically. Radiographically, no pathological findings were seen. The tooth was then 
restored with composite resin (Clearfil™, Kuraray, New York, USA), replacing the top layer of the 
temporary filling material (Biodentine™). During further follow-up at 6 and 12 months, symmetric 
ongoing apexogenesis of both central incisors was seen, referring to a healthy pulp activity in both 
teeth (Figure 7a.1.4 and Figure 6a.1.5). In that period, the boy, in the meantime at an age of 9 
years old, reappeared with a second dental trauma, involving tooth 22, and suffering from another 
complicated crown fracture. Due to incomplete eruption, the margin of the fracture mesially, was 
found subgingival (Figure 7a.1.6). Clinically, pulp exposure was visible. Periapical radiograph 
revealed an immature root with a large open apex (Figure 7a.1.7). 




Figure 7a.1.4 Six months radiographical follow-up of tooth 21 
Figure 7a.1.5 Twelve months radiographical follow-up of tooth 21 
Figure 7a.1.6 Mesial margin of the fracture lies subgingivally 
Figure 7a.1.7 Immature, wide open apex of tooth 22 
Local anaesthesia was followed by isolating the tooth, making an easy entry to the fractured site. 
A partial pulpotomy was executed exactly as was performed one year ago in tooth 21 (high speed 
bur and copious irrigation with water). The vital pulp was gently covered with a layer of 
Biodentine™ followed by a permanent composite restoration (Clearfil™, Kuraray, New York, 
USA). Six weeks later, the patient presented for follow-up. He did not complain and no pain was 
reported. During clinical and radiographical follow-up, no pathologic symptoms were found. The 
radiographs after 3, 6, 12 and 24 months follow-up of 22 and up to 36 months of tooth 21 showed 
further maturation of both teeth (Figures 7a.1.8, 7a.1.9, 7a.1.10 and 7a.1.11). 
 
Figure 7a.1.8 Fifteen months and 3 months radiographical follow-up of tooth 21 and 22 
respectively 
Figure 7a.1.9 Eighteen months and 6 months radiographical follow-up of tooth 21 and 22 
respectively  
Figure 7a.1.10 Twenty four months and 12 months radiographical follow-up of tooth 21 and 22 
respectively 
Figure 7a.1.11 Thirty six months and 24 months radiographical follow-up of tooth 21 and 22 
respectively 
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A 7 year old Caucasian female visited the emergency service after she had an accident at the 
playground. Medical history of the patient revealed negative relevance. An enamel-dentine 
fracture with pulp exposure with respect to tooth 11 was diagnosed (Figures 7a.2.1 and 7a.2.2).  
 
Figure 7a.2.1 Complicated enamel dentine fracture of tooth 11 
Figure 7a.2.2 Pulp exposure of tooth 11 
Due to severe anxiety treatment under local anaesthesia was impossible. The treatment was 
performed the following day under general anaesthesia. The pulp exposure was further opened 
with a sterile high speed diamond bur with sufficient water cooling. The pulp tissue until the 
cement-enamel junction was removed (complete pulpotomy). Pulp capping or partial pulpotomy 
was not a viable option in this instance as the duration of between trauma and treatment was 
more than 24 hours. Haemostasis was achieved with a moist cotton pellet and the pulp exposure 
was capped with Biodentine™ and used as a temporary filling. A radiograph at this appointment 
shows an immature open apex (Figure 7a.2.3) and the Biodentine™ capping could be noted at 
the cingulum level. Three weeks later, a permanent composite restoration was made. Clinical 
tooth vitality and digital radiographical follow-up was performed after 6, 12, 18, 24 and 48 months 
(Figures 7a.2.4, 7a.2.5, 7a.2.6, 7a.2.7 and 7a.2.8).  
Figure 7a.2.3 Immediate post-
operative radiograph of tooth 11 
Figure 7a.2.4 Six months 
radiographical follow-up of tooth 
11 
Figure 7a.2.5 Twelve months 
radiographical follow-up of tooth 
11 
1 2 




Figure 7a.2.6 Eighteen months 
radiographical follow-up of tooth 11 
Figure 7a.2.7 Twenty four months 
radiographical follow-up of tooth 11 
Figure 7a.2.8 Forty eight months 
radiographical follow-up of                                                                                                           
tooth 11 
 
No subjective discomfort was reported during the entire follow-up period. Clinically, the tooth 
remained vital and no discolouration was observed. Radiographically, starting from 18 months 
complete apexogenesis was evident and this was further confirmed at the 24 and 48 month follow-
up. 
Discussion 
Partial pulpotomy has shown a high success rate in previous reports with complicated crown 
fractures in young immature teeth with pulp exposure, however, a long-term follow-up is 
necessary to establish this success rate (Fong, Davis 2002). The outcome criteria for successful 
vital pulp therapy treatment after dental trauma include asymptomatic teeth (clinically and 
radiographically), apexogenesis (indicates ability of tooth to retain vitality) and absence of tooth 
discolouration (for aesthetic reasons).   
A loss of pulp vitality in complicated crown fractures is mainly observed on the day of trauma and 
within the first 6 months (Bucher et al., 2013). During follow-up of the 3 traumatized teeth reported 
at different periods, no tooth sensitivity or pain was reported; also, neither clinical symptoms nor 
radiographic defects were present. Clinical and radiographic examination showed continual 
apexogenesis with no periodontal or periapical pathology, and the restorations were functionally 
acceptable and aesthetically gratifying.  
Difficult handling, long setting time, and potential discolouration are important drawbacks of MTA. 
The newly developed tricalcium silicate cement (Biodentine™) has overcome these 
shortcomings. Biodentine™ demonstrated easy handling comparable to that of phosphate 
cement (Nowicka et al., 2013). In another study, Biodentine™ showed colour stability in light and 
anaerobic conditions and is suitable for use under light-cured restorative materials in aesthetically 
sensitive areas (Valles et al., 2013). The latter has been confirmed in the present cases as 
Biodentine™ did not induce any discolouration. Furthermore, Biodentine™ is advantageous to 




the clinician as it can also be used as a temporary restorative material for up to 6 months owing 
to its superior strength and sealing ability (Koubi et al., 2013).  
Conclusion 
In both cases a complete success both clinically (vitality and aesthetics) as well as 
radiographically (apexogenesis and absence of pathological findings) was shown for the three 
traumatized teeth after 48 months follow-up. On this basis, pulp management is highly 
recommended using Biodentine™ as an effective pulp dressing for the treatment of complicated 






















7b. Endodontic treatment of trauma induced necrotic immature teeth using Biodentine™ - 
A Report of 3 cases with 24 months follow-up. 
Abstract 
Background 
Pulp necrosis is the second most common complication after traumatic dental injuries and occurs 
mostly within the first 6 - 24 months of follow-up period depending on the type of dental trauma.  
Case report 
Three cases with endodontic treatment scenarios of trauma induced necrosis in immature 
permanent anterior teeth. All cases were treated by full canal obturation with Biodentine™ and 
documented for 24 months follow-up period.  
Conclusion 
Copious irrigation of the root canal, minimal mechanical preparation, use of calcium hydroxide for 
a short duration and complete obturation of these immature teeth with a bioactive cement with 
superior mechanical properties such as Biodentine™ were the prominent reasons attributed to 
















Boys in the age-groups 7-9 years and girls in the age-group 5-6 years show a higher incidence of 
traumatic dental injuries (TDI) (Glendor et al., 1996, Andersson, 2013). Pulp necrosis is the 
second most common complication after traumatic dental injuries and occurs mostly within the 
first 6 - 24 months of follow-up period depending on the type of dental trauma and the maturity of 
the tooth (Bucher et al., 2013). The treatment of pulpal injury during this period provides a 
significant challenge for the clinician as a conventional endodontic treatment protocol for these 
immature teeth is significantly more difficult to perform because of the open apex (Rafter, 2005). 
Root development consists of 3 aspects viz. an increase in root wall thickness, an increase in root 
length, and the narrowing of the canal leading to the formation of the root apex (Nosrat et al., 
2013).  Pulp necrosis in immature teeth affects all the above mentioned aspects of root 
development but vital pulp tissue inside the root canal is presumably necessary only for an 
increase in root wall thickness whereas an increase in root length and the formation of the apex 
are functions of the apical papilla and Hertwig epithelial root sheath. Periapical disease following 
pulp necrosis, is thus truly responsible for the retardation of root development (Nosrat et al., 2013). 
Hence, if periradicular disease is eliminated, apexogenesis may be possible even without pulp 
regeneration or revascularization therapy.  
Apexification by induction of a calcified barrier or revascularization / regenerative endodontic 
treatment aiming at regeneration of pulp tissue are the choice of treatments currently available 
for retaining an immature necrotic permanent tooth (Nosrat et al., 2012, Shabahang, 2013). 
Endodontic therapy aiming at elimination of periradicular disease followed by apexification asks 
for an alternative treatment approach in the young, immature pulpless tooth. These teeth 
frequently present with thin, fragile walls, which makes it difficult for adequately cleaning. 
Moreover, the open apex makes it challenging to obtain the necessary apical seal (Shabahang, 
2013). 
Tricalcium silicate cements have been successfully employed in the biomedical field as bioactive 
materials, with widely acclaimed osteoactive properties (Eid et al., 2014). Biodentine™ 
(Septodont, Saint Maur des Fosses, France) is one such highly purified tricalcium silicate 
(Ca3SiO5) based inorganic restorative cement. The superior physical and biologic properties 
suggest Biodentine™ to be an efficient material in the field of paediatric endodontics and dental 





The following case series consists of three case reports with endodontic treatment scenarios of 
trauma induced pulp necrosis in immature teeth. All cases were treated by full canal obturation 
with Biodentine™ and documented for 24 months follow-up period. All patients reported herein 
were treated according to the approved university protocol in the Department of Paediatric 
dentistry and special care, University hospital, Ghent, Belgium. 
Patient One 
An eight year old Caucasian male was referred to the dental hospital by his general dental 
practitioner for endodontic treatment of an immature maxillary central incisor (tooth 21) under 
general anaesthesia. Medical history of the patient did not reveal any relevant information and 
dental history revealed that the tooth had suffered a luxation injury some weeks before. Clinical 
dental examination showed a buccal swelling and a pseudo pocket depth of 10 mm. Percussion 
and palpation revealed negative results and tooth was asymptomatic. Digital radiographic 
examination disclosed a radiolucency along the periapical region. The tooth was diagnosed as 
necrotic and absolute non-cooperation of the patient necessitated the endodontic treatment to be 
performed under general anaesthesia.  
Access to tooth 21 was obtained using a high speed bur. Black pulp tissue indicative of complete 
necrosis was noted. Working length was manually determined (Figure 7b.1.1), followed by 
irrigation with 2.5% sodium hypochlorite. Subsequently, complete drying of the canal using paper 
points (Absorbent points, Dentsply Maillefer, Tulsa, Oklahoma, USA) was obtained and the root 
canal was filled with calcium hydroxide (Figure 7b.1.2) (Ultracal XS, Ultradent, South Jordan, 
Utah, USA). The access cavity was sealed with a glass ionomer cement (Ketac-Fil™ Plus 
Aplicap™, 3M™ Espe™, St.Paul, Minnesota, USA).  
Six weeks later, calcium hydroxide in the root canal was removed by irrigation with saline and 
2.5% sodium hypochlorite. The root canal was dried with paper points and completely obturated 
with Biodentine™ (Figure 7b.1.3). Biodentine™ was mixed according to manufacturer’s 
instructions and dispensed in the root canal using a suitable instrument. Subsequently, 
Biodentine™ was condensed using a plugger. An x-ray was taken immediately to ensure correct 
placement of the material. Two days thereafter, the patient reported buccal swelling and pus 
discharge from the buccal sulcus of 21 (Figure 7b.1.4). Antibiotic therapy (Amoxicilline 1500mg) 
was prescribed alongside chlorhexidine mouthwash for one week. In the following visit, the glass 






Figure 7b.1.1: Working length determination 
Figure 7b.1.2: Temporary obturation with calcium hydroxide 
Figure 7b.1.3: Complete obturation with Biodentine™ 
Figure 7b.1.4: Swelling and pus discharge from the buccal sulcus of 21 
Subsequently, the swelling and pus discharge disappeared and the patient remained 
symptomless for the rest of the observation period. The patient was initially followed up at three 
months interval and then at six months interval for up to 24 months at present. Radiographically, 
normal periodontal ligament and apexification indicative of complete healing was noted at the 
follow-up appointments (Figure 7b.1.5 and Figure 7b.1.6).  
 
Figure 7b.1.5: Radiographic follow-up at 12 months 
Figure 7b.1.6: Radiographic follow-up showing 




A nine year old Caucasian male was referred to the dental hospital by his general dental 
practitioner for treatment of a persistent buccal fistula with respect to the immature maxillary 
central incisor (tooth 11). Anamnesis revealed that the patient was medically fit. Dental history 
showed that the patient had suffered from a traumatic dental injury at the age of eight (ten months 







dentine fracture (without pulp exposure) with increased mobility. Both teeth were splinted for two 
weeks with a semi-flexible splint and eventually restored with composite resin.  
Present clinical dental examination confirmed the presence of a buccal fistula (Figure 7b.2.1) with 
respect to 11. Percussion and palpation revealed negative results and tooth was asymptomatic. 
Digital periapical radiograph displayed asymmetric development of maxillary central incisors with 
apical radiolucency around 11 (Figure 7b.2.2). 
In comparison to the contralateral central incisor (tooth 21), tooth 11 showed arrested root 
development as a consequence of pulp necrosis. The tooth was diagnosed as necrotic and 
endodontic treatment was planned.  
Figure 7b.2.1:  Buccal fistula with respect to 
11 
Figure 7b.2.2: Asymmetric development of 
maxillary central incisors with apical 
radiolucency around 11 
 
During the first appointment, access to the pulp chamber of tooth 11 was obtained using a high 
speed bur and later irrigated with 2.5% sodium hypochlorite to remove all necrotic pulp tissue 
from the root canal. Subsequently, working length was manually determined (Figure 7b.2.3) 
followed by complete drying of the canal using paper points. The root canal was filled with calcium 
hydroxide (Figure 7b.2.4) for two weeks and the access opening was sealed with glass ionomer 
cement. At the second appointment, the calcium hydroxide was removed by means of saline and 
2.5% sodium hypochlorite irrigation. A complete dry root canal was obtained by using paper 
points. Subsequently, the root canal space was completely obturated using Biodentine™. An 
immediate periapical radiograph displayed apical perforation with Biodentine™ overextension 
(Figure 7b.2.5). However, there were no complaints from the patient and it was decided to follow-
up at regular intervals. Two months later, disappearance of the buccal fistula with respect to 11 
was observed in the clinical examination. During subsequent follow-up, the apical Biodentine™ 








Figure 7b.2.3: Working length determination 
Figure 7b.2.4: Temporary obturation with calcium hydroxide  
Figure 7b.2.5: Complete obturation and apical exudation with Biodentine™ 
Figure 7b.2.6: Gradual resorption of the apical Biodentine™ exudate 
The glass ionomer cement was replaced with composite resin at this visit. The tooth remained 
asymptomatic during the entire follow-up period and after 24 months, complete clinical and 
radiographic healing of the tooth was established (Figure 7b.2.7 and 7b.2.8).  
 
Figure 7b.2.7: Clinical follow-up at 
24 months 
Figure 7b.2.8: Radiographic follow-
up at 24 months 
 
Patient Three 
A nine year old Caucasian male was referred to the dental hospital by his general dental 
practitioner for treatment of probable pulp necrosis with respect to an immature maxillary central 
incisor (tooth 21). Medical history of the patient revealed negative relevance. Dental anamnesis 
disclosed a dental traumatic injury of 11 and 21. Although the 11 suffered from an avulsion and 
the parents attended several emergency care centres in the province, the tooth became not 
replanted due to unknown reasons. As a consequence, the general dental practitioner used the 
crown of the avulsed 11 as a space maintainer between teeth 12 and 21 with fibre reinforced 
composite splint.  
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Figure 7b.3.1: Clinical dental examination of toot 21 
Figure 7b.3.2: Delay in root growth and maturation with respect to tooth 21 and conjoining 
periapical radiolucency 
Clinical dental examination displayed probable symptoms of tooth necrosis in relation to tooth 21. 
Percussion and palpation revealed negative results and tooth was asymptomatic (Figure 7b.3.1).  
Delay inroot growth and maturation with respect to tooth 21 and conjoining periapical radiolucency 
was identified in the radiographic examination (Figure 7b.3.2).  
The radiographic picture of lack of root maturation and periapical radiolucency could probably 
refer to the previous history of dental trauma. Endodontic treatment of 21 was planned and access 
to the root canal was obtained during the first appointment using a high speed bur and 
subsequently irrigation with 2.5% sodium hypochlorite and saline in order to remove the necrotic 
pulp tissue. A complete dry canal was visualized without any traces of moisture or pus. Working 
length was determined manually (Figure 7b.3.3) and paper points were used to assure a dry root 
canal. Considering the particular broad, thin and fragile root canal, Biodentine™ was determined 
to be the choice of obturating material. In the same appointment, the root canal was completely 
obturated with Biodentine™ up to the dentine enamel junction and in the following appointment, 
finished with composite resin. Although a clear visual apexification, extrusion of Biodentine™ 
beyond the root canal space was noted in the immediate post-operative radiograph (Figure 
7b.3.4). The first follow-up appointment was 3 months later, followed by control at six months 
interval up to 24 months follow-up. The tooth remained asymptomatic and the patient reported no 









Figure 7b.3.3: Working length determination 
Figure 7b.3.4: Complete obturation and apical exudation with Biodentine™ 
Figure 7b.3.5: Radiographic follow-up at 12 months 
Figure 7b.3.6: Radiographic follow-up at 24 months 
Discussion 
Preservation of tooth integrity and strength is important for the long-term survival of endodontically 
treated teeth (Baba et al., 2009). Root canal irrigants, mechanical root canal preparation 
techniques, medications of root canal filling materials and their influence on the mechanical 
properties of the dentine itself play an important role in determining the prognosis of fracture 
related endodontically treated immature teeth (Moazami et al., 2014).  
The weakening of the dentin by 23-43.9% following root canal filling with calcium hydroxide has 
been attributed to long-term usage of this material to induce an apical barrier in immature teeth 
(Rosenberg et al., 2007). However, for a long time, calcium-hydroxide has also been used as a 
pre-obturation endodontic medication to disinfect the root canal (White et al., 2002). Till date there 
is no conclusive data that calcium hydroxide exposure for one month or less had a negative effect 
on the mechanical properties of radicular dentine (Yassen and Platt, 2013).  In the present cases, 
calcium hydroxide was used as a disinfectant for no longer than two weeks, thereby, assuring no 
weakening of the root dentine.  
Calcium silicate-based cements adhere to root dentine, forming a crystalline bond in a 
biochemical process termed biomineralization (Reyes-Carmona et al., 2010). Biomineralization 
ability of Biodentine™ initiates calcium and silicate uptake by the dentine, which in turn would 
cause chemical and structural modification of dentine, which may result in higher acid resistance 
and physical strength (Han & Okiji, 2011). Hence, the use of Biodentine™ in the present cases 




as an obturation material may eventually improve the resistance of the endodontically treated 
immature teeth against fracture. From an earlier in vitro study, it could be concluded that mineral 
trioxide aggregate significantly strengthened immature root canals (Cauwels et al., 2010). 
Moreover, Biodentine™ exhibits greater compressive strength in comparison to other tricalcium 
silicate cements, which is attributed to the low water/cement ratio made possible by the water 
soluble polymer in the liquid. The physical properties of Biodentine™ such as flexural strength, 
elastic modulus and Vickers hardness are similar to dentine (Grech et al., 2013a, Grech et al., 
2013b). 
Progressive discoloration of the tooth crown is a potential aesthetic complication after endodontic 
treatment of immature anterior teeth. Discoloration is either a result of materials ingressing into 
dentinal tubules or by material remnants in the pulp chamber, which get darker over time and is 
transmitted through the hard tissues (Lenherr et al., 2012). In the present report, no discoloration 
was observed in any of the three cases after using Biodentine™. This is consistent with the 
literature as Biodentine™ exhibited colour stability independent of oxygen and light irradiation 
unlike other tricalcium silicate cements such as mineral trioxide aggregate (Valles et al., 2013). 
Conclusion 
Copious irrigation of the root canal, minimal mechanical preparation, use of calcium hydroxide as 
a disinfectant and complete obturation of these immature teeth with a bioactive cement with 
superior mechanical properties such as Biodentine™ were the prominent reasons for the success 
of these cases. In addition to the clinical and radiographic success, the aesthetically satisfying 
outcome provides compelling motivation for using Biodentine™ in the endodontic treatment of 











7c. Endodontic management of root fracture in immature maxillary anterior teeth with tricalcium 





The majority of root fractures occur in the maxillary central incisor (68%) and most of them affect 
the middle third of the root. This type of injury is rarely seen in teeth with immature root formation 
and management is challenging to paediatric dentists and endodontologists due to the association 
of pulpal and periodontal components. 
 
Case report:  
Three cases with endodontic treatment scenarios of mid-root fractures in immature permanent 
anterior teeth are reported. All cases were treated by obturation of coronal fragment with 
Biodentine™ and documented for 24 months follow-up period. Healing by interposition of hard 
tissue and interposition of connective tissue was observed. 
 
Conclusion:   
The use of Biodentine™ in mid- root fracture cases, demonstrated the ability to find a stable 



















The majority of root fractures occur in the maxillary central incisor (68%) and most of them affect 
the middle third of the root.(Andreasen et al., 2007) Mid-root fractures are generally transverse to 
oblique and may be single or multiple, complete or incomplete. Management mid-root fractures 
is challenging to paediatric dentists and endodontologists due to the association of pulpal and 
periodontal components. Although  this type of injury is rarely seen in teeth with immature root 
formation, the survival rate of a mid-root fractured tooth is reported to be relatively high (83%) for 
up to 10 years of observation.(Choi et al., 2014) Dental pulp necrosis occurs in 20–44% of root 
fracture cases and endodontic treatment is usually indicated only for the coronal fragment as the 
apical part of the fractured tooth usually remains vital or exhibits obliteration.(Celikten et al., 2014, 
Diangelis et al., 2012)  
Mineral trioxide aggregate (MTA) is a biocompatible material with numerous interesting clinical 
applications in endodontics and has been studied extensively with positive results. Nevertheless, 
it must be acknowledged that the material also has several drawbacks such as difficult handling, 
long setting time, possible discolouration if used in the visible crown area, lower compressive and 
flexural strength than dentine.(Hadrossek & Dammaschke, 2014) Researchers have been aiming 
to overcome these drawbacks by modifications to the original composition of MTA by finding a 
suitable substitute for bismuth oxide, minimising particle size, addition of accelerators, altering 
effective water/powder ratio and eliminating impurities. The challenge lies in effectively 
introducing these modifications without affecting the advantages offered by calcium silicate 
cements as such.  
Biodentine™ (Septodont Ltd., Saint Maur des Fausse´s, France) is a hydraulic calcium silicate 
based endodontic cement with major compositional differences when compared to MTA. These 
differences include replacement of bismuth oxide with zirconium oxide, a different variant 
tricalcium silicate with increased purity, liquid component consisting of polycarboxylate 
(plasticizer) along with calcium chloride, increased powder fineness,  and tricalcium aluminoferrite 
and calcium sulphate.(Primus, 2014) Biodentine™ has been known to possess superior clinical 
properties such as good sealing, increased compressive strength, decreased porosity, higher 
density, bioactivity, release of ions acting as epigenetic signals, immediate formation of calcium 
hydroxide, biomineralization ability, biointeractivity and colour stability compared to mineral 




use of Biodentine™ as an obturation material in the treatment of root fractures of immature 
anterior teeth.  
 
Case report   
The aim of this article is to report the successful management of 3 different cases of mid root 
fractures in immature teeth with coronal infection showing complete healing after two years follow-
up. The root fractures were treated by endodontic management of the coronal fragments with a 
relatively recently developed tricalcium silicate cement (Biodentine™). All three patients reported 
were treated according to the standard protocol of the Department of Paediatric Dentistry of the 
University Hospital at Ghent, Belgium. All treatments were performed under rubber dam to ensure 
adequate isolation. 
 
Patient one  
 
An 8 year old Caucasian male was referred to the dental hospital by a general dental practice for 
treatment of complaints pertaining to dental trauma that happened 1 month before. Medical 
history of the patient did not reveal any relevant information. Dental history showed that the patient 
had suffered from a similar trauma around 6 months ago. Clinical and radiographic diagnosis 
showed erupting central incisors with broad immature apex. Maxillary right central incisor showed 
a root fracture between the middle third and apical third of the root with slightly increased mobility 
(Figure 7c.1.1). Both maxillary central incisors reacted negatively to thermal sensitivity tests. At 
that appointment, there were no additional symptoms that might indicate pulp necrosis. The 
patient did not feel any discomfort or pain. Hence, it was decided to follow-up the teeth closely. 
After 4 weeks, clinical and radiographic findings were similar to the previous appointment.  
In the next visit, 6 months after the second trauma, the patient had no complaints of pain or 
discomfort. However, clinically, both maxillary central incisors exhibited continuous negative 
response to thermal sensitivity tests. Palatally, maxillary right central incisor showed a dull, dark 
discolouration (Figure 7c.1.2). Digital periapical radiograph displayed asymmetric development of 
maxillary central incisors. In comparison to the contralateral maxillary left central incisor, maxillary 
right central incisor showed arrested root development indicative of pulp necrosis. These 
additional symptoms allowed diagnosis of pulp necrosis in maxillary right central incisor and 
endodontic treatment was planned. Access to the coronal fragment of maxillary right central 




was noted and irrigated with 0.05% sodium hypochlorite. The working length of the fragment was 
determined to be 11mm. Subsequently, complete drying of the canal using paper points 
(Absorbent points, Dentsply Maillefer, Tulsa, Oklahoma, USA) was obtained and the root 
fragment was filled with calcium hydroxide (Ultracal XS, Ultradent, South Jordan, Utah, USA). 
The access cavity was sealed with a glass ionomer cement (Ketac-Fil™ Plus Aplicap™, 3M™ 
Espe™, St.Paul, Minnesota, USA).  
Figure 7c.1.1: Maxillary right central 
incisor showing a root fracture between 
the middle third and apical third of the root 
Figure 7c.1.2: Clinical image of maxillary 
right central incisor showed a dull, dark 
discolouration 
One week later, calcium hydroxide in the root canal was removed by irrigation with 0.05% sodium 
hypochlorite and saline. The root canal was dried with paper points and obturated up to the 
fracture line with Biodentine™. Palatal restoration of the access opening was done with composite 
resin (A2 shade, Clearfil™, Kuraray, New York, USA) in the same visit (Figure 7c.1.3). Clinical 
and radiographic follow-up after 6 and 12 months indicated healing at the fracture site (Figure 
7c.1.4). Radiographic healing was defined by absence of pathologic radiolucencies, absence of 
diastasis and continuous periodontal ligament. Clinically, there was no difference between both 
maxillary central incisors (Figure 7c.1.5). Both teeth were negative to percussion and the patient 
did not report any discomfort or pain. Despite the continued negative response to thermal 
sensitivity tests, maxillary left central incisor was perceived to be vital as indicated from the 
continued root development seen radiographically. 
 Figure 7c.1.3: Immediate 
post-operative radiograph  
Figure 7c.1.4: 
Radiographic follow-up 
after 12 months 
Figure 7c.1.5: Clinical 
comparison of maxillary                                                                                                                                      
central incisors 
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A 10 year old Caucasian male was referred to the dental hospital by his orthodontist for treatment 
of root fracture with respect to maxillary right central incisor. Anamnesis revealed that the patient 
was medically fit. Dental anamnesis showed that the trauma incident happened 1 week before 
when the patient had a collision injury during sports. On the day of the trauma, the general dental 
practitioner had prescribed antibiotics (amoxicilline). After clinical examination, maxillary central 
incisors showed slightly increased mobility. Maxillary left central incisor responded positively to 
thermal sensitivity tests while maxillary right central incisor reacted negatively. The gingiva around 
the maxillary right central incisor was swollen and palpation induced pus secretion from the 
sulcus. The gingiva around the maxillary left central incisor was discoloured due to infection and 
the patient demonstrated bad oral hygiene (Figure 7c.2.1). Radiographically, maxillary right 
central incisor showed a mid-root fracture (Figure 7c.2.2).  
Figure 7c.2.1: The gingiva around maxillary 
left central incisor showing discolouration due 
to infection 
Figure 7c.2.2: Radiographically, maxillary 
right central incisor showing mid-root fracture 
 
A semi-flexible splint from maxillary right lateral incisor to maxillary left lateral incisor was placed 
with orthodontic wire (0.16/0.22 inch) (3M, Unitek, Diegem, Belgium) and composite resin to 
stabilize both maxillary central incisors. Repositioning of the coronal fragment was not possible 
anymore. In the same appointment, endodontic management of maxillary right central incisor was 
planned. and access to the root canal was obtained using a high speed bur and followed by 
irrigation with 0.05% sodium hypochlorite and saline in order to remove the necrotic pulp tissue. 
Subsequently, complete drying of the root fragment was obtained using paper points. The coronal 
root fragment was filled with calcium hydroxide up to the fracture line for two weeks and the 
access opening was sealed with glass ionomer cement. Radiographically, calcium hydroxide 





In the next appointment, after 1 week, the disappearance of the gingival swelling with respect to 
maxillary right central incisor was observed in the clinical examination but there was no 
improvement in the oral hygiene (Figure 7c.2.4). Maxillary left central incisor showed delayed 
response to thermal sensitivity test but no other symptoms of necrosis was observed. 
Radiographically, there were no changes in comparison to the previous appointment. Two weeks 
later, in the next appointment, calcium hydroxide was removed by means of 0.05% sodium 
hypochlorite and saline irrigation. A complete dry root fragment was obtained by using paper 
points. The coronal root fragment was then obturated up to the fracture line using Biodentine™ 
(Figure 7c.2.5). Palatal restoration of the access opening was done with composite resin in the 
same visit. The semi-flexible splint was removed and the thermal sensitivity tests were performed 
on maxillary left central incisor and responded positively. Both maxillary central incisors had no 
pathologic mobility and the patient did not report any pain or discomfort. 
Five weeks later, the teeth remained asymptomatic with clinical examination revealing complete 
healing of the gingiva and maxillary left central incisor responded positively to thermal sensitivity. 
Periapical digital radiographs showed absence of pathological observations.  Remnants of 
calcium hydroxide between the root fragments can be seen but are expected to resorb. The 
periodontal ligament runs closely and continuously indicating a positive healing process (Figure 
7c.2.6).  
   
Figure 7c.2.3: Radiographically, calcium hydroxide extrusion observed between the fractured 
root segments 
Figure 7c.2.4: Disappearance of the gingival swelling with respect to maxillary right central incisor 
Figure 7c.2.5: Obturation of the coronal root fragment using Biodentine™ 
Figure 7c.2.6: Radiographically, healing of maxillary right central incisor observed 
Two months after splint removal and permanent obturation of maxillary right central incisor, 
clinical examination revealed both teeth to be asymptomatic. Two periapical digital radiographs 




were taken with different exposure angles (15 degrees positive and negative angulation). Both 
the radiographic images indicated normal healing of the root fracture. At the height of the root 
fracture line, a small constriction of the periodontal ligament is observed and it could be indicative 
of connective tissue interposition (Figure 7c.2.7 and 7c.2.8) After 24 months follow-up, the patient 
shows completely asymptomatic teeth with healthy gingiva and better oral hygiene. The teeth 
were also radiographically asymptomatic (Figure 7c.2.9 and 7c.2.10). 
 
Figure 7c.2.7 & Figure 7c.2.8: Constriction of the periodontal ligament at the height of the root 
fracture line from two different exposure angles 
Figure 7c.2.9: Clinically, complete healing of maxillary central incisors after 24 months 
Figure 7c.2.10: Radiographically, complete healing observed after 24 months 
Patient three 
An 8 years old Caucasian male was referred to the dental hospital from a general dental practice 
for treatment of maxillary left central incisor with a fistula. Medical history of the patient revealed 
negative relevance. Clinically, no mobility was observed and the tooth responded negatively to 
thermal vitality tests. Radiographically, a clear radiolucency was seen in the root canal and a 
broad open apex was present. Unilateral (mesial) mid-root fracture was diagnosed (Figure 
7c.3.1). Endodontic treatment of maxillary left central incisor was planned and access to the root 
canal was obtained during the same appointment using a high speed bur and necrotic pulp system 
with little pus was confirmed. Subsequently, the root fragment was irrigated with 0.05% sodium 
hypochlorite and saline in order to remove the necrotic pulp tissue. The canal was entirely dried 
using paper points (working length 16mm) and Ledermix paste (demeclocycline hydrochloride 
and triamcinolone acetonide) was placed in the canal and the access opening was sealed with a 
sterile cotton pellet and glass ionomer cement (Figure 7c.3.2). One week later, the fistula 
disappeared with healing of the periodontium. The tooth was asymptomatic and there was a 
complete absence of pain sensation after percussion tests (longitudinal and buccopalatal). At this 




appointment, ledermix was removed by means of saline and 0.05% sodium hypochlorite irrigation. 
A complete dry root canal was obtained using paper points. Subsequently, the coronal root 
fragment was completely obturated using Biodentine™ (Figure 7c.3.3). The access cavity was 
then sealed with composite resin in the same visit. Follow-up sessions were planned after 3, 6, 9, 
12 and 18 months. During all the follow-up visits, the tooth remained asymptomatic with no 
mobility and percussion as well as palpation tests were negative. Radiographically, after 3 
months, signs of hard tissue formation within the canal were visible (Figure 7c.3.4) and after 6 
months the formation of a periodontal ligament around the apical zone became clear (Figure 
7c.3.5). While the maxillary right central incisor is maturing with a full root formation, the maxillary 
left central incisor remained stable. After 18 months, the mesial broken piece of root is still 
presented and surrounded by a clear periodontal ligament. Radiographic follow-up at 9, 12 and 




Figure 7c.3.1: Unilateral mid-root fracture of maxillary left central incisor 
Figure 7c.3.2: Root canal obturated with ledermix paste 
Figure 7c.3.3: Obturation of the coronal root fragment using Biodentine™ 






Figure 7c.3.5: Formation of a periodontal ligament around the apical zone after 6 months  
Figure 7c.3.6: Radiographic follow-up after 9 months 
Figure 7c.3.7: Radiographic follow-up after 12 months 
Figure 7c.3.8: Radiographic follow-up after 18 months 
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Shortly after trauma, the initial pulp sensitivity tests often show negative results. A negative result 
does not necessarily indicate necrosis, but rather a transitory lack of pulp response, because the 
pulp will often return to normal vitality after a period of time (Fagundes Ddos et al., 2014). Hence, 
while diagnosing a traumatized teeth for pulp necrosis, additional symptoms such as subjective 
complaints of pain, swelling/abscess, pus discharge, fistula and radiographically arrested root 
development should be considered before final diagnosis. Maxillary left central incisor (Case 1 
and case 2) showed a transitory lack of pulpal response but as no additional symptoms were 
noticed, the teeth were followed up closely and the teeth regained vitality after a period of time. 
Elimination of microorganisms from the root canal system determines the full success of 
endodontic therapy, particularly in cases of pulp necrosis and peri-radicular lesions.(Martens et 
al., 2015) In the afore-mentioned cases, calcium hydroxide (maximum of two weeks) or Ledermix 
paste (demeclocycline and triamcinolone acetonide) was used as an short term intra-canal 
dressing based on the severity of the infection.  
Root fracture healing can be classified according to the criteria listed by Andreasen & Hjörting-
Hansen as (i) healing with interposition of hard tissue; (ii) healing with interposition of bone and 
soft tissue (PDL) between the fragments; (iii) healing with interposition of soft tissue (PDL) and 
(iv) no healing.(Cvek et al., 2002, Andreasen & Hjorting-Hansen, 1967) In the cases reported 
here, Case 1 presented healing with interposition of bone and soft tissue (PDL) between the 
healing fragments. Case 2 demonstrated healing with interposition of connective tissue whereas 
case 3 exhibited healing with interposition of bone and soft tissue between the fragments. The 
prognosis and type of healing of the affected tooth is influenced by several factors, such as age 
of the patient, stage of root formation (apical closure), degree of dislocation of the coronal 
fragment, mobility of the coronal fragment, optimal repositioning of the dislocated fragments and 
width of diastasis between the fragment.(Caliskan & Pehlivan, 1996, Bornstein et al., 2009) On 
the other hand, fracture type, treatment delay, splinting, type of splinting and duration of fixation 
are not significantly related to healing.(Cvek et al., 2002) 
Calcium silicate-based materials are hydraulic self-setting materials with intrinsic bioactive 
properties. Biodentine™ and MTA are rich in calcium compounds and an increase in calcium ion 
concentration is known to aid hard-tissue formation. When used as an obturation material, the 
amount of calcium ions released as well as the depth of incorporation into human root canal 




long-term calcium ion release offers advantages similar to the use of calcium hydroxide 
(alkalinizing the environment, preventing inflammatory root resorption, anti-bacterial effect) 
without the drawbacks of calcium hydroxide (need for multiple scheduled visits and susceptibility 
to fracture in immature teeth).(Roig et al., 2011) Along with calcium and silicon, intertubular 
diffusion of carbonate occurred from Biodentine™ into dentine, leading to the formation of the 
“mineral infiltration zone”.(Atmeh et al., 2012) The latter indicates that the dentine-Biodentine™ 
interface is highly dynamic and interactive.(Rajasekharan et al., 2014)  
Permanent restoration of the access opening with composite resin was achieved in the same visit 
after obturation with Biodentine™ in all the three cases. However, Biodentine™ could also be 
used as a temporary filling material for up to 6 months when necessary.(Koubi et al., 2013) When 
a composite resin has to be bonded to Biodentine™, self-etch adhesive systems showed better 
shear bond strength compared to etch and rinse adhesive systems, and the highest bond strength 
value was obtained for two-step self-etch adhesive at a 24-hour period.(Odabas et al., 2013) The 
possibility to place a composite resin restoration in the same visit is particularly useful when 
multiple visits cannot be planned for restoration of the teeth such as in patients indicated for 
treatment under general anaesthesia.  
Discolouration of endodontically treated teeth is either a result of materials ingressing into dentinal 
tubules or by material remnants in the pulp chamber, which get darker over time and is transmitted 
through the hard tissues.(Lenherr et al., 2012) None of the cases reported here, showed tooth 
discolouration after treatment with Biodentine™. This is in accordance to previous literature where 
Biodentine™ has been reported to demonstrate increased colour stability,(Valles et al., 2015) 
thereby warranting its use in aesthetically sensitive areas.(Martens et al., 2015) It is very common 
for dental trauma to occur in the anterior region and specifically in the adolescent age group. 
Considering aesthetics to be an important factor in the oral health related quality of life of 
adolescents, the use of Biodentine™ as the endodontic material of choice following dental trauma 
is profitable. The use of Biodentine™ in the treatment of mid-root fractures is not a routine 
application and to the knowledge of the authors not published yet. However, this series of 3 cases 
clearly show the afore-mentioned advantages of Biodentine™ resulting in an obvious healing at 










Mid-root fractures have been known to have poor prognosis because of the lack of understanding 
of the biological concept. However, with the advent of recently introduced biocompatible materials 
with superior physical properties and absence of discolouration have opened the horizons of 
treatment options available in the management of mid-root fractures. Biodentine™ demonstrated 
the ability to find a stable equilibrium in the healing process following treatment of infection at the 




































































































A modified or newly developed bioactive material inspired from the existing one can be used if it 
is proved to  be  as  good  or  can  overcome  the  weakness  of  its predecessor. Indeed, MTA 
was modified successfully from Portland cement and has got global attention. As a consequence, 
it became a material of daily use in dental practice. Biodentine™ which is synthesized purely in 
laboratory has undergone a few changes in composition and particle size resulting in better 
physical, mechanical and biological properties compared to ProRoot® MTA. All previous studies 
have analysed either the powder form of the material or the set material or both. The present 
study is the first to analyse the setting reaction of tricalcium silicate based cements over different 
time intervals even after the final setting time using XRD and FT-IR spectroscopy techniques. 
Analysing the material over different time intervals helps us to identify the different intermediate 
crystalline phases that are formed during and after the setting reaction.  
Despite the other components in the composition of tricalcium silicate cements, calcium, silicon 
and the radiopacifier used are of utmost importance. The beneficial effect of calcium has been 
emphasized repeatedly in the literature and will be discussed here in detail in the following 
paragraphs. Silicon ions are clinically relevant as they have been reported to promote osteoblast 
proliferation and gene expression by involvement in metabolism, collagen synthesis, bone 
mineralization, and connective tissue cross-linking (Shie et al., 2012). Silicon enhances the rate 
of new bone growth and induce remineralisation of demineralized dentin when released from 
bioactive materials (Hung et al., 2013). Silicon is also known to trigger the formation of an apatite 
layer on the cement surface (Gandolfi et al., 2010). Bismuth oxide used in ProRoot® MTA is 
reported to retard hydration, prolong setting time, increase porosity, induce discoloration and 
reduce durability.  Bismuth oxide is also reported to exhibit toxicity towards human dental pulp 
and periodontal ligament cells. An efficient alternative for Bismuth oxide is zirconium oxide used 
in Biodentine™ and Medcem MTA®. Zirconium oxide is bioinert, biocompatible and does not 
induce discolouration (Li and Coleman, 2014).  
One important finding of the present XRD study was that the tricalcium silicate identified in MTA 
and Biodentine™ were of two different forms. The tricalcium silicate in MTA was mentioned in the 
powder diffraction files as the one with chemical composition closest to that of alite from Portland 
cement whereas the tricalcium silicate in Biodentine™ as mentioned before was purely 
synthesized in the laboratory. The setting reaction of tricalcium silicate cements differs over a long 




2010). The presence of moisture in the surrounding was evaluated and established to be a 
confounding factor in the formation of calcium hydroxide in ProRoot® MTA.   
TSCs  are  rich  in  calcium compounds,  which  is  converted  to  calcium  hydroxide  in aqueous 
solution. It has been established through previous studies that TSCs release calcium hydroxide 
during their setting reaction and that it may have an influence on the regenerative potential of 
these cements (Goncalves et. al. 2010). TSCs are advantageous over traditional calcium 
hydroxide preparations in terms of its structural stability and sealing ability, since calcium 
hydroxide preparations show a high degree of dissolution and lack sealability. The dissociation of 
calcium and hydroxyl ions increases the pH of the solution (Holland et. al. 1999) and promotes 
an unfavourable environment to bacterial growth (Estrela et. al. 2000).  Alternatively,  an  increase  
in  the  pH  and calcium  ion  concentration  improves  biocompatibility (Ding et. al. 2008). Even 
though, the benefits of calcium hydroxide formation and its subsequent dissociation into calcium 
and hydroxide ions have been discussed adequately in the literature, no data exists on their 
quantification. Whether the benefits of calcium hydroxide are dose dependent remains unexplored 
in the clinical setting.   
The  reaction  between  released  calcium  ions  and physiological  carbonate  ions  forms  
insoluble  calcium carbonate which  precipitates  in  the  cracks,  pores,  voids  and margins of 
the cement and is conjectured to improve the sealing ability of the material (Li and Coleman, 
2014). Results of the present study revealed that Biodentine™ released more calcium ions than 
ProRoot® MTA and Medcem MTA® irrespective of the exposed surface area, volume and pH of 
the surrounding. Though this would seem advantageous considering the above mentioned 
benefits of calcium hydroxide and its dissociation. Higher concentration of calcium ions has also 
been associated with cytotoxicity (Maeno et al., 2005). It has long been known that calcium ion 
signals govern a host of vital cell functions and so are necessary for cell survival. However, it has 
also been postulated that extracellular calcium ion overload, or perturbation of intracellular 
calcium ion compartmentalization, can cause cytotoxicity and trigger either apoptotic or necrotic 
cell death (Orrenius et al., 2003). 
The behaviour of osteoblasts is significantly influenced by chemical nature and physical 
characteristics of the substratum on which the cells are cultured. Apart from the chemistry of the 
material substrate, numerous studies demonstrate the importance and the role played by the 
surface physical properties and microstructure on which cells adhere and grow (Montanaro et al., 
2002). A number of studies using MG63 cells suggest that cell growth and attachment are 




profile) in the range of 3–6 µm is able to cause significant effects on cell adhesion, growth and 
differentiation. In the present study, the Ra values of Biodentine™, Medcem MTA® and ProRoot® 
MTA were 1.52 µm, 2.45 µm and 3.20 µm respectively. This low Ra value could perhaps be the 
reason for not detecting a significant effect of surface topography on the cytotoxicity of materials 
tested in the present study. To conclude, surface roughness was in the order of ProRoot MTA > 
Medcem MTA® > Biodentine™. All the TSCs tested were well-tolerated by the cells despite an 
initially high cytotoxicity owing to increased pH. When using unextracted samples, cell viability 
was significantly higher in Medcem MTA® than Biodentine™ (p < 0.05). Cytotoxicity was dose 
dependent and also extraction of the materials after overnight soaking in medium increased cell 
viability.  
Similarly, the clinical trial in carious deciduous molars requiring pulpotomy could not detect a 
significant difference between Biodentine™, ProRoot® MTA and Tempophore after 18 months 
follow-up. However, longer follow-up of the present study could have yielded a different result 
considering the variation in the radiographic success of the three materials compared. While most 
of the authors agree unanimously for scoring a tooth clinically as a success, there have been 
different opinions regarding the grading a tooth as a radiographic success. Internal root 
resorption, dentine bridge formation and pulp canal obliteration have been the subject of 
controversy.  
Not every pathological finding in a primary tooth requires intervention since primary tooth survival 
or the permanent successor may not necessarily be affected. The criteria for evaluating success 
or failure are also dependent on the objective of performing a pulpotomy on the primary teeth with 
caries exposure (40). As mentioned previously in the introduction section, we considered 
pulpotomy to be a procedure that helps retain the treated tooth in a functional state (mastication, 
phonation, swallowing and aesthetics) so that it may fulfil its role as a useful component of the 
primary and young permanent dentition. In the present study we did not consider non-perforated 
internal root resorption as a failure. Even pulp canal obliteration and dentine bridge formation was 
not considered as a failure. Only grade three and four of the Zurn and Seale scale (Zurn & Seale, 
2008) was considered as failure.  
While we compared the compositional, physical, biological and clinical aspects of the three TSC’s, 
another important factor to be considered is the cost the material. Financially, a box of ProRoot 
MTA® (5 sachets of 1g each) cost approximately 300 euros. A box of Biodentine™ (15 capsules 
of 0.7g each) costs around 200 euros. Medcem MTA® on the other hand costs around 200 euros 




but on the other hand, the cost for the dental practitioner depends on the treatment performed 
and how many grams of cement is needed for the treatment provided. As per manufacturer’s 
instructions, ProRoot MTA® could only be used for 5 patients irrespective of the amount (grams) 
needed for the treatment as the material has to kept in sealed packaging prior to use. Although, 
it is not uncommon for dental practitioners to preserve opened sachets in air-tight containers for 
future use. In this manner, a single sachet of MTA could be used for 4-5 treatments. Biodentine™ 
could also be used only for 15 patients as it is only available in pre-packaged capsules. From the 
practitioner’s point of view, this is one of the biggest disadvantages of this material as a lot of 
biomaterial is wasted when used for a minor therapy. Medcem MTA® would in this case be the 
best option as the practitioner can dose the necessary amount of cement needed and 
manufacturer claims 7 grams of powder to be sufficient for 40 to 60 dental applications. These 
comparisons need to be interpreted with caution as the price of the product varies with respect to 
the quantity purchased and the amount and manner of usage is dependent on the practitioner. 
Also, comparison of the price of the product in terms of per gram of powder would be unfair to 
Biodentine™, which requires a separate mixing liquid unlike sterile water in the case of ProRoot 
MTA® and Medcem MTA®. 
Thus to summarize, Biodentine has finer particle size and different kind of tricalcium silicate 
cement compared to ProRoot MTA® and Medcem MTA®. Also, In ProRoot® white MTA, calcium 
hydroxide formation was detected only when the set cement samples were stored in water 
whereas in Biodentine™ and Medcem MTA®, calcium hydroxide formation was observed in 
samples stored in 100% relative humidity at 37oC or in water. Furthermore, Biodentine™ released 
more calcium ions than ProRoot® MTA and Medcem MTA® irrespective of the exposed surface 
area, volume and pH of the environment. On the other hand, Biodentine™ was cytotoxic when 
unextracted but after extraction in medium Biodentine™ showed better biocompatibility. In the 
clinical study of pulpotomy, no significant difference between Biodentine™, ProRoot® MTA and 
Medcem MTA® in the clinical and radiographic success rates. 
Limitations of the present work 
In Chapter 1, due to the very limited clinical articles published on Biodentine™, it was not possible 
to perform a methodological assessment of the clinical articles included in the review. As the 
review was aimed to summarize physical and biological characteristics, a systematic review was 
not feasible despite using a systematic search strategy to eliminate inclusion bias. In Chapter 3, 
calcium hydroxide formation was analysed by XRD and FT-IR techniques. Using these methods, 




formation was not possible. In Chapter 4, limitations of both the studies can be found in the 
clinical relevance of the methodology being used. The calcium release of the cements were 
evaluated following immersion in distilled deionized water, acidic, neutral or alkaline buffer. Even 
though, this is a standard methodology used in previous studies, the cement samples are exposed 
to the environment only after their initial setting time. This is in contrast to the clinical setting where 
TSCs come in contact with the tissues even before their initial setting time. The same limitation 
was observed in Chapter 5, where the cement samples were brought into contact with the 
medium and cells after their initial setting time. Moreover, the efficiency of the MTT test being 
used to quantify cytotoxicity of tricalcium silicate based cements has been controversial. In 
Chapter 6, periapical radiograph procedures at six month follow-up was laborious and impossible 
using film holding devices in young patients with fear and /or anxiety. This resulted in some cases 
where the pre-operative and follow-up x-rays could not be taken with the same angulation.  In the 
present study, although all treated patients were Belgian (Flemish) residents, the fluoride 
background of each patient could not be assessed owing to the considerable amount of immigrant 
patients included in the study. Also, blinding the operator was impossible in this trial as each 
material had different methods of mixing and condensation. Blinding the evaluator for the 
radiographic examination was not fail proof as the difference in radiopacity of each material was 
conspicuous to experienced examiners who were familiar with all the three pulpotomy agents. 
Follow-up loss increased gradually over time, with only 69 teeth (46 patients) of the initial 81 teeth 
(58 patients) available for follow-up at 18 months. However, the follow-up loss was only 15% 
compared to the 30% accounted for during sample size calculation but the follow-up loss was not 



























































































Broad relevance of the work 
Since two decades, calcium silicate cements are widely used within dentistry. The development 
and global use of bioceramics has increased substantially due to their biocompatibility bioactivity. 
Most of them are improvements of the well-known Portland cement used in the clinker industry. 
Analysis of the composition of any newly developed cement is aimed at understanding the 
benefits of each element in the chemical formulation. 
Within this thesis, newly developed tricalcium silicate cements were analysed at the 
compositional, physical, biological and clinical level. The role of each element during and after 
the setting reaction may affect the biological characteristics such as the interaction of cements 
with surrounding tissues. Understanding outcomes of the interaction between a dental material 
and surrounding tissue is important not only in terms of biocompatibility but also of the potential 
for the material to modulate the response of the tissue. Correlation between the physical and 
biological characteristics assessed and the clinical efficacy would help the researcher to improve 
the chemical formulation leading to better cements which can be used in the everyday practice of 
dentists.  
The results of the present study have helped the investigators to move forward towards the 
development of a newer tricalcium silicate cement with better properties without losing the 
advantages offered by the currently available cements. Additionally, the successful use of 
Biodentine™ in certain clinical procedures in paediatric patients (especially cases of endodontics 
and dental traumatology) have been established in the present research.  
From this thesis it became obvious that Biodentine™ synthesized from pure tricalcium silicate 
cement is at least a valuable alternative to the well know tricalcium silicate cements and has some 
superior properties compared to other tricalcium silicate cements. They can be used in a wide 
range of applications in children suffering from deep caries or after dental trauma. In all the cases 
longer vitality or maintaining the teeth for a longer period in the oral environment is obtained. This 
is of utmost importance during childhood and adolescence.   
Thus the broad relevance of the work is that,  
1. The laboratory results contribute into more understanding of the role of some 





2. Changes in composition lead to better physical properties that solve some drawbacks of  
MTA products based on Portland cements 














































































Despite, the enhanced superior physical, biological and clinical properties of Biodentine™, there 
is still scope for improvement and an ideal tricalcium silicate cement for use in dentistry remains 
a distant objective. Much has to be explored regarding the clinical outcomes of TSCs studied and 
the underlying relationship with the physico-chemical processes. The goals of this thesis have 
been achieved but has raised more questions than answers. Further research should be carried 
out in the following direction. 
1. To understand the role of extra- and intracellular calcium in mineralization with specific 
relation to quantification of the effect. Recently developed TSCs aim at higher calcium 
release but if the increased calcium release would be beneficial is yet to be researched.  
2. The optimum pH and calcium ion release that would result in decreased cytotoxicity and 
increased as well as rapid mineralization is to be evaluated.  
3. To evaluate the effect of Ca/Si ratio and to find the most favourable ratio.  
4. Unravelling the underlying molecular mechanism of mineralization and revascularization 
would help develop a new biomaterial with the aim of inducing revascularization.  
5. Inclusion of targeted drug delivery systems within the biomaterial to elicit the required 































































































Nowadays the use of bioceramics especially calcium silicate cements are common in endodontics 
and dental traumatology. Even though, numerous commercially available TSCs are present, the 
major difference between these cements lie in the modification of cement formulation, alternative 
radiopacifiers, introduction of additives and minimizing particle size. However, it was Biodentine™ 
that induced major changes to the composition without altering the advantages offered by 
ProRoot® MTA. 
Within this doctoral thesis the following aims of the study were postulated: 
1. To analyse the composition and setting of three TSCs. 
2. To monitor calcium hydroxide formation and effect of surface area or pH on calcium ion release 
in three TSCs. 
3. To evaluate the cytotoxicity of three TSCs on fibroblasts and osteoblasts. 
4. To assess the clinical and radiographic success of Biodentine™ in various paediatric clinical 
applications. 
Chapter 1 provides a very detailed narrative review of the available literature comparing 
Biodentine™ and other tricalcium silicate based cements with respect to composition, physical 
and biological properties. In addition, the potential clinical applications and outcomes have also 
been summarized. From the review, it could be concluded that Biodentine™ would be an efficient 
alternative to Mineral Trioxide Aggregate to be used in a variety of clinical applications. With this 
data as baseline information, studies were designed to obtain a more detailed insight into the 
other unexplored characteristics of Biodentine™.  
Chapter 3 deals with the analysis of composition and calcium hydroxide formation. ProRoot® MTA 
consisted of bismuth oxide but Biodentine™ on the other hand contained zirconium oxide as 
radiopacifier. Another important finding from the XRD analysis was the different forms of tricalcium 
silicate present in the composition of ProRoot® MTA, Medcem MTA® and Biodentine™. The 
tricalcium silicate cement present in ProRoot® MTA and Medcem MTA® was ascribed to the 
Powder Diffraction File (PDF) number 42-551. This tricalcium silicate is a solid solution containing 
Mg and Al and is called alite. In the clinker it consists of monoclinic form. On the contrary, the 
tricalcium silicate cement in Biodentine™ was ascribed to the Powder Diffraction File (PDF) 
number 31-301. This tricalcium silicate cement is free of Mg and Al and is of the triclinic form. 




In ProRoot® MTA, the particle size varied from 1 to 30 µm and similar particle sizes were observed 
for Medcem MTA® (maximum diameter = 30 µm). In contrast, the Biodentine™ particles were 
smaller (maximum diameter = 10 µm).  
The secondary aim of this section was to evaluate the formation of calcium hydroxide when stored 
at both 100% relative humidity and in water. Calcium hydroxide was formed during the setting 
reaction of all three cements. In ProRoot® white MTA, calcium hydroxide formation was detected 
only when the set cement samples were stored in water whereas in Biodentine™ and Medcem 
MTA®, calcium hydroxide formation was observed in samples stored in 100% relative humidity at 
37oC or in water. However, these analyses detect only the formation and not the release of 
calcium hydroxide. Also, quantification of calcium hydroxide was not possible.  
This resulted in the objective of chapter 4, where the main objective was to quantify calcium ion 
release from the TSCs studied in distilled water. Calcium ions released from tricalcium silicate 
cements are known to promote nucleation and growth of mineralized tissue when in contact with 
the pulp. Knowledge of the effect of environmental pH on calcium release helps the clinician to 
regulate environmental pH to an optimum level. Four groups with different exposed surface area 
and volume were evaluated to check the effect of size on calcium ion release. ∆pH and calcium 
ion release at each measured time interval were dependent on the exposed surface area, 
whereas long-term calcium release was dependent on the volume of the TSC studied. All the 
TSCs studied were of alkaline nature. As a secondary objective, three different pH buffers viz. 
acidic, neutral and alkaline were used to evaluate the effect of calcium ion release as a function 
of pH. All the TSCs released more calcium ions in the acidic solution when compared to the 
neutral solution which was in turn more than in the alkaline solution. In both the studies, 
Biodentine™ released more calcium ions than ProRoot® MTA and Medcem MTA® irrespective of 
the exposed surface area, volume and pH of the environment. ∆pH and calcium ion release are 
important factors that determine cytotoxicity. It was assumed from these results that rise in pH 
would lead to increased cytotoxicity and hence Biodentine™ would result in decreased cell 
viability.  
To confirm this hypothesis, in chapter 5, the cytotoxicity of the three TSCs studied was compared 
by direct contact, extract cytotoxicity and cell adhesion. Additionally, factors know to influence 
cytotoxicity such as surface roughness and surface composition were also evaluated. The results 
of the cytotoxicity tests revealed that Biodentine™ was indeed cytotoxic when unextracted but 
after extraction in medium Biodentine™ showed high biocompatibility and resulted in increased 




Medcem MTA® > Biodentine™. The high correlation observed between the results of extract 
cytotoxicity and cell adhesion could suggest that the results of the cytotoxicity profiles of the 
cements analysed were more dependent on the surface chemistry of the cement rather than the 
surface topography of the sample itself.  
Theoretically, increased calcium ion release would result in liquefaction necrosis, inflammation 
and immediate recruitment of inflammatory cells. Consequently, rapid mineralization and dentine 
bridge formation could be expected. Whether the calcium ion release and cytotoxicity of 
Biodentine™ had any clinical significance was evaluated in chapter 6. A randomized control trial 
in 81 carious deciduous molars requiring pulpotomy was performed with either Biodentine™, 
ProRoot® MTA or Tempophore. After 18 months follow-up, clinical success (radiographic success 
in parenthesis) was 95.24% (94.4%), 100% (90.9%) and 95.65% (82.4%) in the Biodentine™, 
ProRoot® MTA and Tempophore™ groups respectively, but the difference was not significant. 
Furthermore, the other clinical applications of Biodentine™ were explored in chapter 7. Trauma 
of immature permanent teeth with open apex is a frequent occurrence and always poses a clinical 
challenge. The cases demonstrated possible alternative endodontic therapy that could provide 
equally satisfying clinical results in cases where revascularisation/ regenerative endodontic 
treatment is not a viable option. In another case series, Biodentine™ demonstrated the ability to 































































































De ontwikkeling en het gebruik van bioceramics vooral (tri-)calciumsilicaat cementen  (TCS’s) is 
de voorbije decennia enorm toegenomen vooral binnen de endodontologie en de dentale 
traumatologie. Hoewel talrijke commercieel verkrijgbare TSCs aanwezig zijn gebaseerd op 
Portland cement liggen de belangrijkste verschilpunten tussen deze cementen bij het verschil in 
cementsamenstelling, het gebruik van alternatieve radiopacifiers, de introductie van additieven 
en het minimaliseren van de partikelgrootte. Het was echter met de meer zuivere productie van 
Biodentine, niet gebaseerd op Portland cement, dat de grootste verandering in de samenstelling 
geïnduceerd werd zonder de voordelen van ProRoot MTA te verliezen. 
In dit proefschrift werden de volgende doelstellingen gepostuleerd: 
1. Analyse van de samenstelling en de uitharding van drie TSC's . 
2. Monitoring  van de calcium hydroxide vorming en het effect van de oppervlakte of pH op 
calciumionen vrijlating van drie TSC's. 
3. Evaluatie van de cytotoxiciteit van drie TSC's op fibroblasten en osteoblasten. 
4. Evaluatie van het  klinisch en radiologisch succes van Biodentine in diverse klinische 
toepassingen binnen de kindertandheelkunde. 
 
Hoofdstuk 1 geeft een zeer gedetailleerd overzicht van de beschikbare literatuur. Hierbij wordt 
Biodentine vergeleken met andere op tricalciumsilicaat gebaseerde cementen met betrekking tot 
de samenstelling, de fysische en biologische eigenschappen. Bovendien zijn de mogelijke 
klinische toepassingen en resultaten eveneens samengevat. Uit dit overzicht kan worden 
geconcludeerd dat Biodentine een efficiënt alternatief is  voor Mineral Trioxide Aggregate voor 
gebruik in diverse klinische toepassingen. Met deze gegevens als basisinformatie werden diverse 
studieprotocollen uitgewerkt om een meer gedetailleerd inzicht in de andere onontgonnen 
kenmerken en/of toepassingen van Biodentine te verkrijgen. 
 
In hoofdstuk 3 wordt de samenstelling van de 3 gekozen TSC’s en de vorming van calcium 
hydroxide bestudeerd. ProRoot MTA bevat bismuthoxide terwijl Biodentine en Medcem MTA  
zirkoniumoxide bevat als radiopacifier. Een andere belangrijke bevinding uit de XRD analyse was 
de verschillende vorm van het tricalciumsilicaat in de samenstelling van ProRoot MTA, Medcem 




werd toegeschreven aan de Poeder Diffractie File (PDF) nummer 42-551. Dit tricalciumsilicaat is 
een solide oplossing met Mg en Al en wordt ook alite genoemd en is van  monokliene vorm   Dit 
in tegenstelling tot het tricalciumsilicaat cement in Biodentine dat werd toegeschreven aan de 
Poeder Diffractie File (PDF) nummer 31-301. Dit tricalciumsilicaat cement is vrij van Mg en Al en 
is van trikliene vorm. Uit SEM analyse van de poeder component bleek dat bij ProRoot MTA en 
Medcem MTA, de partikelgrootte varieerde van 1 tot 30 µm en bij Biodentine daarentegen waren 
de partikels opvallend kleiner (maximale diameter = 10 pm). 
 
Met betrekking tot de vorming van calciumhydroxide werd deze bestudeerd  na bewaring bij zowel 
100% relatieve vochtigheid als in water. Calciumhydroxide werd gevormd tijdens de 
verhardingsreactie van alle drie cementen. In ProRoot witte MTA en Medcem MTA werd 
calciumhydroxide vorming pas ontdekt toen de uitgeharde monsters werden opgeslagen in het 
water terwijl in Biodentine calciumhydroxide vorming eveneens  werd waargenomen in monsters 
die opgeslagen waren in 100% relatieve vochtigheid bij 37 °C of in het water. Deze analyses 
detecteren echter alleen de aanwezigheid van calciumhydroxide maar geven geen informatie 
over het afgifteprofiel. Kwantificering van calciumhydroxide was via de gebruikte technieken niet 
mogelijk. 
 
De gevonden resultaten hebben tot hoofdstuk 4 geleid, waarbij het belangrijkste doel was om 
de calciumionenvrijlating te kwantificeren van de TSC's in gedestilleerd water. Inzicht in deze 
vrijlating is van belang gezien calciumionen nucleatie en groei van gemineraliseerde weefsel bij 
contact met het pulpaweefsel bevorderen. Vier groepen met verschillende blootgestelde 
oppervlakte en volume werden geëvalueerd om te controleren op het effect van grootte op 
calcium ion release. ∆pH en calcium ion release op elk tijdsinterval gemeten waren afhankelijk 
van de blootgestelde oppervlakte, terwijl op lange termijn calcium release afhankelijk was van het 
volume van de bestudeerde TSC. Alle onderzochte TSCs  waren van alkalische aard. Als 
secundaire doelstelling werden drie verschillende pH buffers ( zuur, neutraal en basisch) gebruikt 
voor het evalueren van het effect van calcium ion release als functie van de pH. Alle TSCs stelden 
meer  calciumionen vrij in de zure oplossing in vergelijking met de neutrale oplossing waarin op 
zijn beurt  meer vrijgesteld werd dan in het alkalisch milieu. In beide studies stelde Biodentine 
meer calciumionen vrij dan ProRoot MTA en Medcem MTA ongeacht de blootgestelde 
oppervlakte, het volume en de pH van het milieu. ∆pH en calcium ion vrijlating zijn belangrijke 




stijging van de pH tot verhoogde cytotoxiciteit zou kunnen leiden en bijgevolg dat Biodentine een 
verminderde cell viabiliteit zou kunnen veroorzaken.  
Om dit te bevestigen werd in hoofdstuk 5, de cytotoxiciteit van de drie TSCs bestudeerd door 
direct contact, extract cytotoxiciteit en cel adhesie. Bovendien werden factoren die cytotoxiciteit 
zou kunnen beïnvloeden zoals oppervlakteruwheid en oppervlak samenstelling eveneens 
beoordeeld. De resultaten van deze studie bevestigden dat Biodentine ‘unextracted’ inderdaad 
cytotoxisch was  maar na extractie in medium vertoonde Biodentine een hoge biocompatibiliteit 
en resulteerde dat in verhoogde viabiliteit van de cellen, hechting en proliferatie. 
Oppervlakteruwheid was in de volgorde van ProRoot MTA > Medcem MTA > Biodentine. De hoge 
correlatie waargenomen tussen de resultaten van extract cytotoxiciteit en cel adhesie zou er op 
kunnen duiden dat de resultaten van de profielen van de cytotoxiciteit van het geanalyseerde 
cement meer afhankelijk waren van de oppervlakte chemie van het cement in plaats van de 
oppervlakte topografie van het monster zelf.  
Theoretisch zou grotere calciumionen afgifte leiden tot vluggere liquefactie necrose, ontsteking 
en onmiddellijke rekrutering van ontstekingscellen. Bijgevolg kunnen ook  snelle mineralisatie en 
dentine brugvorming worden verwacht. Of de calciumionen vrijlating en cytotoxiciteit van 
Biodentine ook een klinische betekenis had werd geëvalueerd in hoofdstuk 6. Een 
gerandomiseerde control trial in 41 carieuze melkmolaren  die een pulpotomie vereisten werd 
uitgevoerd in 81 tanden met ofwel Biodentine, ProRoot MTA of Tempophore. Na 18 maanden 
follow-up was het klinisch succes (radiografisch succes haakjes) respectievelijk 95,24% (94,4%), 
100% (90,9%) en 95,65% (82,4%) voor de Biodentine, ProRoot MTA en Tempophore. De 
verschillen waren echter niet significant. 
Parallell met het laboratorium onderzoek  werden enkele andere klinische toepassingen van 
Biodentine long-term opgevolgd en beschreven in hoofdstuk 7. Trauma van onvolgroeide 
definitieve tanden met open apex komt frequent voor bij kinderen en vormt altijd een klinische 
uitdaging. In de  beschreven case studies (pulpotomie, necrotische pulpa en wortelfracturen) werd 
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